MAKINDO MEDICINEClinical textbook for medical students and doctors
For education and revision only. Not for individual patient decisions or prescribing. Verify current NICE/BNF, MHRA safety advice and local clinical protocols before clinical use. Clinical safety and terms.
Textbook chapter
MAKINDO MEDICINE · Drug monographsClinical textbook

Drug monographs A–Z

One monograph for each of 243 medicines, arranged A–Z, in a standard layout: Mechanism, Uses, Dosing, Side effects, Interactions and Special advice, then the chapters that discuss the drug and the BNF link.

Educational summaries, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Always check dose, indication, interactions and monitoring in the BNF and local guidelines before prescribing.

A

Abatacept

BNF entry for Abatacept · Stand-alone drug page

Mechanism

Fusion protein that blocks CD28 co-stimulation of T cells (selective T-cell co-stimulation modulator).

Uses

Rheumatoid arthritis and psoriatic or juvenile idiopathic arthritis after inadequate response to DMARDs.

Dosing

Side effects

Infections (including respiratory), headache, nausea; rarely serious infection, malignancy, infusion reactions.

Interactions

Avoid with other biologics (TNF inhibitors); live vaccines contraindicated.

Special advice

Screen for TB and hepatitis B before starting; avoid live vaccines; interrupt in serious infection.

More from the textbook: uses, cautions and other points

Where it is discussed

Abiraterone

BNF entry for Abiraterone · Stand-alone drug page

Mechanism

Irreversible inhibitor of CYP17, blocking androgen synthesis in testes, adrenals and tumour.

Uses

Metastatic castration-resistant or high-risk hormone-sensitive prostate cancer, with prednisolone.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Hypertension, hypokalaemia, fluid retention, liver enzyme rise, fatigue.

Interactions

CYP2D6 substrates (e.g. metoprolol) levels rise; strong CYP3A4 inducers lower levels.

Special advice

Always given with a corticosteroid to limit mineralocorticoid excess; monitor BP, potassium, fluid status and LFTs.

More from the textbook: uses, cautions and other points

Where it is discussed

Acarbose

BNF entry for Acarbose · Stand-alone drug page

Mechanism

Alpha-glucosidase inhibitor that slows intestinal carbohydrate digestion and post-meal glucose rise.

Uses

Type 2 diabetes as an add-on.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Flatulence, abdominal bloating, diarrhoea; rarely raised liver enzymes.

Interactions

Hypoglycaemia from other agents must be treated with glucose, not sucrose.

Special advice

Take with the first mouthful of food; treat hypoglycaemia with glucose; avoid in inflammatory bowel disease or intestinal obstruction.

More from the textbook: uses, cautions and other points

Where it is discussed

Acetazolamide

BNF entry for Acetazolamide · Stand-alone drug page

Mechanism

Carbonic anhydrase inhibitor: reduces bicarbonate reabsorption (diuresis, metabolic acidosis) and aqueous and CSF production.

Uses

Glaucoma, idiopathic intracranial hypertension, altitude sickness, some epilepsies, oedema.

Dosing

1 more dose entries from the chapters
  • Acetazolamide (e.g. 125 mg twice daily) — carbonic anhydrase inhibitor (causes a metabolic acidosis that stimulates breathing) — for rapid ascent or previous AMS; side effects — tingling, polyuria, altered taste of fizzy drinks; avoid in sulfonamide allergy.
    Emergency Medicine: Environmental emergencies

Side effects

Paraesthesia, tinnitus, polyuria, metabolic acidosis, hypokalaemia, renal stones, drowsiness.

Interactions

Salicylates increase toxicity; lithium levels may fall; carbamazepine and phenytoin levels may rise.

Special advice

Sulfonamide-related, so caution in sulfonamide allergy; monitor electrolytes and acid-base on long-term use.

More from the textbook: uses, cautions and other points

Where it is discussed

Acetylcysteine

BNF entry for Acetylcysteine · Stand-alone drug page

Mechanism

Replenishes glutathione and supplies cysteine to detoxify the paracetamol metabolite NAPQI.

Uses

Paracetamol overdose; also used as a mucolytic.

Dosing

Quick reference (Makindo topics site)

Main useAdult doseKey pearl / caution
Paracetamol overdose150 mg/kg → 50 mg/kg → 100 mg/kg IVRecheck ALT, INR and paracetamol level at the end.

Source: Makindo topics, Emergency Drugs Collection (topic 1479). Editorial draft, not clinically signed off; doses are as written there. Check BNF and local policy before prescribing.

This drug is not covered by a dedicated section of the textbook chapters.

Side effects

Anaphylactoid reactions (rash, bronchospasm, hypotension), nausea, flushing, vomiting.

Interactions

No major interactions in standard use.

Special advice

Give by IV infusion on a protocol; anaphylactoid reactions are rate-related; treat by pausing infusion, not stopping permanently; recheck INR, ALT and paracetamol level.

Aciclovir

BNF entry for Aciclovir · Stand-alone drug page

Mechanism

Guanosine analogue phosphorylated by viral thymidine kinase; inhibits viral DNA polymerase.

Uses

Herpes simplex (including encephalitis), varicella-zoster, prophylaxis in immunosuppression.

Dosing

  • Encephalitis | IV aciclovir 10 mg/kg 8-hourly within 6 hours; MRI; LP
    Neurology: Emergencies
  • IV aciclovir 10 mg/kg every 8 hours , started within 6 hours of arrival if encephalitis is suspected and results are not available. Use ideal body weight in obesity. Keep the patient well hydrated (it can cause kidney injury).
    Neurology: Emergencies
  • First episode - aciclovir 400 mg three times daily for 5 days (or valaciclovir 500 mg twice daily), started within 5 days or while new lesions are forming; saline bathing, analgesia, topical lidocaine; catheter (suprapubic) for retention.
    Gynaecology: Sexual health
  • Recurrences - self-care; short "episodic" courses (e.g. aciclovir 800 mg three times daily for 2 days).
    Gynaecology: Sexual health
4 more dose entries from the chapters
  • Oral antiviral within 72 hours of rash onset - aciclovir 800 mg five times a day , valaciclovir or famciclovir for 7 days - for people over 50 , immunocompromised, non-truncal involvement (face, neck, limbs, genitals), moderate or severe pain or rash, or eczema. Ophthalmic and immunocompromised patients - treat even after 72 …
    Dermatology: Skin infections and infestations
  • Aciclovir / valaciclovir / famciclovir | Shingles within 72 hours (aciclovir 800 mg five times daily, 7 days); severe HSV; eczema herpeticum.
    Dermatology: Skin infections and infestations
  • Oral antiviral within 72 hours of rash onset (or later if new lesions are still appearing) - aciclovir 800 mg five times daily or valaciclovir 1 g three times daily for 7 days.
    Ophthalmology: Red emergencies
  • Aciclovir 800 mg five times daily or valaciclovir 1 g three times daily | Herpes zoster ophthalmicus for 7 days, within 72 hours.
    Ophthalmology: Red emergencies

Side effects

Nausea, headache; IV: phlebitis, renal impairment (crystal nephropathy), neurological effects.

Interactions

Nephrotoxic drugs and probenecid increase levels; mycophenolate levels may rise.

Special advice

Hydrate well with IV use; dose-adjust in renal impairment; give early in suspected herpes encephalitis.

More from the textbook: uses, cautions and other points

Where it is discussed

Activated charcoal

BNF entry for Activated charcoal · Stand-alone drug page

Mechanism

Adsorbs ingested toxins in the gut to reduce absorption.

Uses

Selected recent overdoses of adsorbable agents.

Dosing

Quick reference (Makindo topics site)

Main useAdult doseKey pearl / caution
Selected recent overdose50 g PO onceAvoid if aspiration risk, corrosives, iron or lithium.

Source: Makindo topics, Emergency Drugs Collection (topic 1479). Editorial draft, not clinically signed off; doses are as written there. Check BNF and local policy before prescribing.

This drug is not covered by a dedicated section of the textbook chapters.

Side effects

Vomiting, constipation, black stools; aspiration if airway not protected.

Interactions

May reduce absorption of other oral drugs given at the same time.

Special advice

Only if the airway is protected and the agent is adsorbed; ineffective for iron, lithium, alcohols and corrosives; take toxicology advice.

Adalimumab

BNF entry for Adalimumab · Stand-alone drug page

Mechanism

Monoclonal antibody that binds and neutralises TNF-alpha.

Uses

Rheumatoid, psoriatic and juvenile arthritis, ankylosing spondylitis, Crohn disease, ulcerative colitis, psoriasis, uveitis.

Dosing

Side effects

Infections, injection-site reactions, headache; reactivated TB, demyelination, lupus-like syndrome, heart failure worsening.

Interactions

Avoid with other biologics; live vaccines contraindicated; methotrexate reduces antibody formation.

Special advice

Screen for TB and hepatitis B; check varicella status; stop and seek advice during serious infection; avoid in moderate to severe heart failure.

More from the textbook: uses, cautions and other points

Where it is discussed

Adenosine

BNF entry for Adenosine · Stand-alone drug page

Mechanism

Activates A1 receptors, causing transient AV nodal block and interrupting re-entrant tachycardia.

Uses

Regular narrow-complex (AV re-entrant) SVT; diagnostic aid in flutter or broad-complex tachycardia.

Dosing

Quick reference (Makindo topics site)

Main useAdult doseKey pearl / caution
Regular narrow-complex SVT6 mg rapid IV → 12 mg → 18 mgAvoid in irregular wide-complex tachycardia; flush immediately.

Source: Makindo topics, Emergency Drugs Collection (topic 1479). Editorial draft, not clinically signed off; doses are as written there. Check BNF and local policy before prescribing.

This drug is not covered by a dedicated section of the textbook chapters.

Side effects

Flushing, chest tightness, dyspnoea, transient asystole or bradycardia, sense of doom.

Interactions

Dipyridamole and theophylline interact (potentiate or antagonise); carbamazepine prolongs block.

Special advice

Give by rapid bolus with a fast flush, with ECG recording; avoid in asthma, high-grade block and pre-excited AF; warn the patient of brief unpleasant symptoms.

Adrenaline

BNF entry for Adrenaline · Stand-alone drug page

Mechanism

Agonist at alpha and beta adrenoceptors: vasoconstriction, bronchodilation, increased cardiac output, mast-cell stabilisation.

Uses

Anaphylaxis, cardiac arrest, severe croup and asthma adjunct, shock (infusion), local anaesthetic additive.

Dosing

Quick reference (Makindo topics site)

Main useAdult doseKey pearl / caution
Anaphylaxis / cardiac arrestAnaphylaxis: 500 microg IM. Arrest: 1 mg IVDo not confuse 1:1,000 IM with 1:10,000 IV.

Source: Makindo topics, Emergency Drugs Collection (topic 1479). Editorial draft, not clinically signed off; doses are as written there. Check BNF and local policy before prescribing.

  • Shockable rhythms — VF and pulseless VT — defibrillate, CPR for 2 minutes; adrenaline 1 mg and amiodarone 300 mg after the 3rd shock.
    Cardiology: Presentations
  • Non-shockable rhythms — PEA and asystole — CPR, adrenaline 1 mg as soon as possible, then every 3–5 minutes.
    Cardiology: Presentations
  • Cardiac arrest - VF/pulseless VT | CPR; shock; 2 minutes CPR between shocks; adrenaline 1 mg and amiodarone 300 mg after the 3rd shock
    Cardiology: Cardiology Emergencies
  • Cardiac arrest - PEA/asystole | CPR; adrenaline 1 mg as soon as possible, then every 3–5 minutes; find a reversible cause
    Cardiology: Cardiology Emergencies
4 more dose entries from the chapters

Side effects

Tachycardia, hypertension, arrhythmias, anxiety, tremor, hyperglycaemia, hypokalaemia.

Interactions

Beta-blockers may blunt effect and cause hypertension; tricyclics and MAOIs potentiate pressor effect.

Special advice

Anaphylaxis is IM into the anterolateral thigh; do not mix 1 in 1000 and 1 in 10,000 strengths; repeat as the protocol says.

More from the textbook: uses, cautions and other points

Where it is discussed

Alendronic acid

BNF entry for Alendronic acid · Stand-alone drug page

Mechanism

Bisphosphonate that binds bone and inhibits osteoclast-mediated resorption.

Uses

Osteoporosis prevention and treatment, including glucocorticoid-induced.

Dosing

  • Treat bone pain from active Paget's with a bisphosphonate. Zoledronic acid 5 mg IV as a single infusion is most effective, often giving years of remission. Ensure vitamin D is replete beforehand. Alternatives are oral risedronate or alendronate.
    Endocrinology: Bone Medicine
  • Alendronic acid (osteoporosis) | 70 mg orally once weekly. Take fasting with a full glass of water and stay upright for 30 minutes. Avoid if CrCl is below 35 mL/min or with oesophageal disease.
    Endocrinology: Bone Medicine

Side effects

Oesophagitis, dyspepsia, abdominal pain, musculoskeletal pain; rarely osteonecrosis of the jaw and atypical femoral fracture.

Interactions

Calcium, antacids and food reduce absorption; NSAIDs increase GI irritation.

Special advice

Take fasting with a full glass of water, upright for at least 30 minutes; correct calcium and vitamin D; dental check; avoid if oesophageal disorder or low eGFR below threshold.

More from the textbook: uses, cautions and other points
  • Avoid if eGFR is under 35 (alendronate). Review the need after 5 years (consider a drug holiday).
    Endocrine: Anatomy Physiology and Pharmacology
  • Alendronic acid | Upright 30 min with water; oesophagitis, jaw osteonecrosis, atypical femoral fractures.
    Endocrine: Anatomy Physiology and Pharmacology
  • High risk: Oral bisphosphonate (alendronic acid or risedronate) first-line. If not tolerated, unsuitable or ineffective: IV zoledronic acid or denosumab. HRT is an option in younger postmenopausal women.
    Endocrinology: Bone Medicine
  • 💡 Clinical Pearl: Many "treatment failures" on alendronate are actually taking it wrongly - with breakfast, tea or calcium. Check how the patient takes it before switching.
    Endocrinology: Bone Medicine
  • Bisphosphonates — alendronic acid (weekly), risedronate, IV zoledronic acid (yearly) | Bind hydroxyapatite; taken up by osteoclasts → inhibit farnesyl pyrophosphate synthase → osteoclast apoptosis — anti-resorptive | Oral — take fasting with a full glass of water, sit upright 30 minutes ( oesophagitis ); avoid if eGFR under 35; …
    Rheumatology Anatomy Physiology Pharmacology
  • Thigh pain and transverse femoral fracture after 8 years of alendronate | Atypical femoral fracture
    Rheumatology Anatomy Physiology Pharmacology

Where it is discussed

Alfuzosin

BNF entry for Alfuzosin · Stand-alone drug page

Mechanism

Selective alpha-1 blocker relaxing prostatic and bladder-neck smooth muscle.

Uses

Lower urinary tract symptoms of benign prostatic hyperplasia.

Dosing

  • Medicines : Drug Use Side effects Alpha-blocker (tamsulosin, alfuzosin) First-line for moderate to severe voiding symptoms; works in days Postural hypotension , dizziness, retrograde ejaculation, floppy iris syndrome (tell the eye surgeon before cataract surgery) 5-alpha reductase inhibitor (finasteride, dutasteride) Enlarged …
    Surgey: Urology

Side effects

Dizziness, postural hypotension, headache, fatigue; intraoperative floppy iris syndrome.

Interactions

Additive hypotension with other antihypertensives and PDE5 inhibitors; avoid with strong CYP3A4 inhibitors.

Special advice

First-dose hypotension, so take at night; tell eye surgeon before cataract surgery.

More from the textbook: uses, cautions and other points
  • Alpha-blockers (tamsulosin, alfuzosin, doxazosin) - relax prostate and bladder-neck muscle; work in days; postural hypotension (first dose, falls), dizziness, retrograde ejaculation , floppy iris syndrome during cataract surgery (tell the eye surgeon).
    Renal: Anatomy, Physiology and Pharmacology
  • Alpha-blocker (tamsulosin, alfuzosin) | First-line for moderate to severe voiding symptoms; works in days | Postural hypotension , dizziness, retrograde ejaculation, floppy iris syndrome (tell the eye surgeon before cataract surgery)
    Surgey: Urology

Where it is discussed

Allopurinol

BNF entry for Allopurinol · Stand-alone drug page

Mechanism

Xanthine oxidase inhibitor reducing uric acid production.

Uses

Gout prevention, tumour lysis prophylaxis, recurrent urate stones.

Dosing

  • Azathioprine 2–2.5 mg/kg/day | Maintenance; check TPMT first; FBC and LFT monitoring; pancreatitis, marrow suppression, skin cancer; avoid allopurinol.
    Gastroenterology: Inflammatory Bowel Disease
  • Allopurinol — xanthine oxidase inhibitor — start low (100 mg daily, lower in CKD) and titrate monthly to a target urate under 360 µmol/L (under 300 if tophi or frequent flares); risks — rash, severe cutaneous reactions (SJS/TEN, DRESS — HLA-B*58:01 in Han Chinese, Thai and Korean ancestry); azathioprine and mercaptopurine …
    Rheumatology Anatomy Physiology Pharmacology
  • Allopurinol starting low (e.g. 50–100 mg daily given CKD) and titrating monthly to urate under 360 µmol/L .
    Rheumatology Anatomy Physiology Pharmacology
  • Allopurinol (xanthine oxidase inhibitor) - first-line ; start low (100 mg daily, or lower in CKD) and increase monthly (by 100 mg) according to urate until at target (often 300–600 mg or more; up to 900 mg); check urate monthly while titrating.
    Rheumatology: Crystal arthritis, osteoarthritis and soft tissue pain
2 more dose entries from the chapters

Side effects

Rash, GI upset; rarely severe hypersensitivity (HLA-B*58:01), hepatitis, marrow suppression.

Interactions

Azathioprine and mercaptopurine toxicity rises (reduce doses); ampicillin rash more likely.

Special advice

Do not start in an acute attack; start low and titrate with serum urate; cover with colchicine or NSAID when starting; stop at first rash.

More from the textbook: uses, cautions and other points

Where it is discussed

Alteplase

BNF entry for Alteplase · Stand-alone drug page

Mechanism

Recombinant tissue plasminogen activator converting plasminogen to plasmin to lyse fibrin.

Uses

Acute ischaemic stroke, STEMI where PCI unavailable, massive PE with haemodynamic compromise.

Dosing

1 more dose entries from the chapters

Side effects

Bleeding (including intracranial), hypotension, angioedema, reperfusion arrhythmias.

Interactions

Anticoagulants and antiplatelets increase bleeding risk.

Special advice

Strict eligibility and contraindication checks; time window matters; neurological and BP monitoring afterwards.

More from the textbook: uses, cautions and other points

Where it is discussed

Amikacin

BNF entry for Amikacin · Stand-alone drug page

Mechanism

Aminoglycoside binding the 30S ribosome to inhibit bacterial protein synthesis.

Uses

Serious Gram-negative infections resistant to gentamicin; some mycobacterial infections.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Nephrotoxicity, ototoxicity (vestibular and cochlear), neuromuscular blockade.

Interactions

Loop diuretics, ciclosporin and other nephrotoxic agents increase toxicity; neuromuscular blockers potentiated.

Special advice

Monitor levels and renal function; adjust dose for renal impairment; avoid in myasthenia gravis.

More from the textbook: uses, cautions and other points
  • MAC: Rifampicin, ethambutol and azithromycin , continued for at least 12 months after cultures become negative. Amikacin (IV or nebulised) for severe or refractory disease.
    Respiratory: Infections
  • Aminoglycosides (gentamicin, amikacin, tobramycin) | Permanent cochlear (high-frequency hearing loss) and vestibular toxicity (gentamicin — oscillopsia, imbalance); risk with high or prolonged levels, renal impairment, loop diuretics; MT-RNR1 m.1555A>G carriers can go deaf after a single dose — monitor levels, shortest course, …
    ENT Anatomy Physiology
  • Aminoglycosides (gentamicin, amikacin, tobramycin) | Permanent hearing loss and balance loss (vestibular toxicity -"oscillopsia" and unsteadiness). Monitor levels; higher risk with the m.1555A>G mitochondrial variant (rapid genetic testing in neonatal units).
    ENT: Common Ear disorders
  • Protein synthesis -30S ribosome | Aminoglycosides (gentamicin, amikacin), tetracyclines (doxycycline)
    ID: How Infection Happens
  • Amikacin | As for gentamicin (different targets) | Ototoxicity, nephrotoxicity
    ID: How Infection Happens
  • Protein synthesis 30S | Aminoglycosides | Gentamicin, amikacin, tobramycin | Gram-negative, synergy in endocarditis; nephro- and ototoxic; concentration-dependent
    Microbiology: Diagnostic microbiology, antimicrobials and resistance

Where it is discussed

Amiloride

BNF entry for Amiloride · Stand-alone drug page

Mechanism

Epithelial sodium channel blocker in the distal tubule; potassium-sparing diuretic.

Uses

Adjunct to loop or thiazide diuretics to prevent hypokalaemia; heart failure; lithium-induced diabetes insipidus.

Dosing

Side effects

Hyperkalaemia, hyponatraemia, GI upset, rash.

Interactions

ACE inhibitors, ARBs, spironolactone and potassium supplements increase hyperkalaemia risk; lithium levels rise.

Special advice

Monitor potassium and renal function; avoid in hyperkalaemia and severe renal impairment.

More from the textbook: uses, cautions and other points

Where it is discussed

Amiodarone

BNF entry for Amiodarone · Stand-alone drug page

Mechanism

Class III antiarrhythmic prolonging repolarisation; also blocks sodium and calcium channels and beta receptors.

Uses

VT/VF, AF and flutter rhythm control, supraventricular tachycardias.

Dosing

Quick reference (Makindo topics site)

Main useAdult doseKey pearl / caution
VT / VF300 mg IV in arrest; 150 mg over 10 min for stable VTMonitor QT, BP, bradycardia.

Source: Makindo topics, Emergency Drugs Collection (topic 1479). Editorial draft, not clinically signed off; doses are as written there. Check BNF and local policy before prescribing.

4 more dose entries from the chapters

Side effects

Thyroid dysfunction, pulmonary fibrosis, hepatitis, photosensitivity, corneal deposits, bradycardia, QT prolongation, neuropathy.

Interactions

Raises levels of digoxin, warfarin and simvastatin; avoid other QT-prolonging drugs; additive bradycardia with beta-blockers and verapamil.

Special advice

Baseline then regular TFT, LFT, chest X-ray, ECG; sun protection; central IV line for infusions; very long half-life.

More from the textbook: uses, cautions and other points

Where it is discussed

Amitriptyline

BNF entry for Amitriptyline · Stand-alone drug page

Mechanism

Tricyclic antidepressant inhibiting serotonin and noradrenaline reuptake; strong antimuscarinic and antihistamine effects.

Uses

Neuropathic pain, migraine prophylaxis, depression, nocturnal enuresis.

Dosing

4 more dose entries from the chapters
  • Second line: Low-dose amitriptyline (10 mg at night, increasing to 30–50 mg; the ATLANTIS trial showed benefit in primary care); an SSRI if a tricyclic doesn't help.
    Gastroenterology: Bowel Disorders
  • Amitriptyline 10 mg at night, up to 30–50 mg | IBS second line; drowsiness, dry mouth.
    Gastroenterology: Bowel Disorders
  • Amitriptyline (and nortriptyline) - TCA; start low at night (10 mg); side effects - drowsiness, dry mouth, constipation, urinary retention, weight gain, postural hypotension, QT prolongation ; dangerous in overdose (arrhythmias, seizures); caution in older people and heart disease.
    Neurology: Anatomy, Physiology and Pharmacology
  • Amitriptyline 10 mg at night, increasing to 25–75 mg (off-label) - also helps sleep and tension-type headache.
    Neurology: Headache and Facial Pain

Side effects

Dry mouth, constipation, urinary retention, sedation, postural hypotension, weight gain, arrhythmias; dangerous in overdose.

Interactions

Serotonergic drugs and MAOIs risk serotonin syndrome; CYP2D6 inhibitors raise levels; additive sedation and antimuscarinic effects.

Special advice

Start low and increase gradually; caution in older people, cardiac disease and epilepsy; limit supply in suicide risk; avoid abrupt withdrawal.

More from the textbook: uses, cautions and other points

Where it is discussed

Amlodipine

BNF entry for Amlodipine · Stand-alone drug page

Mechanism

Dihydropyridine calcium channel blocker causing arterial vasodilation.

Uses

Hypertension, stable angina.

Dosing

1 more dose entries from the chapters
  • 1. An 86-year-old woman (CFS 6) is admitted after a fall. She takes: amlodipine 10 mg, ramipril 10 mg, indapamide, doxazosin, atorvastatin, aspirin 75 mg (no history of vascular disease), omeprazole 40 mg (started 6 years ago for dyspepsia), amitriptyline 25 mg (sleep), zopiclone, oxybutynin and gliclazide (HbA1c 49). Standing …
    Medicine of the older adult: .Prescribing and deprescribing in older people

Side effects

Ankle oedema, flushing, headache, palpitations, gum hyperplasia.

Interactions

Simvastatin dose cap; strong CYP3A4 inhibitors raise levels; additive hypotension.

Special advice

Oedema is dose-related and not responsive to diuretics; avoid in severe aortic stenosis and acute unstable angina.

More from the textbook: uses, cautions and other points

Where it is discussed

Amoxicillin

BNF entry for Amoxicillin · Stand-alone drug page

Mechanism

Aminopenicillin binding penicillin-binding proteins to inhibit bacterial cell-wall synthesis.

Uses

Respiratory, ENT, urinary and dental infections, H. pylori regimens, listeria.

Dosing

4 more dose entries from the chapters
  • Bacterial meningitis | Blood cultures; ceftriaxone 2 g IV (plus amoxicillin if Listeria risk) within 1 hour; dexamethasone
    Neurology: Emergencies
  • Add amoxicillin 2 g IV every 4 hours for Listeria risk: aged 60 or over, immunocompromised, pregnancy, diabetes or alcohol dependence.
    Neurology: Emergencies
  • IV antibiotics - e.g. ceftriaxone 80 mg/kg (cefotaxime plus amoxicillin under 3 months), per local policy.
    Paediatrics: Infections in children
  • Pregnancy, breastfeeding or doxycycline unsuitable - azithromycin 1 g then 500 mg daily for 2 days (or erythromycin, amoxicillin).
    Gynaecology: Sexual health

Side effects

Rash, diarrhoea, nausea; rarely severe hypersensitivity, C. difficile infection.

Interactions

Methotrexate toxicity risk; rash common in infectious mononucleosis; may increase warfarin effect.

Special advice

Check penicillin allergy history; adjust in renal impairment; broad-spectrum so consider C. difficile risk.

More from the textbook: uses, cautions and other points

Where it is discussed

Anastrozole

BNF entry for Anastrozole · Stand-alone drug page

Mechanism

Non-steroidal aromatase inhibitor lowering oestrogen synthesis.

Uses

Hormone receptor-positive breast cancer in postmenopausal women.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Hot flushes, arthralgia, bone loss, vaginal dryness, fatigue.

Interactions

Do not combine with tamoxifen or oestrogens.

Special advice

Baseline bone density and vitamin D/calcium advice; not for premenopausal women unless ovarian suppression.

More from the textbook: uses, cautions and other points
  • Chemoprevention (tamoxifen or anastrozole for women at moderate or high breast cancer risk; aspirin in Lynch syndrome).
    Oncology: Principles
  • Anastrozole / letrozole | Joint pain, osteoporosis (DEXA, bisphosphonate).
    Oncology: Principles
  • Anastrozole / letrozole | Postmenopausal ER-positive breast cancer; joint pain, bone loss; also prevention in high-risk women.
    Oncology: Breast and Gynae Cancers
  • Options for high-risk women - earlier and more frequent screening (annual MRI from 30 for BRCA carriers, with mammography from 40), chemoprevention (tamoxifen or raloxifene before menopause/after; anastrozole after menopause), risk-reducing mastectomy (reduces risk by about 90% or more) and risk-reducing salpingo-oophorectomy.
    Surgey: Breast and endocrine surgery
  • Risk management for moderate or high risk without a known variant - enhanced mammographic surveillance from 40 (annual), MRI in selected high-risk women, chemoprevention - tamoxifen (premenopausal) or anastrozole (postmenopausal) for 5 years.
    Clinical Genetics: Cancer genetics and inherited cardiovascular conditions

Where it is discussed

Apixaban

BNF entry for Apixaban · Stand-alone drug page

Mechanism

Direct factor Xa inhibitor.

Uses

Stroke prevention in non-valvular AF, treatment and prevention of VTE.

Dosing

4 more dose entries from the chapters

Side effects

Bleeding, anaemia, nausea; rarely hepatic injury.

Interactions

Strong CYP3A4 and P-gp inhibitors or inducers alter levels; avoid with other anticoagulants and caution with antiplatelets.

Special advice

Dose reduce by age, weight and renal function criteria; andexanet alfa is the reversal agent; avoid in mechanical valves and antiphospholipid syndrome.

More from the textbook: uses, cautions and other points

Where it is discussed

Aripiprazole

BNF entry for Aripiprazole · Stand-alone drug page

Mechanism

Partial agonist at dopamine D2 and serotonin 5-HT1A, antagonist at 5-HT2A.

Uses

Schizophrenia, mania in bipolar disorder, adjunct in depression.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Akathisia, insomnia, nausea, restlessness; low prolactin and metabolic effect compared with others; impulse-control problems.

Interactions

CYP2D6 and CYP3A4 inhibitors increase levels; inducers lower levels.

Special advice

Monitor weight, glucose and lipids; ask about impulsive behaviours such as gambling.

More from the textbook: uses, cautions and other points
  • Stop the drug if possible - recovery can take months. If an antipsychotic is essential, switch to one with lower risk (quetiapine, clozapine, aripiprazole).
    Neurology: Movement Disorders
  • Drugs for disabling tics: aripiprazole , clonidine or guanfacine (also helps ADHD), risperidone.
    Neurology: Movement Disorders
  • Tourette syndrome - multiple motor tics and at least one vocal tic for over a year, starting before 18; associated with ADHD, OCD and anxiety. Education, behavioural therapy (habit reversal, CBIT); medication (aripiprazole, clonidine) if severe.
    Paediatrics: Neurology, bones and joints in children
  • Severe or refractory - specialist services; antipsychotic augmentation (e.g. aripiprazole, risperidone); deep brain stimulation (research).
    Psychiatry: Anxiety, stress and somatic disorders
  • Behaviour that challenges - look for pain, illness, sensory overload or anxiety first; positive behaviour support; antipsychotics (risperidone or aripiprazole) only short term for severe aggression, with specialist monitoring.
    Psychiatry: Safeguarding
  • Risperidone / aripiprazole | Short-term for severe aggression in autism or learning disability (specialist); weight gain, metabolic monitoring, prolactin (risperidone); tics (aripiprazole).
    Psychiatry: Safeguarding

Where it is discussed

Aspirin

BNF entry for Aspirin · Stand-alone drug page

Mechanism

Irreversibly inhibits cyclooxygenase-1, reducing thromboxane A2 and platelet aggregation.

Uses

Secondary prevention in ischaemic heart disease and stroke, ACS, TIA, analgesia and antipyresis at higher doses.

Dosing

4 more dose entries from the chapters

Side effects

Dyspepsia, GI bleeding, bronchospasm in sensitive asthmatics, tinnitus in overdose; Reye syndrome in children.

Interactions

Anticoagulants, SSRIs and NSAIDs increase bleeding; interacts with ibuprofen antiplatelet effect.

Special advice

Avoid under 16 years; PPI cover for those at GI risk; do not start routine primary prevention in most older adults.

More from the textbook: uses, cautions and other points

Where it is discussed

Atenolol

BNF entry for Atenolol · Stand-alone drug page

Mechanism

Cardioselective (beta-1) adrenoceptor antagonist, water soluble.

Uses

Hypertension, angina, arrhythmia rate control, post-MI.

Dosing

Side effects

Bradycardia, fatigue, cold extremities, bronchospasm, masking of hypoglycaemia, sleep disturbance.

Interactions

Verapamil and diltiazem risk bradycardia or heart block; clonidine rebound hypertension if stopped first.

Special advice

Renally cleared so reduce dose in renal impairment; avoid abrupt withdrawal; caution in asthma and peripheral vascular disease.

More from the textbook: uses, cautions and other points

Where it is discussed

Atorvastatin

BNF entry for Atorvastatin · Stand-alone drug page

Mechanism

HMG-CoA reductase inhibitor lowering hepatic cholesterol synthesis and increasing LDL receptors.

Uses

Primary and secondary cardiovascular prevention, hypercholesterolaemia.

Dosing

4 more dose entries from the chapters

Side effects

Myalgia, raised ALT, GI upset; rarely myopathy, rhabdomyolysis, new-onset diabetes.

Interactions

Clarithromycin, azole antifungals and ciclosporin raise levels; grapefruit juice in large amounts; fibrates increase myopathy risk.

Special advice

Baseline lipids and LFT; report unexplained muscle pain; check CK if symptomatic; avoid in pregnancy.

More from the textbook: uses, cautions and other points
  • Clarithromycin and erythromycin - pause simvastatin and atorvastatin during the course.
    Endocrinology: Lipids and obesity
  • Grapefruit juice - simvastatin and atorvastatin.
    Endocrinology: Lipids and obesity
  • CK 12,000 and progressive weakness after stopping atorvastatin | Anti-HMGCR necrotising myopathy
    Neurology: Neuromuscular disease
  • 2. A 28-year-old woman with hypertension on ramipril and atorvastatin wants to become pregnant. Answer: Pre-conception medication review.
    Obstetrics
  • CK 8,000 persisting months after stopping atorvastatin | Anti-HMGCR necrotising myopathy
    Rheumatology: Connective tissue diseases
  • Interactions - clarithromycin and erythromycin are strong CYP3A4 inhibitors : simvastatin and atorvastatin (myopathy - pause the statin), warfarin , DOACs, colchicine (dangerous), theophylline, carbamazepine, ciclosporin and tacrolimus , some calcium channel blockers; azithromycin has fewer interactions.
    ID: How Infection Happens

Where it is discussed

Atropine

BNF entry for Atropine · Stand-alone drug page

Mechanism

Competitive muscarinic antagonist.

Uses

Symptomatic bradycardia, organophosphate and cholinergic poisoning, antimuscarinic premedication.

Dosing

Quick reference (Makindo topics site)

Main useAdult doseKey pearl / caution
Symptomatic bradycardia500 microg IV every 3–5 min (max 3 mg)May not work in high-grade block; prepare pacing.

Source: Makindo topics, Emergency Drugs Collection (topic 1479). Editorial draft, not clinically signed off; doses are as written there. Check BNF and local policy before prescribing.

This drug is not covered by a dedicated section of the textbook chapters.

Side effects

Dry mouth, blurred vision, tachycardia, urinary retention, confusion, hot dry skin.

Interactions

Additive antimuscarinic effects with tricyclics and antihistamines.

Special advice

May not work in high-grade or infranodal block (prepare pacing); caution in glaucoma and prostatic hypertrophy; in organophosphate poisoning large doses may be needed.

Azathioprine

BNF entry for Azathioprine · Stand-alone drug page

Mechanism

Prodrug of mercaptopurine; purine analogue inhibiting lymphocyte DNA synthesis.

Uses

Immunosuppression in transplantation, autoimmune disease, inflammatory bowel disease, vasculitis.

Dosing

  • Thiopurines - azathioprine (2–2.5 mg/kg/day) and mercaptopurine (1–1.5 mg/kg/day):
    Gastroenterology: Inflammatory Bowel Disease
  • Azathioprine 2–2.5 mg/kg/day | Maintenance; check TPMT first; FBC and LFT monitoring; pancreatitis, marrow suppression, skin cancer; avoid allopurinol.
    Gastroenterology: Inflammatory Bowel Disease
  • Prednisolone (e.g. 30–40 mg daily, then reducing), with azathioprine (1–2 mg/kg) added after about 2 weeks once bilirubin falls (check TPMT first).
    Gastroenterology: Liver disease
  • Immunosuppressants compatible with pregnancy — prednisolone (mostly inactivated by the placenta), hydroxychloroquine , azathioprine , sulfasalazine (with folic acid 5 mg), ciclosporin, tacrolimus, most anti-TNF drugs (certolizumab minimal transfer).
    Obstetrics
3 more dose entries from the chapters
  • … µmol/L (under 300 if tophi or frequent flares); risks — rash, severe cutaneous reactions (SJS/TEN, DRESS — HLA-B*58:01 in Han Chinese, Thai and Korean ancestry); azathioprine and mercaptopurine interaction (xanthine oxidase metabolises them — toxicity).
    Rheumatology Anatomy Physiology Pharmacology
  • 5. A 48-year-old man with chronic tophaceous gout has had flares despite allopurinol 300 mg for a year. His urate is 450 µmol/L. He has a kidney transplant and takes azathioprine. Answer: Uncontrolled gout with a dangerous drug interaction.
    Rheumatology: Crystal arthritis, osteoarthritis and soft tissue pain
  • Idiopathic, trauma, steroids, mumps and other viruses, autoimmune, scorpion venom, hypercalcaemia , hypertriglyceridaemia (often over 10 mmol/L), hypothermia, ERCP , drugs (azathioprine, valproate, thiazides, mesalazine, GLP-1 agonists and others), pancreatic cancer.
    Surgery: Acute abdomen and emergency general surgery

Side effects

Bone marrow suppression, nausea, hepatotoxicity, infection, skin cancer, pancreatitis.

Interactions

Allopurinol markedly raises toxicity (reduce dose to a quarter); warfarin effect reduced; live vaccines contraindicated.

Special advice

Check TPMT or NUDT15 before starting; regular FBC and LFT; sun protection; avoid in pregnancy unless benefit outweighs risk.

More from the textbook: uses, cautions and other points

Where it is discussed

Azithromycin

BNF entry for Azithromycin · Stand-alone drug page

Mechanism

Macrolide binding the 50S ribosome to inhibit protein synthesis.

Uses

Atypical pneumonia, chlamydia, some enteric and sexually transmitted infections, COPD exacerbation prophylaxis.

Dosing

Side effects

Nausea, diarrhoea, abdominal pain; QT prolongation, hearing loss, hepatotoxicity.

Interactions

Other QT-prolonging drugs; may raise levels of digoxin and ciclosporin.

Special advice

ECG caution in QT risk; long tissue half-life allows short courses; check for alternatives in pregnancy.

More from the textbook: uses, cautions and other points
  • Long-term macrolides (azithromycin) - anti-inflammatory and fewer exacerbations in bronchiectasis, CF and COPD (selected patients); check ECG (QT), hearing, LFTs, and exclude non-tuberculous mycobacteria first.
    Respiratory: Anatomy, Physiology and Pharmacology
  • Azithromycin (long-term) | Fewer exacerbations in bronchiectasis and COPD; ECG (QT), hearing, LFTs; exclude NTM.
    Respiratory: Anatomy, Physiology and Pharmacology
  • Three or more exacerbations a year: Consider long-term macrolide (azithromycin, after excluding NTM and checking QT) or nebulised antibiotics (colistin, gentamicin) if Pseudomonas is present.
    Respiratory: Airways Disease
  • Treatment: A macrolide (clarithromycin or azithromycin) if started within 3 weeks of cough onset - mainly to reduce spread rather than symptoms.
    Respiratory: Infections
  • MAC: Rifampicin, ethambutol and azithromycin , continued for at least 12 months after cultures become negative. Amikacin (IV or nebulised) for severe or refractory disease.
    Respiratory: Infections
  • Macrolide if within 21 days of cough onset (reduces spread, not symptoms) - azithromycin (under 1 month and others) or clarithromycin; co-trimoxazole if macrolides unsuitable.
    Paediatrics: Respiratory and heart problems in children

Where it is discussed

B

Baclofen

BNF entry for Baclofen · Stand-alone drug page

Mechanism

GABA-B agonist reducing spinal reflex activity.

Uses

Spasticity in multiple sclerosis and spinal cord disease.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Drowsiness, weakness, dizziness, confusion, hypotonia; abrupt withdrawal can cause seizures and hallucinations.

Interactions

Additive sedation with alcohol and CNS depressants; antihypertensives increase hypotension.

Special advice

Taper slowly; renally cleared so reduce dose in renal impairment; caution in epilepsy and in older people.

More from the textbook: uses, cautions and other points

Where it is discussed

Beclometasone

BNF entry for Beclometasone · Stand-alone drug page

Mechanism

Inhaled corticosteroid reducing airway inflammation by gene regulation.

Uses

Asthma maintenance and COPD (combination inhalers), allergic rhinitis.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Oral candidiasis, hoarseness; at high doses systemic steroid effects.

Interactions

CYP3A4 inhibitors may raise systemic exposure; additive with oral steroids.

Special advice

Rinse mouth and use spacer; check inhaler technique; step down to lowest effective dose; carry steroid card at high doses.

More from the textbook: uses, cautions and other points
  • Examples - beclometasone, budesonide, fluticasone (propionate and furoate), mometasone, ciclesonide. Doses are graded as low, moderate or high (devices aren't interchangeable dose-for-dose - prescribe by brand).
    Respiratory: Anatomy, Physiology and Pharmacology
  • ICS + LABA - budesonide–formoterol, beclometasone–formoterol, fluticasone–salmeterol, fluticasone furoate–vilanterol.
    Respiratory: Anatomy, Physiology and Pharmacology
  • Inhaled corticosteroid (beclometasone, budesonide, fluticasone) | Asthma preventer; spacer; monitor growth at higher doses.
    Paediatrics: Respiratory and heart problems in children
  • Intranasal corticosteroids (mometasone, fluticasone, beclometasone) — allergic rhinitis, nasal polyps , chronic rhinosinusitis — regular use, take days to work; technique — head forward, aim away from the septum (reduces nosebleeds and septal irritation); minimal systemic absorption with modern agents.
    ENT Anatomy Physiology
  • Intranasal corticosteroid - mometasone, fluticasone, beclometasone - the most effective treatment , especially for blockage. Takes days to work fully; use regularly through the season; teach technique (aim away from the septum).
    ENT: Common Nose and Throat disorders
  • Treatment - chlorhexidine mouthwash, benzydamine spray, topical steroids (e.g. hydrocortisone mucoadhesive buccal tablets, beclometasone inhaler sprayed onto ulcers).
    ENT: Common Nose and Throat disorders

Where it is discussed

Bendroflumethiazide

BNF entry for Bendroflumethiazide · Stand-alone drug page

Mechanism

Thiazide diuretic inhibiting sodium-chloride cotransport in the distal tubule.

Uses

Hypertension, mild oedema.

Dosing

  • 5. An 80-year-old woman started on carbamazepine for trigeminal neuralgia is brought in confused. Sodium 119 mmol/L. She also takes bendroflumethiazide and warfarin; her INR has fallen to 1.4. Answer: Carbamazepine-induced hyponatraemia (worsened by the thiazide) and enzyme induction lowering warfarin effect.
    Neurology: Anatomy, Physiology and Pharmacology
  • 5. A 70-year-old man on lithium was started on bendroflumethiazide for hypertension 2 weeks ago. He is confused and unsteady with a coarse tremor. Lithium level 2.1 mmol/L. Answer: Chronic lithium toxicity (thiazide interaction).
    Psychiatric emergencies
  • 4. A 75-year-old woman on lithium for 20 years is admitted with diarrhoea and vomiting for 3 days. She is confused with a coarse tremor and ataxia. Creatinine 210 (baseline 110). Lithium level 2.4 mmol/L. She takes ramipril and bendroflumethiazide. Answer: Lithium toxicity precipitated by dehydration, AKI and interacting drugs.
    Clinical pharmacology and prescribing: High-risk drugs, therapeutic drug monitoring, IV fluids and antimicrobial prescribing
  • Scenario. An 80-year-old on bendroflumethiazide is confused with Na⁺ 118 mmol/L that developed over 2 weeks. How fast can it be corrected? Answer: Chronic hyponatraemia - aim for no more than 10 mmol/L in 24 hours (8 if high risk) to avoid osmotic demyelination; give hypertonic saline only if severe symptoms (seizures, reduced …
    Physiology: Cells, tissues, homeostasis, fluids and acid–base balance

Side effects

Hyponatraemia, hypokalaemia, hyperuricaemia and gout, hyperglycaemia, postural hypotension, erectile dysfunction.

Interactions

NSAIDs reduce effect; lithium levels rise; digoxin toxicity with hypokalaemia.

Special advice

Monitor sodium, potassium and renal function; avoid in gout and severe renal impairment.

More from the textbook: uses, cautions and other points

Where it is discussed

Benzylpenicillin

BNF entry for Benzylpenicillin · Stand-alone drug page

Mechanism

Penicillin disrupting bacterial cell-wall synthesis.

Uses

Meningococcal disease, streptococcal and syphilis infections, serious sensitive infections.

Dosing

Side effects

Allergy and anaphylaxis, diarrhoea; high doses cause neurotoxicity and seizures in renal failure.

Interactions

Methotrexate toxicity; probenecid raises levels.

Special advice

Give urgently in suspected meningococcal disease if no allergy history of anaphylaxis; adjust in renal impairment.

More from the textbook: uses, cautions and other points
  • Bacterial meningitis - ceftriaxone (or cefotaxime) urgently, plus amoxicillin if Listeria is possible (over 60, immunocompromised, pregnant); dexamethasone with or just before the first antibiotic dose in adults with suspected bacterial meningitis; benzylpenicillin IM in the community for suspected meningococcal disease.
    Neurology: Anatomy, Physiology and Pharmacology
  • Before hospital: If meningococcal disease is suspected (non-blanching rash), give benzylpenicillin IM or IV - but do not delay transfer.
    Neurology: Emergencies
  • Benzylpenicillin Pre-hospital meningococcal disease | IM or IV if non-blanching rash, without delaying transfer.
    Neurology: Emergencies
  • Treatment: IV benzylpenicillin for 14 days (or procaine penicillin with probenecid); test for HIV.
    Neurology: Spine and Sleep Disorders
  • Benzylpenicillin IV 14 days | Neurosyphilis.
    Neurology: Spine and Sleep Disorders
  • Early-onset - IV benzylpenicillin with gentamicin , within 1 hour of the decision.
    Paediatrics: Neonatology

Where it is discussed

Betahistine

BNF entry for Betahistine · Stand-alone drug page

Mechanism

Histamine H3 antagonist and weak H1 agonist improving inner-ear microcirculation.

Uses

Meniere disease symptoms.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Nausea, headache, dyspepsia; rarely rash.

Interactions

Antihistamines may oppose effect.

Special advice

Caution in asthma, peptic ulcer and phaeochromocytoma; evidence of benefit is limited.

More from the textbook: uses, cautions and other points

Where it is discussed

Betamethasone

BNF entry for Betamethasone · Stand-alone drug page

Mechanism

Potent glucocorticoid with minimal mineralocorticoid activity.

Uses

Antenatal fetal lung maturation, inflammatory skin disease (topical), systemic inflammation.

Dosing

  • Antenatal corticosteroids - 24+0 to 33+6 weeks (consider from 22–23 weeks after discussion, and to 35+6 weeks): betamethasone 12 mg IM, two doses 24 hours apart (or dexamethasone). Reduce breathing problems, brain bleeds, NEC and death. Best effect 24 hours to 7 days after the first dose.
    Obstetrics: Complications
  • Betamethasone 12 mg IM, two doses 24 hours apart | Antenatal steroids 24+0–33+6 weeks (consider to 35+6); can raise maternal glucose (diabetes - adjust insulin).
    Obstetrics: Complications

Side effects

Systemic: hyperglycaemia, immunosuppression, mood effects, adrenal suppression, osteoporosis; topical: skin atrophy.

Interactions

CYP3A4 inducers lower effect; NSAIDs raise GI risk.

Special advice

Single antenatal courses are used for threatened preterm birth; long-term systemic use needs bone protection and steroid card.

More from the textbook: uses, cautions and other points
  • Antenatal corticosteroids (dexamethasone or betamethasone) speed lung maturation - offered for threatened preterm birth (from 24 weeks to 33+6 weeks, and considered up to 35+6 weeks).
    Respiratory: Anatomy, Physiology and Pharmacology
  • Topical steroid (e.g. betamethasone) | Pathological phimosis (BXO).
    Paediatrics: Gastroenterology and surgery in children
  • Antenatal corticosteroids (betamethasone or dexamethasone — IM, 2 doses) | Fetal lung maturation (also reduce IVH and NEC) — preterm birth expected between 24+0 and 33+6 weeks (consider from 22 weeks and to 35+6 — NICE NG25) | Transient maternal hyperglycaemia (adjust insulin in diabetes); best effect if birth within 7 days
    Obstetrics
  • Antenatal corticosteroids (betamethasone or dexamethasone — 2 IM doses).
    Obstetrics
  • Potent | Betamethasone valerate 0.1% (Betnovate), mometasone furoate 0.1% (Elocon) | Severe eczema, psoriasis on body, scalp
    Dermatology: Skin basics, eczema and psoriasis
  • Severe eczema - potent topical steroid (betamethasone valerate) for the body (not the face or neck; specialist advice under 12 months); short courses (up to 7–14 days for flares).
    Dermatology: Skin basics, eczema and psoriasis

Where it is discussed

Bisoprolol

BNF entry for Bisoprolol · Stand-alone drug page

Mechanism

Highly cardioselective beta-1 blocker.

Uses

Heart failure with reduced EF, hypertension, angina, AF rate control.

Dosing

3 more dose entries from the chapters

Side effects

Bradycardia, fatigue, cold extremities, bronchospasm, vivid dreams, impotence.

Interactions

Rate-limiting calcium channel blockers (verapamil, diltiazem) risk heart block; clonidine withdrawal rebound.

Special advice

Start low and titrate in heart failure when euvolaemic; avoid abrupt withdrawal; caution in asthma.

More from the textbook: uses, cautions and other points

Where it is discussed

Budesonide

BNF entry for Budesonide · Stand-alone drug page

Mechanism

Glucocorticoid with high first-pass hepatic metabolism, giving topical action.

Uses

Asthma (inhaled), Crohn disease and microscopic colitis (oral), nasal polyps.

Dosing

3 more dose entries from the chapters

Side effects

Inhaled: candidiasis, dysphonia; oral: lower systemic steroid effects than prednisolone but still possible.

Interactions

CYP3A4 inhibitors (ketoconazole, ritonavir) increase systemic exposure.

Special advice

Rinse mouth after inhalation; check technique; steroid-sparing but long courses still need monitoring.

More from the textbook: uses, cautions and other points
  • Examples - beclometasone, budesonide, fluticasone (propionate and furoate), mometasone, ciclesonide. Doses are graded as low, moderate or high (devices aren't interchangeable dose-for-dose - prescribe by brand).
    Respiratory: Anatomy, Physiology and Pharmacology
  • ICS + LABA - budesonide–formoterol, beclometasone–formoterol, fluticasone–salmeterol, fluticasone furoate–vilanterol.
    Respiratory: Anatomy, Physiology and Pharmacology
  • … SABA without inhaled steroid is linked to severe attacks and asthma deaths. Treatment is now built around a combined inhaled steroid plus formoterol inhaler (e.g. budesonide/formoterol). Formoterol works within minutes, so the same inhaler can be both the reliever and the preventer.
    Respiratory: Airways Disease
  • ICS/formoterol (e.g. budesonide/formoterol) Asthma AIR and MART | AIR: 1 inhalation as needed. Low-dose MART: 1 inhalation twice daily plus as needed; moderate-dose MART: 2 inhalations twice daily plus as needed. Check the licensed maximum daily inhalations.
    Respiratory: Airways Disease
  • Interactions - CYP3A4 inhibitors (ritonavir and cobicistat, itraconazole, clarithromycin) block breakdown of inhaled or nasal fluticasone and budesonide → Cushing's syndrome and adrenal suppression; enzyme inducers (rifampicin, carbamazepine, phenytoin) reduce steroid effect - double replacement doses may be needed.
    Endocrine: Anatomy Physiology and Pharmacology
  • Budesonide - high first-pass metabolism (fewer systemic effects) - mild ileocaecal Crohn's, microscopic colitis , mild UC (MMX formulation).
    Gastroenterology: Anatomy Physiology Pharmacology

Where it is discussed

Bumetanide

BNF entry for Bumetanide · Stand-alone drug page

Mechanism

Loop diuretic inhibiting the Na-K-2Cl cotransporter in the thick ascending limb.

Uses

Oedema from heart failure, cirrhosis and renal disease.

Dosing

3 more dose entries from the chapters

Side effects

Hypokalaemia, hyponatraemia, hypomagnesaemia, hypotension, ototoxicity, gout.

Interactions

Aminoglycosides increase ototoxicity; NSAIDs blunt effect; lithium levels rise; digoxin toxicity with low potassium.

Special advice

Monitor weight, electrolytes and renal function; potency about 40 times furosemide by weight.

More from the textbook: uses, cautions and other points
  • Furosemide / bumetanide | Loop diuretics; low K, Na, Mg; gout; ototoxicity.
    Cardiology: Anatomy Physiology and Pharmacology
  • Loop diuretics : Furosemide. Bumetanide. Act on the Na-K-2Cl cotransporter in the thick ascending limb of Henle. Effective for pulmonary and peripheral congestion. Can cause hypokalaemia, hyponatraemia, dehydration and renal dysfunction.
    Cardiology: Heart Failure › 2.16 💉 Diuretics in Heart Failure
  • Loop of Henle - thick ascending limb | Reabsorbs about 25% of sodium via NKCC2 ; impermeable to water (dilutes urine and builds the concentration gradient in the medulla); reabsorbs calcium and magnesium between cells | Loop diuretics (furosemide, bumetanide) | Bartter syndrome (like taking a loop diuretic)
    Renal: Anatomy, Physiology and Pharmacology
  • Loop - furosemide, bumetanide | Thick ascending limb - NKCC2 | Fluid overload - heart failure, pulmonary oedema, nephrotic syndrome, CKD; hypercalcaemia (after fluids) | Low K , low Na, low Mg , low Ca, alkalosis, dehydration and AKI , gout, hyperglycaemia; ototoxicity with fast high-dose IV
    Renal: Anatomy, Physiology and Pharmacology

Where it is discussed

Buprenorphine

BNF entry for Buprenorphine · Stand-alone drug page

Mechanism

Partial mu-opioid agonist with high receptor affinity and long duration.

Uses

Opioid dependence maintenance and chronic pain (transdermal).

Dosing

Side effects

Nausea, constipation, sedation, respiratory depression (ceiling effect), hepatitis with misuse.

Interactions

Other CNS depressants and benzodiazepines increase respiratory depression; precipitates withdrawal if started too early in full agonist users.

Special advice

Start only when in mild withdrawal; slow-release patches change dose only after several days; naloxone supply for community settings.

More from the textbook: uses, cautions and other points
  • Opioids - avoid morphine and codeine in advanced CKD (metabolites accumulate); oxycodone with caution; fentanyl, alfentanil and buprenorphine are safer.
    Renal: Chronic Kidney Disease
  • Pain - renally safe opioids (fentanyl, alfentanil, buprenorphine).
    Renal: Chronic Kidney Disease
  • eGFR under 30: Use oxycodone at reduced doses with longer intervals, or fentanyl or alfentanil (and buprenorphine). Seek specialist advice.
    Palliative: Symptoms Management
  • Fentanyl / buprenorphine patches | Stable pain; kidney failure; slow onset; heat increases absorption.
    Palliative: Symptoms Management
  • What it is: Withdrawal in a baby exposed in the womb to opioids (heroin, methadone, buprenorphine), benzodiazepines, or other drugs.
    Paediatrics: Neonatology
  • Substance misuse - opioid substitution (methadone, buprenorphine) safer than withdrawal; neonatal abstinence syndrome; safeguarding.
    Obstetrics: Medical Problems

Where it is discussed

Bupropion

BNF entry for Bupropion · Stand-alone drug page

Mechanism

Noradrenaline and dopamine reuptake inhibitor.

Uses

Smoking cessation (as aid) and depression in some regions.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Insomnia, dry mouth, headache, anxiety; seizure risk dose-related; hypertension.

Interactions

CYP2D6 inhibition raises levels of antidepressants, beta-blockers and antipsychotics; avoid with MAOIs.

Special advice

Contraindicated in epilepsy, eating disorders and abrupt alcohol or benzodiazepine withdrawal.

More from the textbook: uses, cautions and other points
  • Stop smoking - the only measure (with oxygen in selected people) proven to slow decline and improve survival. Offer behavioural support plus drugs (NRT, varenicline where available, bupropion). E-cigarettes are a less harmful alternative to smoking.
    Respiratory: Airways Disease
  • Smoking cessation | NRT (combination patch plus short-acting form), varenicline where available, bupropion; with behavioural support.
    Respiratory: Airways Disease
  • Seizures (lower threshold) | Tramadol , bupropion, theophylline , ciprofloxacin and other quinolones, high-dose penicillins and carbapenems, clozapine and other antipsychotics, TCAs, lithium toxicity, isoniazid (pyridoxine), local anaesthetic toxicity, withdrawal of alcohol, benzodiazepines, baclofen or antiseizure drugs; drugs …
    Neurology: Anatomy, Physiology and Pharmacology
  • Look for provoking causes: Hypoglycaemia, hyponatraemia, hypocalcaemia, alcohol or benzodiazepine withdrawal, drugs (tramadol, bupropion, recreational drugs), head injury, infection.
    Neurology: Emergencies
  • Drugs (tramadol, bupropion, ciprofloxacin, cocaine).
    Neurology: Epilepsy
  • Others - vortioxetine, agomelatine, trazodone, bupropion (smoking) | Vortioxetine - fewer sexual side effects; agomelatine - LFT monitoring; trazodone - sedating.
    Psychiatry: Mood disorders

Where it is discussed

C

Cabergoline

BNF entry for Cabergoline · Stand-alone drug page

Mechanism

Long-acting dopamine D2 agonist reducing prolactin secretion.

Uses

Hyperprolactinaemia and prolactinoma, acromegaly adjunct, suppression of lactation.

Dosing

  • Cabergoline (preferred): Usually 250–500 micrograms once or twice weekly, titrated to normalise prolactin. In most patients it normalises prolactin, shrinks the tumour (often within weeks) and restores vision and fertility.
    Endocrinology: Pituitary Disease
  • Cabergoline Prolactinoma | Typically 250–500 micrograms once or twice weekly, titrated monthly to normalise prolactin. Warn about impulse control disorders; echo surveillance at higher cumulative doses.
    Endocrinology: Pituitary Disease

Side effects

Nausea, dizziness, headache, postural hypotension; psychiatric effects including impulse-control disorders; valvular fibrosis at high doses.

Interactions

Dopamine antagonists (antipsychotics, metoclopramide) oppose effect.

Special advice

Echocardiography for long-term or high-dose use; monitor prolactin and tumour size.

More from the textbook: uses, cautions and other points

Where it is discussed

Calcitriol

BNF entry for Calcitriol · Stand-alone drug page

Mechanism

Active vitamin D (1,25-dihydroxycholecalciferol) increasing gut calcium and phosphate absorption.

Uses

Hypocalcaemia in CKD and hypoparathyroidism, renal osteodystrophy.

Dosing

  • Glucocorticoids (e.g. prednisolone 20–40 mg daily): For calcitriol-driven hypercalcaemia - sarcoidosis, lymphoma, vitamin D toxicity.
    Endocrinology: Bone Medicine
  • Normal physiology: The fetus takes about 30 g of calcium, mostly in the third trimester. The mother adapts by doubling gut absorption (calcitriol rises). During breastfeeding, calcium is drawn from the skeleton, but bone density usually recovers after weaning.
    Endocrinology: Bone Medicine
  • Calcium — gut absorption doubles (more calcitriol) to supply the fetal skeleton; vitamin D supplements recommended (10 micrograms daily).
    Obstetrics

Side effects

Hypercalcaemia, hypercalciuria, nausea, polyuria.

Interactions

Thiazides and calcium supplements increase hypercalcaemia risk.

Special advice

Monitor calcium, phosphate and PTH regularly; avoid in hypercalcaemia.

More from the textbook: uses, cautions and other points
  • Calcium: Granulomas make active vitamin D (calcitriol), causing hypercalcaemia and hypercalciuria (kidney stones, nephrocalcinosis).
    Respiratory: Interstitial Lung Disease
  • Made in the skin with UVB (or eaten) → liver makes 25-hydroxyvitamin D (the measured storage form) → kidney makes 1,25-dihydroxyvitamin D (calcitriol - active).
    Endocrine: Anatomy Physiology and Pharmacology
  • CKD - the kidney can't activate vitamin D → low calcium, high phosphate → secondary hyperparathyroidism (use alfacalcidol or calcitriol, which don't need kidney activation).
    Endocrine: Anatomy Physiology and Pharmacology
  • Then hydroxylated in the kidney to 1,25-dihydroxyvitamin D (calcitriol) - the active hormone. It increases gut absorption of calcium and phosphate.
    Endocrinology: Bone Medicine
  • FGF23: Made by osteocytes when phosphate is high. It makes the kidney excrete phosphate and suppresses calcitriol. Excess FGF23 causes phosphate-wasting rickets and osteomalacia.
    Endocrinology: Bone Medicine
  • Vitamin D activation - the kidney makes active 1,25-dihydroxyvitamin D (calcitriol) using 1-alpha-hydroxylase (stimulated by PTH and low phosphate).
    Renal: Anatomy, Physiology and Pharmacology

Where it is discussed

Calcium carbonate

BNF entry for Calcium carbonate · Stand-alone drug page

Mechanism

Calcium salt used as a supplement, antacid and phosphate binder.

Uses

Calcium deficiency, osteoporosis adjunct, heartburn, hyperphosphataemia in CKD.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Constipation, bloating, hypercalcaemia, milk-alkali syndrome.

Interactions

Reduces absorption of levothyroxine, quinolones and tetracyclines; thiazides raise calcium.

Special advice

Take with food as a binder; space from interacting drugs; avoid in hypercalcaemia.

More from the textbook: uses, cautions and other points

Where it is discussed

Calcium gluconate 10%

BNF entry for Calcium gluconate 10% · Stand-alone drug page

Mechanism

Calcium salt that stabilises cardiac myocyte membranes against hyperkalaemic depolarisation.

Uses

Hyperkalaemia with ECG changes, hypocalcaemia, calcium channel blocker or magnesium toxicity.

Dosing

Quick reference (Makindo topics site)

Main useAdult doseKey pearl / caution
Hyperkalaemia with ECG changes30 mL IV over 2–5 minProtects the myocardium only; does not lower potassium.

Source: Makindo topics, Emergency Drugs Collection (topic 1479). Editorial draft, not clinically signed off; doses are as written there. Check BNF and local policy before prescribing.

Check: the MHRA national patient safety alert on calcium gluconate in severe hyperkalaemia advises 30 mL of 10% (6.8 mmol) given over 10 minutes, repeated if ECG changes persist at 5–10 minutes. The 2–5 minute rate above is as written on the topics site and may need updating.

This drug is not covered by a dedicated section of the textbook chapters.

Side effects

Hypotension, bradycardia, arrhythmias, tissue necrosis if extravasated, peripheral vein irritation.

Interactions

Digoxin toxicity risk with IV calcium.

Special advice

Give with ECG monitoring; does not lower potassium, so also give insulin-dextrose; use the protocol-stated volume and rate (MHRA alert).

Candesartan

BNF entry for Candesartan · Stand-alone drug page

Mechanism

Angiotensin II type 1 receptor blocker.

Uses

Hypertension, heart failure with reduced EF.

Dosing

Side effects

Dizziness, hyperkalaemia, renal impairment, hypotension; angioedema rare.

Interactions

NSAIDs, potassium-sparing diuretics and ACE inhibitors increase renal and potassium risk; lithium levels rise.

Special advice

Check U&E 1 to 2 weeks after starting or increasing; avoid in pregnancy and bilateral renal artery stenosis.

More from the textbook: uses, cautions and other points

Where it is discussed

Capecitabine

BNF entry for Capecitabine · Stand-alone drug page

Mechanism

Oral prodrug of fluorouracil activated preferentially in tumour tissue.

Uses

Colorectal, breast and gastric cancer.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Hand-foot syndrome, diarrhoea, mucositis, nausea, myelosuppression, cardiotoxicity.

Interactions

Warfarin interaction with major INR rise; phenytoin levels rise; folinic acid increases toxicity.

Special advice

Check DPD deficiency risk; monitor INR with warfarin; stop for severe diarrhoea or hand-foot reactions.

More from the textbook: uses, cautions and other points
  • Chemotherapy: Capecitabine and temozolomide for pancreatic NETs. Platinum and etoposide for neuroendocrine carcinomas.
    Endocrinology: NETS and Hypoglycaemia
  • Surgery is the only cure, but fewer than 1 in 4 tumours are resectable. Adjuvant capecitabine afterwards.
    Gastroenterology: Pancreas and Biliary
  • Then adjuvant chemotherapy - modified FOLFIRINOX if fit, or gemcitabine with capecitabine.
    Gastroenterology: Pancreas and Biliary
  • Antimetabolites | 5-fluorouracil and capecitabine - diarrhoea, mucositis, hand–foot syndrome , coronary vasospasm; test for DPD deficiency first (risk of fatal toxicity). Methotrexate - mucositis, kidney and liver toxicity (folinic acid rescue). Gemcitabine - flu-like symptoms, rarely HUS
    Oncology: Principles
  • ⚠️ Safety Pearl: Chemotherapy prescribing is a specialist task, with checked protocols. Never prescribe or continue oral anti-cancer drugs (e.g. capecitabine) without clear specialist guidance - dosing errors cause serious harm.
    Oncology: Principles
  • Hold oral chemotherapy (capecitabine).
    Oncology: Emergencies

Where it is discussed

Captopril

BNF entry for Captopril · Stand-alone drug page

Mechanism

Short-acting ACE inhibitor containing a thiol group.

Uses

Hypertension, heart failure, post-MI, diabetic nephropathy.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Dry cough, hypotension, hyperkalaemia, renal impairment, angioedema, taste disturbance, neutropenia.

Interactions

NSAIDs, potassium-sparing diuretics and lithium; first-dose hypotension with diuretics.

Special advice

Check renal function and potassium; avoid in pregnancy and bilateral renal artery stenosis; stop if angioedema.

More from the textbook: uses, cautions and other points

Where it is discussed

Carbamazepine

BNF entry for Carbamazepine · Stand-alone drug page

Mechanism

Blocks voltage-gated sodium channels; stabilises neuronal membranes.

Uses

Focal and generalised tonic-clonic epilepsy, trigeminal neuralgia, bipolar disorder.

Dosing

  • … is euvolaemic - after excluding hypothyroidism, adrenal insufficiency and diuretics. Causes include lung disease, CNS disease, cancers (small cell), drugs (SSRIs, carbamazepine, PPIs, opioids), pain, nausea and surgery.
    Endocrine: Anatomy Physiology and Pharmacology
  • Increased dose needs - pregnancy (increase as soon as pregnancy is confirmed - often by 25–50 micrograms - and check TFTs each trimester), oral oestrogen, enzyme inducers (rifampicin, carbamazepine, phenytoin), weight gain.
    Endocrine: Anatomy Physiology and Pharmacology
  • Carbamazepine level | About 4–12 mg/L
    Neurology: Anatomy, Physiology and Pharmacology
  • 5. An 80-year-old woman started on carbamazepine for trigeminal neuralgia is brought in confused. Sodium 119 mmol/L. She also takes bendroflumethiazide and warfarin; her INR has fallen to 1.4. Answer: Carbamazepine-induced hyponatraemia (worsened by the thiazide) and enzyme induction lowering warfarin effect.
    Neurology: Anatomy, Physiology and Pharmacology
3 more dose entries from the chapters
  • Carbamazepine Start 100 mg once or twice daily | Trigeminal neuralgia; low sodium, rash, enzyme induction.
    Neurology: Headache and Facial Pain
  • Carbamazepine 100 mg once or twice daily, increasing slowly.
    Neurology: Headache and Facial Pain
  • Carbamazepine, phenytoin, phenobarbital, topiramate | Malformations (NTDs, cleft lip and palate, heart defects); topiramate — cleft lip, low birth weight, possible neurodevelopmental effects; lamotrigine and levetiracetam are preferred (with folic acid 5 mg)
    Obstetrics

Side effects

Dizziness, diplopia, ataxia, hyponatraemia, rash, leucopenia; serious skin reactions (HLA-B*15:02), hepatotoxicity.

Interactions

Potent enzyme inducer lowering warfarin, DOACs, COC pill and many drugs; levels raised by macrolides and some azoles.

Special advice

Check sodium, LFT and FBC; contraception advice; avoid in pregnancy where possible (neural tube defects); do not stop abruptly.

More from the textbook: uses, cautions and other points
  • Many interactions - enzyme inhibitors raise INR (amiodarone, clarithromycin, erythromycin, fluconazole, metronidazole, ciprofloxacin, alcohol binges); inducers lower it (rifampicin, carbamazepine, phenytoin, St John's wort); diet (vitamin K-rich foods).
    Cardiology: Anatomy Physiology and Pharmacology
  • Metabolised by CYP1A2 - levels raised by ciprofloxacin , clarithromycin , erythromycin, fluvoxamine, cimetidine, heart failure, liver disease, viral infection, stopping smoking; lowered by smoking , rifampicin, carbamazepine, phenytoin, alcohol.
    Respiratory: Anatomy, Physiology and Pharmacology
  • Interactions - CYP3A4 inhibitors (ritonavir and cobicistat, itraconazole, clarithromycin) block breakdown of inhaled or nasal fluticasone and budesonide → Cushing's syndrome and adrenal suppression; enzyme inducers (rifampicin, carbamazepine, phenytoin) reduce steroid effect - double replacement doses may be needed.
    Endocrine: Anatomy Physiology and Pharmacology
  • Combined pill (oestrogen raises binding proteins) - falsely raises total T4 and cortisol; interacts with enzyme inducers (rifampicin, carbamazepine, St John's wort) and lamotrigine.
    Endocrine: Anatomy Physiology and Pharmacology
  • SSRIs , SNRIs, tricyclics. Carbamazepine , oxcarbazepine, sodium valproate.
    Endocrinology: Sodium and Water disorders
  • Drugs (thiazides, SSRIs, carbamazepine, PPIs) are the commonest reversible causes.
    Endocrinology: Sodium and Water disorders

Where it is discussed

Carbimazole

BNF entry for Carbimazole · Stand-alone drug page

Mechanism

Prodrug of methimazole; inhibits thyroid peroxidase and hormone synthesis.

Uses

Graves disease and hyperthyroidism.

Dosing

  • Titration regimen: Carbimazole 20–40 mg daily initially, reduced gradually to a maintenance dose (typically 5–15 mg) as FT4 normalises. Check TFTs every 4–6 weeks.
    Endocrinology: Thyroid disease
  • Block-and-replace: Carbimazole 40 mg daily plus levothyroxine, usually for about 6 months. It gives more stable levels but higher drug exposure. Not used in pregnancy.
    Endocrinology: Thyroid disease

Side effects

Rash, itch, nausea; agranulocytosis, cholestatic jaundice, acute pancreatitis rare.

Interactions

Warfarin effect may reduce as thyroid state normalises.

Special advice

Counsel to report sore throat, fever or mouth ulcers immediately and check FBC; pregnancy teratogenicity risk.

More from the textbook: uses, cautions and other points
  • Thyroid peroxidase (TPO) attaches iodine to tyrosines on thyroglobulin and couples them into T4 and T3 (the step blocked by carbimazole and propylthiouracil ; TPO antibodies mark autoimmune thyroid disease).
    Endocrine: Anatomy Physiology and Pharmacology
  • Rash and itch (common), joint pains, liver problems (cholestatic with carbimazole; severe hepatitis with PTU ), vasculitis (PTU - ANCA).
    Endocrine: Anatomy Physiology and Pharmacology
  • Thionamide: Propylthiouracil preferred, or high-dose carbimazole, to block new hormone synthesis.
    Endocrinology: Emergencies
  • 4. A woman with Graves' disease who stopped carbimazole is febrile, in fast AF and agitated. Answer: Thyroid storm.
    Endocrinology: Emergencies
  • Drugs: Amiodarone, lithium, immune checkpoint inhibitors, tyrosine kinase inhibitors, interferon, over-treatment with carbimazole.
    Endocrinology: Thyroid disease
  • 💡 Clinical Pearl: Before starting carbimazole, make sure the gland is actually overproducing. Antithyroid drugs are useless in thyroiditis - the problem is leakage of stored hormone, not overproduction.
    Endocrinology: Thyroid disease

Where it is discussed

Carvedilol

BNF entry for Carvedilol · Stand-alone drug page

Mechanism

Non-selective beta blocker with alpha-1 blocking activity.

Uses

Heart failure with reduced EF, hypertension, post-MI.

Dosing

Side effects

Dizziness, postural hypotension, fatigue, bradycardia, fluid retention initially.

Interactions

Amiodarone and rate-limiting calcium channel blockers risk bradycardia and block; insulin hypoglycaemia masking.

Special advice

Introduce when euvolaemic and titrate slowly; avoid in asthma and decompensated heart failure.

More from the textbook: uses, cautions and other points

Where it is discussed

Cefalexin

BNF entry for Cefalexin · Stand-alone drug page

Mechanism

First-generation cephalosporin inhibiting cell-wall synthesis.

Uses

Skin and soft tissue, urinary and respiratory tract infections, surgical prophylaxis.

Dosing

Side effects

Diarrhoea, nausea, rash; C. difficile infection; rarely hypersensitivity.

Interactions

Probenecid raises levels; may increase warfarin effect.

Special advice

Cross-reactivity with penicillin allergy is low but avoid after anaphylaxis; adjust in renal impairment.

More from the textbook: uses, cautions and other points

Where it is discussed

Cefotaxime

BNF entry for Cefotaxime · Stand-alone drug page

Mechanism

Third-generation cephalosporin with good CSF penetration.

Uses

Meningitis, sepsis, serious Gram-negative and streptococcal infections.

Dosing

  • IV antibiotics - e.g. ceftriaxone 80 mg/kg (cefotaxime plus amoxicillin under 3 months), per local policy.
    Paediatrics: Infections in children
  • Ceftriaxone (once daily - useful for OPAT) and cefotaxime - bacterial meningitis , severe pneumonia, pyelonephritis, gonorrhoea (1 g IM), Lyme neuroborreliosis, typhoid; ceftriaxone can cause biliary sludge and must not be mixed with calcium in neonates.
    ID: How Infection Happens
  • IV antibiotics — e.g. ceftriaxone 80 mg/kg (cefotaxime plus amoxicillin under 3 months), per local policy.
    Integrated paediatrics chapter › Sepsis in Children

Side effects

Diarrhoea, rash, C. difficile; rarely haemolytic anaemia, neutropenia.

Interactions

Aminoglycosides increase nephrotoxicity; may enhance warfarin effect.

Special advice

Check allergy history; adjust in renal impairment; neonatal calcium precipitation warning applies to ceftriaxone, not cefotaxime.

More from the textbook: uses, cautions and other points

Where it is discussed

Ceftazidime

BNF entry for Ceftazidime · Stand-alone drug page

Mechanism

Third-generation cephalosporin with antipseudomonal activity.

Uses

Pseudomonas infections, hospital-acquired pneumonia, neutropenic sepsis, melioidosis.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Diarrhoea, rash, C. difficile; neurotoxicity in renal failure.

Interactions

Aminoglycosides increase nephrotoxicity.

Special advice

Adjust in renal impairment to avoid encephalopathy; weaker against Gram-positives.

More from the textbook: uses, cautions and other points
  • Cover both Gram-positives ( vancomycin or a cephalosporin) and Gram-negatives ( ceftazidime or an aminoglycoside), as per local policy.
    Renal: Dialysis and Transplant
  • Ceftazidime / gentamicin | Gram-negative cover in PD peritonitis (intraperitoneal) or line sepsis.
    Renal: Dialysis and Transplant
  • Necrotising (malignant) otitis externa — older people with diabetes or immunosuppression; severe pain, granulation tissue at the bony–cartilaginous junction, cranial nerve palsies — Pseudomonas skull base osteomyelitis — urgent ENT, CT or MRI, prolonged IV anti-pseudomonal antibiotics (e.g. ceftazidime, ciprofloxacin).
    ENT Anatomy Physiology
  • Prolonged antipseudomonal antibiotics - IV (e.g. ceftazidime, piperacillin–tazobactam) then oral ciprofloxacin , often for 6 weeks or more .
    ENT: Emergencies
  • Ciprofloxacin / ceftazidime / piperacillin–tazobactam | Necrotising otitis externa (Pseudomonas) for 6 weeks or more.
    ENT: Emergencies
  • Endophthalmitis (after surgery or injection) — intravitreal antibiotics (vancomycin and ceftazidime) — emergency.
    Ophthalmology: Anatomy Physiology and Pharmacology

Where it is discussed

Ceftriaxone

BNF entry for Ceftriaxone · Stand-alone drug page

Mechanism

Third-generation cephalosporin with long half-life and biliary excretion.

Uses

Meningitis, pneumonia, gonorrhoea, sepsis, biliary sepsis, Lyme disease.

Dosing

4 more dose entries from the chapters

Side effects

Diarrhoea, rash, biliary sludging, C. difficile; rarely haemolysis.

Interactions

Calcium-containing infusions in neonates (fatal precipitates); may increase warfarin effect.

Special advice

Avoid with IV calcium in neonates; useful once-daily dosing; no renal adjustment unless combined renal and hepatic impairment.

More from the textbook: uses, cautions and other points

Where it is discussed

Celecoxib

BNF entry for Celecoxib · Stand-alone drug page

Mechanism

Selective cyclooxygenase-2 inhibitor.

Uses

Osteoarthritis, rheumatoid arthritis, ankylosing spondylitis.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Dyspepsia, hypertension, fluid retention, renal impairment; increased cardiovascular risk.

Interactions

Warfarin effect rises; ACE inhibitors and diuretics raise renal risk; fluconazole increases levels.

Special advice

Avoid in ischaemic heart disease, stroke and heart failure; lowest dose for shortest time; sulfonamide allergy caution.

More from the textbook: uses, cautions and other points

Where it is discussed

Cetirizine

BNF entry for Cetirizine · Stand-alone drug page

Mechanism

Second-generation H1 antihistamine with little CNS penetration.

Uses

Allergic rhinitis, urticaria.

Dosing

Side effects

Mild drowsiness, dry mouth, headache.

Interactions

Additive sedation with alcohol and other sedatives.

Special advice

Reduce dose in renal impairment; avoid with prolonged driving effect risk if drowsy.

More from the textbook: uses, cautions and other points

Where it is discussed

Chloramphenicol

BNF entry for Chloramphenicol · Stand-alone drug page

Mechanism

Binds the 50S ribosome, inhibiting bacterial protein synthesis.

Uses

Bacterial conjunctivitis (topical); systemic use for severe infections in rare circumstances.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Topical: local irritation; systemic: bone marrow suppression, aplastic anaemia, grey baby syndrome.

Interactions

Warfarin, phenytoin and sulfonylurea levels rise with systemic use.

Special advice

Systemic use needs blood monitoring and is avoided in neonates and pregnancy.

More from the textbook: uses, cautions and other points

Where it is discussed

Chlorphenamine

BNF entry for Chlorphenamine · Stand-alone drug page

Mechanism

Sedating first-generation H1 antihistamine.

Uses

Urticaria, allergic reactions, pruritus.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Drowsiness, dry mouth, urinary retention, confusion in older adults.

Interactions

Additive sedation with alcohol, opioids and sedatives.

Special advice

Not part of first-line anaphylaxis treatment; avoid driving and in older people if possible.

More from the textbook: uses, cautions and other points

Where it is discussed

Chlorpromazine

BNF entry for Chlorpromazine · Stand-alone drug page

Mechanism

Typical phenothiazine antipsychotic blocking dopamine D2 and several other receptors.

Uses

Schizophrenia, severe agitation, intractable hiccups, nausea.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Sedation, postural hypotension, extrapyramidal effects, anticholinergic effects, hyperprolactinaemia, QT prolongation, photosensitivity.

Interactions

Other QT-prolonging drugs and CNS depressants; anticholinergics additive; lowers seizure threshold.

Special advice

Monitor ECG, weight and glucose; neuroleptic malignant syndrome risk; caution in dementia (stroke and mortality risk).

More from the textbook: uses, cautions and other points
  • Cholestatic (ALP up) | Co-amoxiclav (may start up to 6 weeks after the course), flucloxacillin (older people; may be delayed), chlorpromazine, combined pill , anabolic steroids , carbimazole, sulfonylureas, erythromycin, terbinafine
    Gastroenterology: Anatomy Physiology Pharmacology
  • Cholestatic | Co-amoxiclav (often weeks after the course ends; older men), flucloxacillin , chlorpromazine, anabolic steroids , the combined pill, erythromycin, terbinafine
    Gastroenterology: Liver disease
  • Chlorpromazine or haloperidol.
    Palliative: Symptoms Management
  • Phenothiazines (thioridazine, chlorpromazine) | Pigmentary retinopathy (thioridazine), lens and corneal deposits
    Ophthalmology: Anatomy Physiology and Pharmacology
  • Causes - TCAs, antihistamines (diphenhydramine, promethazine), antipsychotics (chlorpromazine, clozapine, olanzapine), procyclidine, hyoscine, oxybutynin, some plants (deadly nightshade, Jimson weed); older people on multiple anticholinergic drugs (anticholinergic burden).
    Psychiatric emergencies
  • Chlorpromazine (first-generation) | Sedation, hypotension, anticholinergic effects, photosensitivity, jaundice.
    Psychiatry: Psychosis and schizophrenia

Where it is discussed

Ciclosporin

BNF entry for Ciclosporin · Stand-alone drug page

Mechanism

Calcineurin inhibitor blocking IL-2 transcription and T-cell activation.

Uses

Transplant immunosuppression, severe psoriasis, atopic dermatitis, nephrotic syndrome, rheumatoid arthritis.

Dosing

3 more dose entries from the chapters
  • Immunosuppressants compatible with pregnancy — prednisolone (mostly inactivated by the placenta), hydroxychloroquine , azathioprine , sulfasalazine (with folic acid 5 mg), ciclosporin, tacrolimus, most anti-TNF drugs (certolizumab minimal transfer).
    Obstetrics
  • … (e.g. 500 micrograms 2–4 times daily); diarrhoea is the dose-limiting effect; toxic in overdose; reduce dose in renal impairment; interactions — clarithromycin , ciclosporin, verapamil, diltiazem (CYP3A4 and P-glycoprotein) — myopathy and toxicity.
    Rheumatology Anatomy Physiology Pharmacology
  • … course dose) is as effective as high dose with fewer side effects; diarrhoea is common; reduce or avoid in CKD; interactions - clarithromycin, erythromycin, ciclosporin, verapamil, diltiazem, some statins (toxicity, myopathy).
    Rheumatology: Crystal arthritis, osteoarthritis and soft tissue pain

Side effects

Nephrotoxicity, hypertension, tremor, hirsutism, gum hyperplasia, hyperkalaemia, hypomagnesaemia.

Interactions

Many CYP3A4 interactions (macrolides, azoles, diltiazem raise levels; rifampicin, phenytoin lower); nephrotoxic drugs; statins myopathy.

Special advice

Monitor trough levels, creatinine, BP, potassium; avoid grapefruit; live vaccines contraindicated.

More from the textbook: uses, cautions and other points

Where it is discussed

Ciprofloxacin

BNF entry for Ciprofloxacin · Stand-alone drug page

Mechanism

Fluoroquinolone inhibiting bacterial DNA gyrase and topoisomerase IV.

Uses

Complicated urinary tract infection, pseudomonal infection, anthrax, travellers diarrhoea.

Dosing

Side effects

Nausea, diarrhoea, tendon rupture, QT prolongation, seizures, aortic aneurysm risk, dysglycaemia.

Interactions

Antacids, calcium and iron chelate it; theophylline levels rise; corticosteroids increase tendon risk; warfarin effect rises.

Special advice

MHRA restrictions: use only when other agents are unsuitable; stop at first tendon pain; avoid in epilepsy and myasthenia gravis.

More from the textbook: uses, cautions and other points

Where it is discussed

Citalopram

BNF entry for Citalopram · Stand-alone drug page

Mechanism

SSRI blocking serotonin reuptake.

Uses

Depression, panic disorder.

Dosing

  • SSRIs - sertraline, citalopram, escitalopram, fluoxetine, paroxetine | Usual first choice - safer in overdose. Sertraline - preferred after MI or with heart disease. Citalopram/escitalopram - QT prolongation (citalopram max 20 mg over 65). Fluoxetine - long half-life (fewer withdrawal effects), many interactions; first-line in …
    Psychiatry: Mood disorders
  • Citalopram / escitalopram | QT prolongation - citalopram max 20 mg over 65.
    Psychiatry: Mood disorders
  • SSRIs - sertraline is often first choice in older people (fewer interactions); citalopram (max 20 mg over 65 - QT); watch for hyponatraemia (check sodium at baseline and 2–4 weeks), GI bleeding (add PPI with NSAIDs or anticoagulants), falls.
    Medicine of the older adult: Delirium, dementia and mood in older people
  • Antidepressants - SSRIs (sertraline) - hyponatraemia (check sodium), bleeding (with NSAIDs, anticoagulants), falls; citalopram max 20 mg over 65 (QT); avoid tricyclics ; mirtazapine (sedation, weight gain).
    Medicine of the older adult: .Prescribing and deprescribing in older people

Side effects

Nausea, insomnia, sexual dysfunction, hyponatraemia, QT prolongation (dose-related), bleeding risk.

Interactions

Other QT-prolonging drugs; MAOIs and triptans (serotonin syndrome); NSAIDs and anticoagulants increase bleeding.

Special advice

Maximum dose is lower in older people and hepatic impairment; monitor sodium in older adults; taper on stopping.

More from the textbook: uses, cautions and other points

Where it is discussed

Clarithromycin

BNF entry for Clarithromycin · Stand-alone drug page

Mechanism

Macrolide binding 50S ribosome.

Uses

Community-acquired pneumonia (atypical cover), H. pylori eradication, Penicillin-allergic respiratory infections.

Dosing

4 more dose entries from the chapters
  • First line: PPI + amoxicillin 1 g + clarithromycin 500 mg or metronidazole 400 mg .
    Gastroenterology: Oesophagus and Stomach
  • Penicillin allergy: PPI + clarithromycin 250 mg + metronidazole 400 mg.
    Gastroenterology: Oesophagus and Stomach
  • Antibiotics - flucloxacillin 500 mg four times daily for 10–14 days (erythromycin or clarithromycin if allergic) if symptoms don't improve within 12–24 hours, if there is a cracked nipple that looks infected, or if culture is positive.
    Obstetrics: Post Natal Care
  • … — low dose (e.g. 500 micrograms 2–4 times daily); diarrhoea is the dose-limiting effect; toxic in overdose; reduce dose in renal impairment; interactions — clarithromycin , ciclosporin, verapamil, diltiazem (CYP3A4 and P-glycoprotein) — myopathy and toxicity.
    Rheumatology Anatomy Physiology Pharmacology

Side effects

Nausea, diarrhoea, taste disturbance, QT prolongation, hepatotoxicity.

Interactions

Strong CYP3A4 inhibitor: raises statins, colchicine, ciclosporin, DOACs, carbamazepine and warfarin effect.

Special advice

Check interactions before prescribing; stop simvastatin and atorvastatin cautiously; ECG risk with QT-prolonging drugs.

More from the textbook: uses, cautions and other points

Where it is discussed

Clindamycin

BNF entry for Clindamycin · Stand-alone drug page

Mechanism

Lincosamide binding 50S ribosome.

Uses

Bone and joint infection, skin and soft tissue, toxin suppression in necrotising infection, dental infection.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Diarrhoea, C. difficile colitis, rash, nausea.

Interactions

Neuromuscular blockers potentiated; erythromycin antagonism.

Special advice

Highest risk of C. difficile among common antibiotics; stop for significant diarrhoea.

More from the textbook: uses, cautions and other points

Where it is discussed

Clobazam

BNF entry for Clobazam · Stand-alone drug page

Mechanism

Benzodiazepine enhancing GABA-A receptor activity (1,5-benzodiazepine).

Uses

Adjunct in epilepsy, Lennox-Gastaut, intermittent seizure prophylaxis.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Drowsiness, dizziness, tolerance, withdrawal seizures, behavioural change.

Interactions

Additive sedation with alcohol and opioids; enzyme inducers lower levels; stiripentol and cannabidiol raise active metabolite.

Special advice

Avoid abrupt withdrawal; tolerance may develop; avoid driving until effects known.

More from the textbook: uses, cautions and other points
  • Brand consistency (MHRA categories) - keep patients on the same manufacturer for category 1 drugs ( phenytoin, carbamazepine, phenobarbital, primidone ); use clinical judgement for category 2 (valproate, lamotrigine, topiramate, oxcarbazepine, clobazam, others).
    Neurology: Anatomy, Physiology and Pharmacology
  • Clobazam and clonazepam (benzodiazepines) - add-on and short-term "cover" (e.g. around periods - catamenial epilepsy); tolerance, sedation, dependence.
    Neurology: Anatomy, Physiology and Pharmacology
  • Catamenial epilepsy (around periods) - specialist options include intermittent clobazam.
    Neurology: Epilepsy
  • Clobazam | Short-term add-on (e.g. catamenial, clusters); tolerance.
    Neurology: Epilepsy
  • Dravet syndrome | SCN1A mutation; prolonged febrile and afebrile seizures from the first year, then developmental slowing. Avoid sodium channel blockers (carbamazepine, lamotrigine, phenytoin). Valproate, clobazam, stiripentol, fenfluramine, cannabidiol.
    Paediatrics: Neurology, bones and joints in children

Where it is discussed

Clopidogrel

BNF entry for Clopidogrel · Stand-alone drug page

Mechanism

Irreversible P2Y12 platelet receptor antagonist (prodrug activated by CYP2C19).

Uses

ACS, after stent, secondary prevention after stroke, peripheral arterial disease.

Dosing

4 more dose entries from the chapters

Side effects

Bleeding, dyspepsia, rash; rarely TTP.

Interactions

Omeprazole and esomeprazole reduce activation (use pantoprazole instead); anticoagulants and NSAIDs increase bleeding.

Special advice

Stop 5 to 7 days before elective surgery where possible; poor CYP2C19 metabolisers have less benefit.

More from the textbook: uses, cautions and other points

Where it is discussed

Clozapine

BNF entry for Clozapine · Stand-alone drug page

Mechanism

Atypical antipsychotic with weak D2 and strong 5-HT2A and other receptor blockade.

Uses

Treatment-resistant schizophrenia.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Sedation, hypersalivation, constipation (can cause ileus), tachycardia, weight gain, seizures, myocarditis, agranulocytosis.

Interactions

Smoking cessation raises levels; ciprofloxacin and fluvoxamine raise levels; avoid with marrow-suppressant drugs and carbamazepine.

Special advice

Mandatory blood monitoring programme (neutrophils); treat constipation actively; re-titrate after missed doses; fever may signal neutropenia or myocarditis.

More from the textbook: uses, cautions and other points

Where it is discussed

Codeine

BNF entry for Codeine · Stand-alone drug page

Mechanism

Weak opioid agonist, prodrug converted to morphine by CYP2D6.

Uses

Mild to moderate pain, cough suppression, diarrhoea.

Dosing

  • Oral codeine → oral morphine | Divide by 10 (240 mg codeine a day ≈ 24 mg morphine)
    Palliative: Symptoms Management
  • 240 mg codeine a day ≈ 24 mg oral morphine a day: start MR morphine 10–15 mg twice daily (keep paracetamol).
    Palliative: Symptoms Management
  • Restrict hypotonic oral fluids (about 500–1,000 mL a day) and give an oral rehydration solution (St Mark's); loperamide 30–60 minutes before meals (high doses may be needed), ± codeine and a PPI.
    Surgery: Colorectal and anal surgery
  • Step-wise approach (by pain severity — RCEM): Pain Options Mild (1–3) Oral paracetamol and/or ibuprofen Moderate (4–6) Paracetamol plus ibuprofen; oral codeine or oral morphine; Entonox for short periods Severe (7–10) IV morphine (titrated — e.g. 0.1 mg/kg in 1–2 mg increments in adults); IV paracetamol; intranasal fentanyl or …
    Emergency Medicine: ED procedures
3 more dose entries from the chapters

Side effects

Constipation, nausea, drowsiness, dependence, respiratory depression in ultra-rapid metabolisers.

Interactions

CNS depressants additive; CYP2D6 inhibitors reduce effect; MAOIs contraindicated.

Special advice

Avoid in children under 12 and breastfeeding; give laxatives; avoid in ultra-rapid metabolisers.

More from the textbook: uses, cautions and other points

Where it is discussed

Colchicine

BNF entry for Colchicine · Stand-alone drug page

Mechanism

Binds tubulin, inhibiting microtubule assembly and neutrophil chemotaxis.

Uses

Acute gout, gout prophylaxis during urate-lowering therapy, pericarditis, familial Mediterranean fever.

Dosing

Side effects

Diarrhoea, nausea, vomiting; toxicity causes marrow suppression, multi-organ failure, neuromyopathy.

Interactions

Clarithromycin, ciclosporin and strong CYP3A4/P-gp inhibitors raise levels; statins increase myopathy.

Special advice

Narrow therapeutic index; reduce in renal impairment and avoid with strong inhibitors; stop if severe diarrhoea.

More from the textbook: uses, cautions and other points

Where it is discussed

Colecalciferol

BNF entry for Colecalciferol · Stand-alone drug page

Mechanism

Vitamin D3, hydroxylated in liver and kidney to active calcitriol.

Uses

Vitamin D deficiency, osteoporosis treatment, rickets and osteomalacia prevention.

Dosing

  • Colecalciferol (deficiency) | Loading of about 300,000 units over 6–10 weeks (e.g. 50,000 units weekly for 6 weeks). Then 800–2,000 units daily. Check calcium at 1 month.
    Endocrinology: Bone Medicine
  • Colecalciferol | Prevention (400 units) and treatment of vitamin D deficiency and rickets.
    Paediatrics: Growth, development and nutrition
  • Vitamin D status - measure 25-hydroxyvitamin D: <25 nmol/L deficient, 25–50 insufficient (UK). Treatment: loading (e.g. colecalciferol 300,000 IU over 6–10 weeks), then maintenance 800–2,000 IU daily; check calcium after loading.
    Biochemistry: Enzymes, vitamins and trace elements

Side effects

Hypercalcaemia and hypercalciuria with excess dosing; nausea.

Interactions

Thiazides raise calcium risk; orlistat and anticonvulsants lower levels.

Special advice

Check calcium in high dose, sarcoidosis and renal disease; usual maintenance is daily or weekly.

More from the textbook: uses, cautions and other points

Where it is discussed

D

Dabigatran

BNF entry for Dabigatran · Stand-alone drug page

Mechanism

Direct thrombin inhibitor (prodrug dabigatran etexilate).

Uses

Stroke prevention in non-valvular AF, treatment and prevention of VTE.

Dosing

2 more dose entries from the chapters

Side effects

Dyspepsia, bleeding, GI bleeding; rarely hepatic injury.

Interactions

P-gp inhibitors (dronedarone, ketoconazole) and inducers (rifampicin) alter levels; avoid other anticoagulants.

Special advice

Idarucizumab reverses; avoid in severe renal impairment; capsules must be swallowed whole in original packaging.

More from the textbook: uses, cautions and other points

Where it is discussed

Dalteparin

BNF entry for Dalteparin · Stand-alone drug page

Mechanism

Low molecular weight heparin enhancing antithrombin inhibition of factor Xa.

Uses

VTE prophylaxis and treatment, ACS, cancer-associated VTE, dialysis.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Bleeding, injection-site haematoma, thrombocytopenia (HIT), hyperkalaemia, osteoporosis in long-term use.

Interactions

Anticoagulants, antiplatelets and NSAIDs increase bleeding risk.

Special advice

Dose by weight; reduce or monitor anti-Xa in renal impairment; check platelet count on prolonged treatment.

More from the textbook: uses, cautions and other points
  • Low molecular weight heparin (enoxaparin, dalteparin, tinzaparin) - subcutaneous, weight-based dosing; mainly anti-Xa ; renally excreted (reduce dose with low creatinine clearance); monitor anti-Xa levels in pregnancy, extremes of weight or CKD; only partly reversed by protamine.
    Cardiology: Anatomy Physiology and Pharmacology
  • Enoxaparin / dalteparin | SC by weight; reduce if CrCl under 30; anti-Xa monitoring in pregnancy, CKD, extreme weight; HIT, hyperkalaemia.
    Haematology: Anatomy Physiology and Pharmacology
  • LMWH (enoxaparin, dalteparin, tinzaparin) | Weight-based; reduce in severe kidney impairment; monitor platelets if exposed to unfractionated heparin recently (HIT); anti-Xa levels in pregnancy, kidney failure or extremes of weight
    Haematology: Haemostasis and Thrombosis

Where it is discussed

Dantrolene

BNF entry for Dantrolene · Stand-alone drug page

Mechanism

Inhibits ryanodine receptor calcium release from sarcoplasmic reticulum.

Uses

Malignant hyperthermia, neuroleptic malignant syndrome (selected), spasticity.

Dosing

Side effects

Muscle weakness, drowsiness, hepatotoxicity, phlebitis.

Interactions

Calcium channel blockers (IV) risk hyperkalaemia and cardiovascular collapse.

Special advice

Early IV use in malignant hyperthermia with supportive cooling; monitor LFT with prolonged use.

More from the textbook: uses, cautions and other points
  • Neuroleptic malignant syndrome - dopamine blockade (antipsychotics) or sudden withdrawal of Parkinson's drugs : fever, rigidity ("lead pipe"), confusion, autonomic instability, very high CK; slower onset (days); stop the drug, cooling, fluids, ITU; dantrolene or bromocriptine in severe cases.
    Neurology: Anatomy, Physiology and Pharmacology
  • Suxamethonium (depolarising) - fast and short; causes hyperkalaemia (avoid in burns, crush injury, neuromuscular disease), malignant hyperthermia (with volatile anaesthetics - treat with dantrolene ), and prolonged paralysis with plasma cholinesterase deficiency.
    Neurology: Anatomy, Physiology and Pharmacology
  • Treatment | NMS: Stop the drug; cooling; fluids; benzodiazepines; dantrolene or bromocriptine in severe cases. Serotonin syndrome: Stop the drugs; benzodiazepines; cooling; cyproheptadine in moderate or severe cases
    Neurology: Emergencies
  • Malignant hyperthermia - volatile anaesthetics or suxamethonium; treat with dantrolene.
    Neurology: Emergencies
  • Dantrolene (muscle relaxant) and/or bromocriptine (dopamine agonist) in severe cases; ECT for refractory cases.
    Psychiatric emergencies
  • Specific treatment | Dantrolene, bromocriptine | Cyproheptadine
    Psychiatric emergencies

Where it is discussed

Dapagliflozin

BNF entry for Dapagliflozin · Stand-alone drug page

Mechanism

SGLT2 inhibitor increasing urinary glucose excretion; also natriuretic with cardiorenal benefits.

Uses

Type 2 diabetes, heart failure, chronic kidney disease.

Dosing

4 more dose entries from the chapters
  • Examples: Dapagliflozin 10 mg, empagliflozin 10 mg (25 mg for extra glucose lowering), canagliflozin 100–300 mg, ertugliflozin - once daily.
    Endocrinology: Diabetes
  • Dapagliflozin / empagliflozin Type 2 first-line with metformin; HF; CKD | 10 mg once daily (empagliflozin 25 mg for extra glucose lowering). Genital infection, volume depletion, euglycaemic DKA. Sick day rules; omit around surgery.
    Endocrinology: Diabetes
  • Dapagliflozin 10 mg daily (TA775) - eGFR 25–75 , plus either type 2 diabetes or ACR 22.6 mg/mmol or more .
    Renal: Chronic Kidney Disease
  • Dapagliflozin 10 mg daily | CKD (TA775): eGFR 25–75 with type 2 diabetes or ACR 22.6 or more. Thrush, euglycaemic DKA, early eGFR dip.
    Renal: Chronic Kidney Disease

Side effects

Genital candidiasis, urinary infection, volume depletion, euglycaemic ketoacidosis, Fournier gangrene (rare).

Interactions

Loop diuretics and insulin or sulfonylureas increase volume depletion or hypoglycaemia.

Special advice

Sick-day rules: stop during acute illness, fasting or before surgery; ketone check if unwell even with normal glucose.

More from the textbook: uses, cautions and other points

Where it is discussed

Desmopressin

BNF entry for Desmopressin · Stand-alone drug page

Mechanism

Synthetic vasopressin analogue acting at V2 receptors; increases water reabsorption and factor VIII/vWF release.

Uses

Cranial diabetes insipidus, nocturnal enuresis, mild haemophilia A and von Willebrand disease.

Dosing

  • Consider IV desmopressin (e.g. 1–2 micrograms), with specialist advice, to bring sodium back down.
    Endocrinology: Sodium and Water disorders
  • Desmopressin AVP deficiency | Oral 100–200 micrograms two to three times daily (range varies), or 1–2 micrograms SC/IV. Never omit. Risk of hyponatraemia.
    Endocrinology: Sodium and Water disorders
  • Desmopressin AVP deficiency (DI) | Oral 100 micrograms two to three times daily (maintenance often 100–200 micrograms three times daily); sublingual 60–120 micrograms; intranasal 10–40 micrograms daily; injection 1–4 micrograms daily. Risk of hyponatraemia. Never omit in hospital.
    Endocrinology: Pituitary Disease
  • … (overactive bladder) if persisting Antimuscarinics - dry mouth, constipation, confusion in older people (anticholinergic burden), retention; mirabegron - raises BP Desmopressin or late-afternoon loop diuretic Nocturnal polyuria Desmopressin - hyponatraemia (check sodium; caution in older people)
    Surgey: Urology
2 more dose entries from the chapters

Side effects

Hyponatraemia, headache, nausea; fluid retention.

Interactions

NSAIDs, SSRIs, carbamazepine and tricyclics increase hyponatraemia risk.

Special advice

Fluid restriction around dosing; monitor sodium; avoid in heart failure and hyponatraemia.

More from the textbook: uses, cautions and other points

Where it is discussed

Dexamethasone

BNF entry for Dexamethasone · Stand-alone drug page

Mechanism

Potent long-acting glucocorticoid with negligible mineralocorticoid effect.

Uses

Cerebral oedema, croup, COVID-19 hypoxia, antiemetic, myeloma, adrenal testing.

Dosing

4 more dose entries from the chapters

Side effects

Hyperglycaemia, insomnia, psychiatric effects, infection, adrenal suppression, osteoporosis, myopathy.

Interactions

CYP3A4 inducers reduce levels; NSAIDs raise GI bleed risk; antidiabetic drugs need adjustment.

Special advice

Give PPI cover in higher-risk patients; taper after prolonged courses; monitor glucose.

More from the textbook: uses, cautions and other points

Where it is discussed

Diazepam

BNF entry for Diazepam · Stand-alone drug page

Mechanism

Benzodiazepine increasing GABA-A receptor chloride channel opening.

Uses

Status epilepticus and seizures, alcohol withdrawal, anxiety, muscle spasm, sedation.

Dosing

4 more dose entries from the chapters

Side effects

Drowsiness, ataxia, respiratory depression, dependence, paradoxical agitation; accumulates in older people.

Interactions

Opioids, alcohol and other CNS depressants increase respiratory depression; cimetidine and omeprazole raise levels.

Special advice

Long active metabolites in older adults and liver disease; slow IV injection; flumazenil is a poor routine antidote in mixed overdose.

More from the textbook: uses, cautions and other points

Where it is discussed

Diclofenac

BNF entry for Diclofenac · Stand-alone drug page

Mechanism

Non-selective NSAID inhibiting cyclo-oxygenase.

Uses

Pain and inflammation in arthritis, musculoskeletal and postoperative pain, renal colic.

Dosing

Side effects

Dyspepsia, GI bleeding, hypertension, renal impairment, fluid retention; higher cardiovascular thrombotic risk.

Interactions

Anticoagulants, SSRIs, ACE inhibitors, diuretics and lithium.

Special advice

Contraindicated in heart failure, ischaemic heart disease, stroke and peripheral arterial disease; lowest dose for shortest time with PPI.

More from the textbook: uses, cautions and other points
  • Hepatocellular (ALT up) | Paracetamol (overdose), isoniazid , rifampicin, pyrazinamide, valproate , methotrexate, statins (usually mild), amiodarone, nitrofurantoin , ketoconazole, NSAIDs (diclofenac), herbal supplements (green tea extract, kava, turmeric), checkpoint inhibitors
    Gastroenterology: Anatomy Physiology Pharmacology
  • Hepatocellular | Paracetamol (dose-related), isoniazid, rifampicin, pyrazinamide , NSAIDs (diclofenac), statins (rarely serious), valproate, ketoconazole, nitrofurantoin, herbal products (green tea extract, ashwagandha, turmeric)
    Gastroenterology: Liver disease
  • NSAIDs first-line (e.g. diclofenac IM, oral or PR) if not contraindicated; IV paracetamol if NSAIDs can't be used; opioids only if both are unsuitable.
    Renal: Anatomy, Physiology and Pharmacology
  • NSAID first line by any route (e.g. diclofenac) - if not contraindicated (kidney impairment, bleeding, heart failure).
    Renal: Tubular Inherited Stones
  • Diclofenac (NSAID) | First-line renal colic pain relief if no contraindication.
    Renal: Tubular Inherited Stones
  • Actinic (solar) keratoses - rough, scaly, sun-damaged patches; a small risk of SCC. Sun protection, 5-fluorouracil cream, imiquimod, diclofenac gel, cryotherapy, photodynamic therapy.
    Oncology: Skin Cancer

Where it is discussed

Digoxin

BNF entry for Digoxin · Stand-alone drug page

Mechanism

Inhibits Na-K ATPase, increasing intracellular calcium and vagal tone.

Uses

AF rate control, heart failure with AF symptoms.

Dosing

4 more dose entries from the chapters

Side effects

Nausea, visual disturbance (yellow-green), confusion, arrhythmias, gynaecomastia; hypokalaemia increases toxicity.

Interactions

Amiodarone, verapamil, clarithromycin raise levels; diuretics cause hypokalaemia; calcium IV caution.

Special advice

Narrow therapeutic index; check level 6 hours post-dose if toxicity suspected; reduce dose in renal impairment and older people; antibody fragments for severe toxicity.

More from the textbook: uses, cautions and other points
  • Contractility (inotropy) - the strength of contraction at a given preload; increased by sympathetic stimulation and inotropes (dobutamine, adrenaline, milrinone, digoxin); reduced by beta-blockers, rate-limiting calcium channel blockers, ischaemia, acidosis and hypoxia.
    Cardiology: Anatomy Physiology and Pharmacology
  • Digoxin inhibits the Na+/K+ ATPase → more sodium inside → less calcium removed by the exchanger → more calcium → stronger contraction.
    Cardiology: Anatomy Physiology and Pharmacology
  • Digoxin — renal function, potassium, levels if toxicity suspected.
    Cardiology: Presentations
  • Look for causes — inferior MI, drugs (beta-blockers, digoxin), hyperkalaemia; permanent pacemaker.
    Cardiology: Presentations
  • ST depression and T wave inversion - ischaemia (NSTEMI, unstable angina), strain, digoxin, or reciprocal change.
    Cardiology Investigations
  • Digoxin effect: " Reverse tick " (sloping) ST depression - not by itself toxicity. Toxicity causes almost any arrhythmia.
    Cardiology Investigations

Where it is discussed

Diltiazem

BNF entry for Diltiazem · Stand-alone drug page

Mechanism

Non-dihydropyridine calcium channel blocker with negative chronotropic and inotropic effects.

Uses

Angina, hypertension, AF and SVT rate control.

Dosing

4 more dose entries from the chapters

Side effects

Bradycardia, ankle oedema, headache, constipation, heart block.

Interactions

Beta-blockers risk bradycardia and block; raises levels of statins, ciclosporin, carbamazepine; avoid with ivabradine.

Special advice

Avoid in reduced EF heart failure and with beta-blockers if conduction disease.

More from the textbook: uses, cautions and other points
  • Phase 0 - slower upstroke via L-type calcium channels (blocked by verapamil and diltiazem - slowing AV conduction).
    Cardiology: Anatomy Physiology and Pharmacology
  • Interactions - CYP3A4 inhibitors ( clarithromycin , erythromycin, itraconazole, grapefruit juice with simvastatin), amiodarone and diltiazem (simvastatin dose limits), fibrates (gemfibrozil - avoid).
    Cardiology: Anatomy Physiology and Pharmacology
  • Avoid — verapamil and diltiazem in HFrEF (negatively inotropic) unless a specialist advises; NSAIDs in heart failure; QT-prolonging combinations.
    Cardiology: Presentations
  • Prescribing | Check renal function and K + ; no verapamil or diltiazem in HFrEF
    Cardiology: Presentations
  • Drugs: Beta-blockers, rate-limiting calcium channel blockers (verapamil, diltiazem), digoxin, amiodarone, ivabradine.
    Cardiology: Cardiology Emergencies
  • Beta-blocker (e.g. bisoprolol orally, or IV metoprolol in increments) or rate-limiting calcium channel blocker (diltiazem, verapamil) - avoid calcium channel blockers in heart failure with reduced EF.
    Cardiology: Cardiology Emergencies

Where it is discussed

Dipyridamole

BNF entry for Dipyridamole · Stand-alone drug page

Mechanism

Inhibits platelet phosphodiesterase and adenosine reuptake.

Uses

Secondary stroke prevention (modified release); diagnostic stress agent.

Dosing

  • Use a lower dose (e.g. 3 mg) via a central line, after heart transplant, or with dipyridamole. Effect reduced by theophylline and caffeine.
    Cardiology: Cardiology Emergencies

Side effects

Headache, dizziness, GI upset, flushing; worsens angina.

Interactions

Potentiates adenosine; antacids reduce absorption of tablets.

Special advice

Headache usually settles; avoid in unstable angina and aortic stenosis; stop before adenosine testing as directed.

More from the textbook: uses, cautions and other points

Where it is discussed

Dobutamine

BNF entry for Dobutamine · Stand-alone drug page

Mechanism

Beta-1 agonist increasing inotropy with mild vasodilation.

Uses

Cardiogenic shock and low-output states; stress echocardiography.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Tachycardia, arrhythmias, hypotension, hypokalaemia.

Interactions

Beta-blockers antagonise effect; MAOIs potentiate.

Special advice

Central or large peripheral vein; titrate to response; monitor continuously.

More from the textbook: uses, cautions and other points

Where it is discussed

Domperidone

BNF entry for Domperidone · Stand-alone drug page

Mechanism

Peripheral dopamine D2 antagonist enhancing gastric motility.

Uses

Nausea and vomiting, gastroparesis.

Dosing

  • Domperidone - 10 mg up to three times daily, for the shortest time (QT prolongation; avoid in cardiac disease).
    Gastroenterology: Oesophagus and Stomach
  • Domperidone 10 mg up to three times daily | Shortest duration; QT prolongation; avoid in heart disease.
    Gastroenterology: Oesophagus and Stomach
  • Domperidone 10 mg up to three times daily | Antiemetic of choice in PD; QT prolongation.
    Neurology: Movement Disorders
  • Gastric stasis - "squashed stomach" (liver enlargement, ascites), autonomic failure, opioids | Early fullness, large-volume vomits soon after eating, relief after vomiting. Metoclopramide 10 mg three times daily (or domperidone). Avoid in complete bowel obstruction
    Palliative: Symptoms Management

Side effects

Dry mouth, headache, QT prolongation and arrhythmias, hyperprolactinaemia.

Interactions

QT-prolonging drugs and strong CYP3A4 inhibitors contraindicated.

Special advice

Short course at lowest dose; avoid in cardiac disease and electrolyte disturbance.

More from the textbook: uses, cautions and other points
  • Antipsychotics (haloperidol), citalopram, escitalopram, methadone, ondansetron, domperidone.
    Cardiology: Cardiology Emergencies
  • Causes of high prolactin - pregnancy and breastfeeding, drugs (antipsychotics, metoclopramide, domperidone, some antidepressants), prolactinoma, stalk compression, primary hypothyroidism (high TRH stimulates prolactin), kidney failure, stress (including a difficult blood test), seizures, chest wall injury, macroprolactin …
    Endocrine: Anatomy Physiology and Pharmacology
  • Antipsychotics , metoclopramide, domperidone | Hyperprolactinaemia ; olanzapine and clozapine - weight gain and diabetes
    Endocrine: Anatomy Physiology and Pharmacology
  • Gastroparesis - early fullness, vomiting, bloating and erratic glucose (food absorbed unpredictably, causing post-meal hypoglycaemia). Manage with small, low-fat, low-fibre meals; prokinetics (metoclopramide or domperidone short-term, erythromycin); adjust insulin timing; gastric electrical stimulation in severe cases.
    Endocrinology: Diabetes
  • Metoclopramide and domperidone .
    Endocrinology: Pituitary Disease
  • Domperidone | Peripheral D2 antagonist (doesn't cross the blood–brain barrier) | Nausea in Parkinson's (e.g. with dopaminergic drugs), gastroparesis | QT prolongation and sudden cardiac death - lowest dose, shortest time (usually up to 7 days), avoid with QT-prolonging drugs and CYP3A4 inhibitors and in cardiac disease (MHRA)
    Gastroenterology: Anatomy Physiology Pharmacology

Where it is discussed

Donepezil

BNF entry for Donepezil · Stand-alone drug page

Mechanism

Reversible acetylcholinesterase inhibitor.

Uses

Mild to moderate Alzheimer disease.

Dosing

Side effects

Nausea, diarrhoea, insomnia, vivid dreams, bradycardia, syncope, weight loss, urinary incontinence.

Interactions

Anticholinergics oppose effect; beta-blockers risk bradycardia; neuromuscular blockers affected.

Special advice

Check pulse and ECG in cardiac disease; caution in asthma and peptic ulcer; review benefit.

More from the textbook: uses, cautions and other points

Where it is discussed

Dopamine

BNF entry for Dopamine · Stand-alone drug page

Mechanism

Endogenous catecholamine; dose-dependent dopaminergic, beta-1 and alpha-1 agonist.

Uses

Cardiogenic and vasodilatory shock where noradrenaline unavailable or bradycardia with hypotension (specialist).

Dosing

  • Restless legs syndrome - check ferritin and give iron if low (ferritin under about 75 micrograms/L); gabapentinoids or dopamine agonists (low dose - augmentation : symptoms get worse and earlier over time); avoid antihistamines, antidepressants and dopamine blockers that worsen it.
    Neurology: Anatomy, Physiology and Pharmacology
  • If still not responding - isoprenaline or adrenaline infusion (2–10 micrograms/minute), or other drugs (dopamine; glucagon for beta-blocker or CCB overdose; DigiFab for digoxin toxicity), and/or transcutaneous pacing (with analgesia and sedation).
    Acute Medicine: Cardiac arrest, advanced life support and peri-arrest arrhythmias

Side effects

Tachycardia, arrhythmias, hypertension, peripheral ischaemia, extravasation necrosis, nausea.

Interactions

MAOIs and tricyclics potentiate; beta-blockers antagonise; phenytoin IV hypotension.

Special advice

Central line preferred; titrate to response with continuous monitoring; low-dose "renal" use is not supported by evidence.

More from the textbook: uses, cautions and other points

Where it is discussed

Doxycycline

BNF entry for Doxycycline · Stand-alone drug page

Mechanism

Tetracycline binding the 30S ribosome.

Uses

Chlamydia, Lyme disease, rickettsiae, COPD exacerbation, acne, malaria prophylaxis.

Dosing

4 more dose entries from the chapters
  • Antibiotic choice: Phenoxymethylpenicillin 500 mg four times daily for 5 days first line; doxycycline or clarithromycin if allergic; co-amoxiclav if very unwell or high risk.
    ENT: Common Nose and Throat disorders
  • Probable STI - ceftriaxone 1 g IM (gonorrhoea) plus doxycycline 100 mg twice daily for 10–14 days; contact tracing and partner notification; refer to sexual health.
    Surgey: Urology
  • Treatment (NICE NG141) - flucloxacillin 500 mg–1 g four times daily (oral for mild; IV for severe); clarithromycin , doxycycline or erythromycin in penicillin allergy; co-amoxiclav for facial cellulitis (near the eyes or nose); 5–7 days; mark the edge; elevate the leg; treat the entry point (tinea pedis, ulcers).
    Acute Medicine: The acute medical take
  • Chlamydia: doxycycline 100 mg twice daily for 7 days (azithromycin if pregnant); partner notification; test of cure if pregnant.
    General Practice: Child health, women's health and men's health in primary care

Side effects

Nausea, oesophagitis, photosensitivity, thrush; avoid in pregnancy and children for dental staining.

Interactions

Antacids, iron and calcium reduce absorption; warfarin effect rises; carbamazepine reduces levels.

Special advice

Take upright with a full glass of water; sun protection.

More from the textbook: uses, cautions and other points

Where it is discussed

Duloxetine

BNF entry for Duloxetine · Stand-alone drug page

Mechanism

Serotonin and noradrenaline reuptake inhibitor.

Uses

Depression, generalised anxiety, diabetic neuropathic pain, stress urinary incontinence.

Dosing

  • Amitriptyline / duloxetine / pregabalin / gabapentin Painful neuropathy | E.g. amitriptyline 10 mg at night, titrated; duloxetine 60 mg daily; pregabalin 75 mg twice daily, titrated. Adjust for renal function and frailty.
    Endocrinology: Diabetes

Side effects

Nausea, dry mouth, insomnia, hypertension, hyponatraemia, sexual dysfunction.

Interactions

MAOIs and other serotonergic drugs; fluvoxamine and ciprofloxacin raise levels.

Special advice

Monitor BP; taper on stopping; avoid in uncontrolled hypertension and liver disease.

More from the textbook: uses, cautions and other points

Where it is discussed

E

Edoxaban

BNF entry for Edoxaban · Stand-alone drug page

Mechanism

Direct factor Xa inhibitor.

Uses

Stroke prevention in non-valvular AF, treatment and prevention of VTE.

Dosing

Side effects

Bleeding, anaemia, rash, abnormal LFT.

Interactions

P-gp inhibitors raise levels; avoid with other anticoagulants.

Special advice

Dose reduce by weight, renal function and interacting drugs; reduced efficacy with CrCl above 95 in AF.

More from the textbook: uses, cautions and other points

Where it is discussed

Empagliflozin

BNF entry for Empagliflozin · Stand-alone drug page

Mechanism

SGLT2 inhibitor increasing urinary glucose and sodium excretion.

Uses

Type 2 diabetes, heart failure, chronic kidney disease.

Dosing

4 more dose entries from the chapters
  • Examples: Dapagliflozin 10 mg, empagliflozin 10 mg (25 mg for extra glucose lowering), canagliflozin 100–300 mg, ertugliflozin - once daily.
    Endocrinology: Diabetes
  • Dapagliflozin / empagliflozin Type 2 first-line with metformin; HF; CKD | 10 mg once daily (empagliflozin 25 mg for extra glucose lowering). Genital infection, volume depletion, euglycaemic DKA. Sick day rules; omit around surgery.
    Endocrinology: Diabetes
  • Empagliflozin 10 mg daily (TA942) - eGFR 20–45 , or eGFR 45–90 with ACR 22.6 or more or type 2 diabetes.
    Renal: Chronic Kidney Disease
  • Empagliflozin 10 mg daily | CKD (TA942): eGFR 20–45, or 45–90 with ACR 22.6 or more or type 2 diabetes.
    Renal: Chronic Kidney Disease

Side effects

Genital infections, urinary infection, volume depletion, euglycaemic ketoacidosis, Fournier gangrene.

Interactions

Diuretics increase volume depletion; insulin and sulfonylureas increase hypoglycaemia risk.

Special advice

Sick-day rules and pre-operative stopping; ketone check if unwell.

More from the textbook: uses, cautions and other points

Where it is discussed

Enalapril

BNF entry for Enalapril · Stand-alone drug page

Mechanism

ACE inhibitor prodrug (active enalaprilat).

Uses

Hypertension, heart failure, post-MI left ventricular dysfunction.

Dosing

Side effects

Dry cough, hypotension, hyperkalaemia, renal impairment, angioedema, taste change.

Interactions

NSAIDs, potassium-sparing diuretics, lithium, ARBs.

Special advice

Check U&E before and after starting; avoid in pregnancy; stop if angioedema.

More from the textbook: uses, cautions and other points
  • Common drugs : Ramipril. Enalapril. Lisinopril. Candesartan, an ARB alternative.
    Cardiology: Heart Failure › 2.18 💊 ACE Inhibitors and ARBs
  • After delivery: Full HFrEF therapy (enalapril or captopril are compatible with breastfeeding); bromocriptine with prophylactic anticoagulation considered in specialist care.
    Cardiology: Cardiomyopathies › 3.42 Peripartum Cardiomyopathy (PPCM)
  • … 3 weeks postpartum and breastfeeding, is breathless with an LVEF of 28%. Answer: Peripartum cardiomyopathy - HFrEF therapy compatible with breastfeeding (e.g. enalapril, metoprolol), diuretics, consider bromocriptine with anticoagulation (stops lactation), wearable defibrillator, and counselling against further pregnancy …
    Cardiology: Cardiomyopathies › 3.59 Exam-style Scenarios
  • ACE inhibitors (ramipril, lisinopril, perindopril, enalapril) block angiotensin II production; ARBs (losartan, candesartan, irbesartan, valsartan) block its receptor.
    Renal: Anatomy, Physiology and Pharmacology
  • Generally compatible — paracetamol, ibuprofen, penicillins, cephalosporins, macrolides, LMWH and warfarin, labetalol, nifedipine, enalapril, insulin, metformin, levothyroxine, most inhalers, prednisolone, sertraline, lamotrigine (monitor baby), levetiracetam, hydroxychloroquine, sulfasalazine (caution in preterm or jaundiced …
    Obstetrics
  • Methyldopa — avoid postpartum (depression) — switch to enalapril, nifedipine or labetalol (NICE NG133).
    Obstetrics

Where it is discussed

Enoxaparin

BNF entry for Enoxaparin · Stand-alone drug page

Mechanism

Low molecular weight heparin enhancing antithrombin activity against factor Xa.

Uses

VTE prophylaxis and treatment, ACS, bridging anticoagulation.

Dosing

3 more dose entries from the chapters
  • Pharmacological prophylaxis - usually LMWH (e.g. enoxaparin 40 mg daily, adjusted for weight and kidney function), starting 6–12 hours after surgery (timing around neuraxial anaesthesia matters), continued until mobility returns (often at least 7 days for major surgery).
    Surgery: Surgical principles and perioperative care
  • Pharmacological prophylaxis - LMWH (e.g. enoxaparin 40 mg daily - adjust for weight and kidney function) or fondaparinux, for at least 7 days if VTE risk outweighs bleeding risk; unfractionated heparin in severe kidney impairment (eGFR under 15–30).
    Acute Medicine: The acute medical take
  • VTE prophylaxis (NICE NG89) - assess risk on admission; LMWH (e.g. enoxaparin 40 mg SC once daily, adjusted for weight and renal function) unless contraindicated (active bleeding, low platelets, recent stroke with haemorrhage); mechanical prophylaxis (anti-embolism stockings) for some surgical patients - not after stroke.
    OSCEs II: Practical procedures, prescribing and acute care stations

Side effects

Bleeding, injection-site bruising, thrombocytopenia (HIT), hyperkalaemia, elevated transaminases.

Interactions

Anticoagulants, antiplatelets, NSAIDs and SSRIs increase bleeding.

Special advice

Dose by weight; reduce in severe renal impairment; platelet counts during prolonged use; neuraxial anaesthesia timing.

More from the textbook: uses, cautions and other points

Where it is discussed

Eplerenone

BNF entry for Eplerenone · Stand-alone drug page

Mechanism

Selective mineralocorticoid receptor antagonist.

Uses

Heart failure after MI, heart failure with reduced EF.

Dosing

Side effects

Hyperkalaemia, renal impairment, dizziness; fewer endocrine effects than spironolactone.

Interactions

CYP3A4 inhibitors (clarithromycin, ketoconazole) contraindicated; ACE inhibitors, ARBs, potassium raise potassium.

Special advice

Monitor potassium and creatinine early and regularly.

More from the textbook: uses, cautions and other points

Where it is discussed

Ergocalciferol

BNF entry for Ergocalciferol · Stand-alone drug page

Mechanism

Vitamin D2 converted to active vitamin D metabolites.

Uses

Vitamin D deficiency, hypoparathyroidism, rickets and osteomalacia.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Hypercalcaemia, hypercalciuria, nausea with excess.

Interactions

Thiazides, anticonvulsants.

Special advice

Monitor calcium on high doses.

More from the textbook: uses, cautions and other points

Where it is discussed

Ertapenem

BNF entry for Ertapenem · Stand-alone drug page

Mechanism

Carbapenem inhibiting cell-wall synthesis; once-daily dosing.

Uses

Intra-abdominal and pelvic infection, ESBL infections, diabetic foot and complicated urinary infection.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Diarrhoea, nausea, headache, injection-site reactions, seizures (rare).

Interactions

Valproate levels fall markedly (avoid); probenecid raises levels.

Special advice

No activity against Pseudomonas or Acinetobacter; adjust in renal impairment; seizure caution.

More from the textbook: uses, cautions and other points

Where it is discussed

Escitalopram

BNF entry for Escitalopram · Stand-alone drug page

Mechanism

SSRI, the S-enantiomer of citalopram.

Uses

Depression, generalised anxiety, panic and social anxiety disorders.

Dosing

  • SSRIs - sertraline, citalopram, escitalopram, fluoxetine, paroxetine | Usual first choice - safer in overdose. Sertraline - preferred after MI or with heart disease. Citalopram/escitalopram - QT prolongation (citalopram max 20 mg over 65). Fluoxetine - long half-life (fewer withdrawal effects), many interactions; first-line in …
    Psychiatry: Mood disorders
  • Citalopram / escitalopram | QT prolongation - citalopram max 20 mg over 65.
    Psychiatry: Mood disorders

Side effects

Nausea, insomnia, sexual dysfunction, hyponatraemia, QT prolongation (dose-related), bleeding risk.

Interactions

MAOIs, serotonergic drugs and QT-prolonging drugs; NSAIDs increase bleeding.

Special advice

Taper on stopping; lower maximum in older adults; monitor sodium.

More from the textbook: uses, cautions and other points

Where it is discussed

Esomeprazole

BNF entry for Esomeprazole · Stand-alone drug page

Mechanism

Proton pump inhibitor irreversibly inhibiting H+/K+ ATPase.

Uses

GORD, peptic ulcer and prevention with NSAIDs, H. pylori regimens, Zollinger-Ellison.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Headache, diarrhoea; hypomagnesaemia, B12 deficiency, fracture risk, C. difficile, microscopic colitis with long-term use.

Interactions

Clopidogrel activation reduced; levothyroxine and iron absorption reduced; methotrexate levels rise.

Special advice

Review long-term need; use lowest effective dose.

More from the textbook: uses, cautions and other points

Where it is discussed

Estradiol

BNF entry for Estradiol · Stand-alone drug page

Mechanism

Natural oestrogen acting at oestrogen receptors.

Uses

Menopausal vasomotor symptoms, atrophic vaginitis, hypoestrogenism, gender-affirming care.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Breast tenderness, nausea, headache, VTE, endometrial hyperplasia (without progestogen), breast cancer risk.

Interactions

Enzyme inducers lower effect; warfarin and thyroid hormone needs may change.

Special advice

Add progestogen if uterus intact; transdermal route carries lower VTE risk; review annually.

More from the textbook: uses, cautions and other points

Where it is discussed

Etanercept

BNF entry for Etanercept · Stand-alone drug page

Mechanism

TNF-alpha receptor fusion protein.

Uses

Rheumatoid, psoriatic and juvenile arthritis, ankylosing spondylitis, plaque psoriasis.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Injection-site reactions, infections, headache; reactivated TB, demyelination, cytopenias.

Interactions

Avoid with other biologics; live vaccines contraindicated.

Special advice

Screen for TB and hepatitis B; avoid in active infection.

More from the textbook: uses, cautions and other points

Where it is discussed

Ezetimibe

BNF entry for Ezetimibe · Stand-alone drug page

Mechanism

Inhibits intestinal cholesterol absorption (NPC1L1).

Uses

Primary hypercholesterolaemia (add-on to statin or statin-intolerant).

Dosing

2 more dose entries from the chapters

Side effects

Diarrhoea, abdominal pain, myalgia, raised liver enzymes.

Interactions

Ciclosporin raises levels; fibrates and cholestyramine alter absorption.

Special advice

Check LFT with a statin; modest LDL lowering.

More from the textbook: uses, cautions and other points

Where it is discussed

F

Famotidine

BNF entry for Famotidine · Stand-alone drug page

Mechanism

Histamine H2 receptor antagonist reducing acid secretion.

Uses

Dyspepsia, GORD, peptic ulcer.

Dosing

Side effects

Headache, dizziness, constipation or diarrhoea; confusion in older adults with renal impairment.

Interactions

Reduces absorption of drugs needing acid (itraconazole, ketoconazole).

Special advice

Adjust in renal impairment; tolerance can develop.

More from the textbook: uses, cautions and other points

Where it is discussed

Fentanyl

BNF entry for Fentanyl · Stand-alone drug page

Mechanism

Potent synthetic mu-opioid agonist.

Uses

Severe pain, anaesthesia, breakthrough pain, palliative care.

Dosing

  • Fentanyl patch | 12 micrograms/hour ≈ about 30 mg oral morphine a day. Takes 12–24 hours to start working; lasts 72 hours. Not for unstable pain or opioid-naive patients
    Palliative: Symptoms Management
  • … 5 mg; 5–9 years 7.5 mg; 10 years and over 10 mg) Lorazepam IV 0.1 mg/kg (max 4 mg) Ceftriaxone (sepsis or meningitis) 80 mg/kg (max 4 g) once daily Intranasal fentanyl 1.5 micrograms/kg Paracetamol oral 15 mg/kg (max 4 doses a day; age-banded doses on packets) Ibuprofen oral 5–10 mg/kg (up to 3 times a day)
    Emergency Medicine: Paediatric emergency medicine
  • Intranasal fentanyl | 1.5 micrograms/kg
    Emergency Medicine: Paediatric emergency medicine
  • … or oral morphine; Entonox for short periods Severe (7–10) IV morphine (titrated — e.g. 0.1 mg/kg in 1–2 mg increments in adults); IV paracetamol; intranasal fentanyl or diamorphine (children); nerve blocks; methoxyflurane (Penthrox) inhaler
    Emergency Medicine: ED procedures
4 more dose entries from the chapters

Side effects

Respiratory depression, nausea, constipation, bradycardia, muscle rigidity, dependence.

Interactions

CYP3A4 inhibitors (clarithromycin, ritonavir) markedly raise levels; additive sedation with benzodiazepines.

Special advice

Patches only for opioid-tolerant patients and change every 72 hours; heat increases absorption; avoid in acute pain.

More from the textbook: uses, cautions and other points
  • Opioids: Use cautiously at low doses; they can trigger encephalopathy (through constipation and sedation). Give laxatives. Avoid codeine, and avoid morphine in severe disease (oxycodone in low doses, or fentanyl, is used with specialist advice).
    Gastroenterology: Cirrhosis and Transplantation
  • Serotonin syndrome | SSRIs and SNRIs with tramadol , MAOIs, linezolid , triptans (rare), St John's wort, fentanyl, MDMA
    Neurology: Anatomy, Physiology and Pharmacology
  • Morphine and codeine (active metabolites - drowsiness, myoclonus, respiratory depression) - prefer low-dose oxycodone, or fentanyl or alfentanil in advanced CKD and palliative care; tramadol with caution.
    Renal: Anatomy, Physiology and Pharmacology
  • Switch to a safer opioid at a low dose (e.g. oxycodone with caution, or fentanyl or alfentanil with specialist advice); regular paracetamol; consider a nerve block for the hip.
    Renal: Anatomy, Physiology and Pharmacology
  • Opioids - avoid morphine and codeine in advanced CKD (metabolites accumulate); oxycodone with caution; fentanyl, alfentanil and buprenorphine are safer.
    Renal: Chronic Kidney Disease
  • Pain - renally safe opioids (fentanyl, alfentanil, buprenorphine).
    Renal: Chronic Kidney Disease

Where it is discussed

Ferrous fumarate

BNF entry for Ferrous fumarate · Stand-alone drug page

Mechanism

Oral iron salt replacing body iron stores.

Uses

Iron deficiency anaemia.

Dosing

Side effects

Constipation, dark stools, nausea, abdominal pain.

Interactions

Absorption reduced by antacids, calcium, PPIs and tetracyclines; levothyroxine absorption reduced.

Special advice

Take on an empty stomach or with vitamin C if tolerated; alternate-day dosing may improve tolerance; check Hb after a few weeks; keep away from children.

More from the textbook: uses, cautions and other points

Where it is discussed

Ferrous sulfate

BNF entry for Ferrous sulfate · Stand-alone drug page

Mechanism

Oral iron salt replacing body iron stores.

Uses

Iron deficiency anaemia and prevention.

Dosing

2 more dose entries from the chapters
  • Ferrous sulfate 200 mg once daily or alternate days | Iron deficiency; Hb rise about 20 g/L in 3–4 weeks; continue 3 months after normal.
    Haematology: Anaemia
  • Oral iron (e.g. ferrous sulfate 200 mg once daily, or on alternate days to improve absorption); recheck Hb in 2–4 weeks (should rise).
    Obstetrics: Medical Problems

Side effects

Constipation, dark stools, nausea, epigastric pain.

Interactions

Absorption reduced by antacids, calcium, PPIs and tetracyclines.

Special advice

Alternate-day dosing; continue for several months after Hb corrects; investigate the cause of deficiency; accidental overdose in children is dangerous.

More from the textbook: uses, cautions and other points

Where it is discussed

Fidaxomicin

BNF entry for Fidaxomicin · Stand-alone drug page

Mechanism

Narrow-spectrum macrolide inhibiting RNA polymerase in C. difficile.

Uses

Clostridioides difficile infection.

Dosing

1 more dose entries from the chapters

Side effects

Nausea, vomiting, abdominal pain; rarely hypersensitivity.

Interactions

P-gp inhibitors (ciclosporin) may raise levels.

Special advice

Preferred first-line; lower recurrence than vancomycin; stop the offending antibiotic where possible.

More from the textbook: uses, cautions and other points

Where it is discussed

Finasteride

BNF entry for Finasteride · Stand-alone drug page

Mechanism

5-alpha reductase type 2 inhibitor reducing dihydrotestosterone.

Uses

Benign prostatic hyperplasia, male-pattern hair loss.

Dosing

  • … in days Postural hypotension , dizziness, retrograde ejaculation, floppy iris syndrome (tell the eye surgeon before cataract surgery) 5-alpha reductase inhibitor (finasteride, dutasteride) Enlarged prostate (over about 30 g, or PSA over 1.4) at high risk of progression; takes 6 months ; reduces retention and surgery Reduced …
    Surgey: Urology
  • 5-alpha reductase inhibitor (finasteride, dutasteride) | Enlarged prostate (over about 30 g, or PSA over 1.4) at high risk of progression; takes 6 months ; reduces retention and surgery | Reduced libido, erectile dysfunction, gynaecomastia; halves PSA (double the value when interpreting)
    Surgey: Urology
  • … PSA after counselling; frequency–volume chart. Treatment: lifestyle, alpha-blocker (tamsulosin) for moderate–severe voiding symptoms, 5-alpha reductase inhibitor (finasteride) if prostate is estimated >30 g or PSA >1.4; antimuscarinic or mirabegron for storage symptoms.
    General Practice: Child health, women's health and men's health in primary care

Side effects

Reduced libido, erectile dysfunction, ejaculatory problems, gynaecomastia; mood changes.

Interactions

Few clinically important interactions.

Special advice

PSA falls by about half after 6 months; do not handle crushed tablets in pregnancy; breast changes need review.

More from the textbook: uses, cautions and other points

Where it is discussed

Flucloxacillin

BNF entry for Flucloxacillin · Stand-alone drug page

Mechanism

Penicillinase-resistant penicillin.

Uses

Skin and soft-tissue infection, staphylococcal sepsis, osteomyelitis, endocarditis (selected).

Dosing

  • Antibiotics - flucloxacillin 500 mg four times daily for 10–14 days (erythromycin or clarithromycin if allergic) if symptoms don't improve within 12–24 hours, if there is a cracked nipple that looks infected, or if culture is positive.
    Obstetrics: Post Natal Care
  • Flucloxacillin 500 mg four times daily | Mastitis not settling in 12–24 hours; 10–14 days.
    Obstetrics: Post Natal Care
  • Oral flucloxacillin (500 mg to 1 g four times a day) for 5–7 days .
    Dermatology: Skin infections and infestations
  • Treatment (NICE NG141) - flucloxacillin 500 mg–1 g four times daily (oral for mild; IV for severe); clarithromycin , doxycycline or erythromycin in penicillin allergy; co-amoxiclav for facial cellulitis (near the eyes or nose); 5–7 days; mark the edge; elevate the leg; treat the entry point (tinea pedis, ulcers).
    Acute Medicine: The acute medical take

Side effects

Diarrhoea, rash, cholestatic jaundice (can occur weeks after stopping), C. difficile.

Interactions

Warfarin effect may reduce; paracetamol with flucloxacillin can cause metabolic acidosis (pyroglutamic acidosis) in at-risk patients.

Special advice

Avoid in penicillin allergy and previous flucloxacillin liver injury; take on an empty stomach.

More from the textbook: uses, cautions and other points

Where it is discussed

Fluconazole

BNF entry for Fluconazole · Stand-alone drug page

Mechanism

Triazole inhibiting fungal ergosterol synthesis (CYP51).

Uses

Candidiasis, cryptococcal meningitis, fungal prophylaxis.

Dosing

2 more dose entries from the chapters

Side effects

Nausea, headache, raised LFT, QT prolongation; teratogenic at high doses in pregnancy.

Interactions

CYP2C9 and 3A4 inhibitor: raises warfarin, phenytoin, sulfonylureas, statins; QT-prolonging drugs.

Special advice

Reduce dose in renal impairment; avoid in pregnancy for high doses.

More from the textbook: uses, cautions and other points

Where it is discussed

Flumazenil

BNF entry for Flumazenil · Stand-alone drug page

Mechanism

Competitive benzodiazepine receptor antagonist.

Uses

Reversal of benzodiazepine sedation after procedures.

Dosing

Quick reference (Makindo topics site)

Main useAdult doseKey pearl / caution
Iatrogenic benzodiazepine oversedation0.2 mg IV increments up to 1 mgAvoid in mixed overdose, seizure risk or chronic benzodiazepine use.

Source: Makindo topics, Emergency Drugs Collection (topic 1479). Editorial draft, not clinically signed off; doses are as written there. Check BNF and local policy before prescribing.

Side effects

Seizures, agitation, nausea, withdrawal in dependent patients.

Interactions

Reverses benzodiazepines only; seizure risk with tricyclic co-ingestion.

Special advice

Avoid in mixed overdose, epilepsy and chronic benzodiazepine use; short half-life so resedation can occur.

More from the textbook: uses, cautions and other points
  • Reversal - naloxone for opioids (titrated in small IV doses in palliative or chronic opioid users to avoid severe pain and withdrawal; short half-life - infusion may be needed); flumazenil for benzodiazepines (rarely used - seizure risk).
    Respiratory: Anatomy, Physiology and Pharmacology
  • Benzodiazepines: Supportive care. Flumazenil is not routinely used - it can cause seizures, especially in mixed overdoses or long-term users.
    Respiratory: Emergencies
  • Reversal agents: flumazenil (benzodiazepines) and naloxone (opioids).
    Gastroenterology: Investigations
  • Midazolam | Conscious sedation; lower doses in older people; reverse with flumazenil.
    Gastroenterology: Investigations
  • Have available - flumazenil (benzodiazepine reversal), procyclidine (dystonia), oxygen, suction, bag-valve-mask, defibrillator.
    Psychiatric emergencies
  • Respiratory depression (benzodiazepines) - oxygen, airway support; flumazenil if respiratory rate under 10.
    Psychiatric emergencies

Where it is discussed

Fluoxetine

BNF entry for Fluoxetine · Stand-alone drug page

Mechanism

SSRI with a long half-life active metabolite.

Uses

Depression, bulimia nervosa, OCD, in young people (first-line antidepressant).

Dosing

  • SSRIs - sertraline, citalopram, escitalopram, fluoxetine, paroxetine | Usual first choice - safer in overdose. Sertraline - preferred after MI or with heart disease. Citalopram/escitalopram - QT prolongation (citalopram max 20 mg over 65). Fluoxetine - long half-life (fewer withdrawal effects), many interactions; first-line in …
    Psychiatry: Mood disorders

Side effects

Nausea, insomnia, anxiety, sexual dysfunction, hyponatraemia, bleeding risk; activation.

Interactions

CYP2D6 inhibitor: raises tricyclics, beta-blockers and antipsychotics; MAOIs; warfarin effect rises.

Special advice

Long half-life means slow washout; fewer discontinuation symptoms; review young patients for suicidal thoughts early.

More from the textbook: uses, cautions and other points

Where it is discussed

Fluticasone

BNF entry for Fluticasone · Stand-alone drug page

Mechanism

Potent inhaled or nasal corticosteroid.

Uses

Asthma, COPD (combination), allergic rhinitis.

Dosing

  • Mometasone / fluticasone nasal spray | Most effective treatment for allergic rhinitis and chronic rhinosinusitis; high dose (mometasone 200 micrograms twice daily for 14 days) for sinusitis over 10 days.
    ENT: Common Nose and Throat disorders
  • 4. A 52-year-old man with HIV, well controlled on darunavir with cobicistat plus two NRTIs, is started on simvastatin 40 mg by his GP and uses a fluticasone nasal spray for rhinitis. Two months later he has muscle pain, weight gain and a round face. Answer: CYP3A4 interactions - statin myopathy and iatrogenic Cushing's syndrome …
    ID: HIV, viral hepatitis and blood-borne viruses

Side effects

Oral candidiasis, dysphonia, nasal irritation; systemic effects at high doses.

Interactions

Ritonavir and ketoconazole markedly increase systemic exposure.

Special advice

Spacer and mouth rinse; check technique; carry steroid card at high doses.

More from the textbook: uses, cautions and other points
  • Examples - beclometasone, budesonide, fluticasone (propionate and furoate), mometasone, ciclesonide. Doses are graded as low, moderate or high (devices aren't interchangeable dose-for-dose - prescribe by brand).
    Respiratory: Anatomy, Physiology and Pharmacology
  • Pneumonia - increased risk with ICS in COPD (especially fluticasone).
    Respiratory: Anatomy, Physiology and Pharmacology
  • Interactions - CYP3A4 inhibitors (ritonavir and cobicistat, itraconazole, clarithromycin) block breakdown of inhaled or nasal fluticasone and budesonide → Cushing's syndrome and adrenal suppression; enzyme inducers (rifampicin, carbamazepine, phenytoin) reduce steroid effect - double replacement doses may be needed.
    Endocrine: Anatomy Physiology and Pharmacology
  • Cushingoid features in a patient on ritonavir and inhaled fluticasone | CYP3A4 inhibition - iatrogenic Cushing's and adrenal suppression
    Endocrine: Anatomy Physiology and Pharmacology
  • Any steroid combined with a CYP3A4 inhibitor (e.g. ritonavir, cobicistat, itraconazole, clarithromycin). These block steroid breakdown - even inhaled fluticasone or injected triamcinolone can then cause Cushing's syndrome and adrenal suppression.
    Endocrinology: Adrenal Disease
  • Inhaled corticosteroid (beclometasone, budesonide, fluticasone) | Asthma preventer; spacer; monitor growth at higher doses.
    Paediatrics: Respiratory and heart problems in children

Where it is discussed

Folic acid

BNF entry for Folic acid · Stand-alone drug page

Mechanism

Vitamin B9 required for DNA synthesis.

Uses

Megaloblastic anaemia from folate deficiency, neural tube defect prevention, methotrexate toxicity mitigation.

Dosing

4 more dose entries from the chapters

Side effects

Rarely GI upset; may mask B12 deficiency.

Interactions

Phenytoin levels fall; methotrexate rescue regimens.

Special advice

Check B12 first or together; higher dose in pregnancy with risk factors.

More from the textbook: uses, cautions and other points

Where it is discussed

Furosemide

BNF entry for Furosemide · Stand-alone drug page

Mechanism

Loop diuretic inhibiting Na-K-2Cl cotransporter.

Uses

Pulmonary oedema, heart failure and renal oedema, ascites.

Dosing

4 more dose entries from the chapters

Side effects

Hypokalaemia, hyponatraemia, hypotension, hyperuricaemia, ototoxicity at high infusion rates.

Interactions

NSAIDs blunt effect; aminoglycosides ototoxicity; digoxin toxicity if potassium low; lithium levels rise.

Special advice

Daily weights, U&E monitoring; give IV slowly at high doses.

More from the textbook: uses, cautions and other points

Where it is discussed

G

Gabapentin

BNF entry for Gabapentin · Stand-alone drug page

Mechanism

Binds the alpha-2-delta subunit of voltage-gated calcium channels.

Uses

Neuropathic pain, focal seizures adjunct.

Dosing

  • Amitriptyline / duloxetine / pregabalin / gabapentin Painful neuropathy | E.g. amitriptyline 10 mg at night, titrated; duloxetine 60 mg daily; pregabalin 75 mg twice daily, titrated. Adjust for renal function and frailty.
    Endocrinology: Diabetes

Side effects

Drowsiness, dizziness, ataxia, weight gain, peripheral oedema; misuse potential; respiratory depression with opioids.

Interactions

Opioids and CNS depressants; antacids reduce absorption.

Special advice

Controlled drug in the UK; reduce in renal impairment; taper on stopping.

More from the textbook: uses, cautions and other points
  • Respiratory depressants - opioids , benzodiazepines , Z-drugs, gabapentin and pregabalin , alcohol, barbiturates, anaesthetic agents. Combinations are especially dangerous (MHRA warnings on opioids with benzodiazepines or gabapentinoids). Highest risk - COPD, sleep apnoea, obesity hypoventilation, neuromuscular disease, older …
    Respiratory: Anatomy, Physiology and Pharmacology
  • Offer amitriptyline, duloxetine, gabapentin or pregabalin ; switch to another if one is ineffective or not tolerated.
    Endocrinology: Diabetes
  • The action potential reaches the nerve ending → voltage-gated calcium channels open (target of gabapentin and pregabalin , and of antibodies in Lambert–Eaton syndrome) → calcium enters.
    Neurology: Anatomy, Physiology and Pharmacology
  • Neuropathic - nerve damage: burning, shooting, electric shock-like , pins and needles, allodynia (pain from light touch) - responds poorly to standard painkillers; use amitriptyline, duloxetine, gabapentin or pregabalin.
    Neurology: Anatomy, Physiology and Pharmacology
  • Juvenile myoclonic epilepsy | Teenagers; morning myoclonic jerks , tonic-clonic seizures (often after sleep deprivation or alcohol), sometimes absences. Lifelong. Valproate (men), levetiracetam or lamotrigine. Carbamazepine, phenytoin and gabapentin worsen it
    Neurology: Epilepsy
  • Myoclonic | Levetiracetam or valproate (males). Avoid carbamazepine, oxcarbazepine, phenytoin, gabapentin, pregabalin, vigabatrin (they can worsen it)
    Neurology: Epilepsy

Where it is discussed

Gentamicin

BNF entry for Gentamicin · Stand-alone drug page

Mechanism

Aminoglycoside inhibiting 30S ribosome.

Uses

Sepsis, pyelonephritis, endocarditis (synergy), serious Gram-negative infection.

Dosing

Side effects

Nephrotoxicity, ototoxicity, neuromuscular blockade.

Interactions

Loop diuretics, vancomycin, ciclosporin increase toxicity; neuromuscular blockers potentiated.

Special advice

Weight-based dosing with level monitoring and local protocol; avoid in myasthenia gravis; check renal function.

More from the textbook: uses, cautions and other points
  • Three or more exacerbations a year: Consider long-term macrolide (azithromycin, after excluding NTM and checking QT) or nebulised antibiotics (colistin, gentamicin) if Pseudomonas is present.
    Respiratory: Airways Disease
  • Drugs that can worsen myasthenia - aminoglycosides (gentamicin), fluoroquinolones (ciprofloxacin), macrolides , magnesium , beta-blockers , quinine, chloroquine and hydroxychloroquine, penicillamine, lithium, phenytoin, statins (rarely), immune checkpoint inhibitors , botulinum toxin, neuromuscular blocking drugs. Check before …
    Neurology: Anatomy, Physiology and Pharmacology
  • Weakness after gentamicin in a patient with ptosis | Aminoglycoside worsening myasthenia
    Neurology: Anatomy, Physiology and Pharmacology
  • Myasthenia, given gentamicin, now choking and FVC falling | Myasthenic crisis
    Neurology: Emergencies
  • Bilateral vestibular failure: Imbalance worse in the dark, and oscillopsia when walking. Often from gentamicin toxicity.
    Neurology: Spine and Sleep Disorders
  • Pyelonephritis (NICE NG111) - cefalexin, co-amoxiclav (if sensitive), trimethoprim (if sensitive), or ciprofloxacin ; IV options (e.g. gentamicin, cefuroxime, ceftriaxone) if severe.
    Renal: Anatomy, Physiology and Pharmacology

Where it is discussed

Gliclazide

BNF entry for Gliclazide · Stand-alone drug page

Mechanism

Sulfonylurea increasing insulin secretion from pancreatic beta cells.

Uses

Type 2 diabetes.

Dosing

  • 4. An 80-year-old woman on gliclazide 160 mg twice daily is found drowsy with glucose 1.9 mmol/L. eGFR has fallen from 55 to 24 with a UTI. Answer: Sulfonylurea-induced hypoglycaemia worsened by AKI.
    Endocrine: Anatomy Physiology and Pharmacology
  • Example: Gliclazide - 40–80 mg daily initially, up to 160 mg twice daily (or a modified-release preparation).
    Endocrinology: Diabetes
  • Morning gliclazide (e.g. 40 mg, titrated), or morning isophane (NPH) insulin (e.g. 10% dose increments), timed to match the steroid peak.
    Endocrinology: Diabetes
  • 1. A 72-year-old man with AF on apixaban 5 mg twice daily (creatinine clearance 55 mL/min) is listed for an elective total hip replacement under spinal anaesthesia. He also takes ramipril and gliclazide. Answer: Peri-operative medicines plan.
    Surgery: Surgical principles and perioperative care
4 more dose entries from the chapters

Side effects

Hypoglycaemia, weight gain, GI upset, rash.

Interactions

Fluconazole, trimethoprim and beta-blockers increase hypoglycaemia or mask it; alcohol effects.

Special advice

Avoid or reduce in older and renal-impaired patients; take with meals.

More from the textbook: uses, cautions and other points

Where it is discussed

Glimepiride

BNF entry for Glimepiride · Stand-alone drug page

Mechanism

Sulfonylurea increasing insulin secretion.

Uses

Type 2 diabetes.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Hypoglycaemia, weight gain, GI upset.

Interactions

Fluconazole, warfarin interactions; alcohol.

Special advice

Long-acting so greater hypoglycaemia risk in older people.

More from the textbook: uses, cautions and other points

Where it is discussed

Glucagon

BNF entry for Glucagon · Stand-alone drug page

Mechanism

Pancreatic hormone raising blood glucose by hepatic glycogenolysis.

Uses

Severe hypoglycaemia, beta-blocker overdose, bowel imaging.

Dosing

4 more dose entries from the chapters

Side effects

Nausea, vomiting, transient tachycardia; ineffective if glycogen depleted.

Interactions

Warfarin effect may increase.

Special advice

Needs hepatic glycogen stores; give carbohydrate once awake; less effective in starvation, alcohol and adrenal insufficiency.

More from the textbook: uses, cautions and other points

Where it is discussed

Glyceryl trinitrate (GTN)

BNF entry for Glyceryl trinitrate (GTN) · Stand-alone drug page

Mechanism

Nitric oxide donor causing venodilation and, at higher doses, arteriolar dilation.

Uses

Angina, acute coronary syndrome, acute heart failure, hypertensive emergency in specific settings.

Dosing

Quick reference (Makindo topics site)

Main useAdult doseKey pearl / caution
ACS / pulmonary oedema5–200 microg/min IV infusionAvoid in RV infarct, hypotension, recent PDE5 inhibitor use.

Source: Makindo topics, Emergency Drugs Collection (topic 1479). Editorial draft, not clinically signed off; doses are as written there. Check BNF and local policy before prescribing.

This drug is not covered by a dedicated section of the textbook chapters.

Side effects

Headache, flushing, hypotension, reflex tachycardia, tolerance.

Interactions

PDE5 inhibitors (sildenafil, tadalafil) cause profound hypotension; antihypertensives additive.

Special advice

Avoid in hypotension, RV infarction and severe aortic stenosis; sublingual use sitting down.

Glycopyrronium

BNF entry for Glycopyrronium · Stand-alone drug page

Mechanism

Quaternary antimuscarinic.

Uses

COPD (inhaled), excessive drooling and secretions, premedication.

Dosing

  • Symptomatic: Pyridostigmine 30–60 mg 4–6 times daily. Side effects: diarrhoea, cramps, sweating, salivation (glycopyrronium or propantheline help). Too much causes a cholinergic crisis (weakness, secretions).
    Neurology: Neuromuscular disease
  • Respiratory secretions | Glycopyrronium 200 micrograms SC 4-hourly, or hyoscine butylbromide 20 mg SC hourly to 4-hourly (maximum 120 mg in 24 hours)
    Palliative: End of Life Care
  • Glycopyrronium SC 200 micrograms 4-hourly | Respiratory secretions; doesn't cross into the brain (no sedation).
    Palliative: End of Life Care

Side effects

Dry mouth, urinary retention, tachycardia, constipation, blurred vision.

Interactions

Other antimuscarinics additive.

Special advice

Caution in glaucoma and urinary retention.

More from the textbook: uses, cautions and other points

Where it is discussed

H

Haloperidol

BNF entry for Haloperidol · Stand-alone drug page

Mechanism

Butyrophenone antipsychotic blocking dopamine D2 receptors.

Uses

Acute psychosis and agitation, delirium (short term), nausea in palliative care, tics.

Dosing

  • Drugs only if the person is very distressed or a risk to themselves or others, and other measures have failed: e.g. haloperidol 0.5 mg , at the lowest dose for the shortest time.
    Neurology: Emergencies
  • Haloperidol Delirium (distressed) | e.g. 0.5 mg, lowest dose for shortest time; avoid in Parkinson's and Lewy body dementia.
    Neurology: Emergencies
  • Chemical or metabolic - opioids, other drugs, hypercalcaemia, uraemia, infection | Constant nausea, little relief from vomiting. Haloperidol 0.5–1.5 mg at night or twice daily (oral or SC). Correct the cause
    Palliative: Symptoms Management
  • Cyclizine 150 mg over 24 hours and/or haloperidol 1.5–5 mg over 24 hours.
    Palliative: Symptoms Management
4 more dose entries from the chapters

Side effects

Extrapyramidal effects, akathisia, QT prolongation, neuroleptic malignant syndrome, hyperprolactinaemia.

Interactions

QT-prolonging drugs, other dopamine antagonists, levodopa antagonism.

Special advice

ECG before use if cardiac risk; avoid in Parkinson disease and Lewy body dementia; lowest dose in older people.

More from the textbook: uses, cautions and other points

Where it is discussed

Heparin

BNF entry for Heparin · Stand-alone drug page

Mechanism

Unfractionated heparin potentiating antithrombin inhibition of thrombin and factor Xa.

Uses

Acute VTE, ACS, dialysis circuits, bridging, patients with severe renal impairment.

Dosing

3 more dose entries from the chapters

Side effects

Bleeding, heparin-induced thrombocytopenia, osteoporosis, hyperkalaemia.

Interactions

Anticoagulants, antiplatelets, NSAIDs increase bleeding risk; GTN may reduce effect.

Special advice

Monitor APTT or anti-Xa as per local protocol; check platelet counts; protamine reverses.

More from the textbook: uses, cautions and other points

Where it is discussed

Hydralazine

BNF entry for Hydralazine · Stand-alone drug page

Mechanism

Direct arterial vasodilator.

Uses

Hypertensive emergencies in pregnancy, resistant hypertension, heart failure with nitrates.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Headache, tachycardia, fluid retention, lupus-like syndrome.

Interactions

Beta-blockers limit reflex tachycardia; additive hypotension.

Special advice

Slow acetylators have higher lupus risk; avoid in SLE.

More from the textbook: uses, cautions and other points

Where it is discussed

Hydrocortisone

BNF entry for Hydrocortisone · Stand-alone drug page

Mechanism

Glucocorticoid and mineralocorticoid replacement.

Uses

Adrenal insufficiency, adrenal crisis, anaphylaxis adjunct, severe asthma, topical anti-inflammatory.

Dosing

Quick reference (Makindo topics site)

Main useAdult doseKey pearl / caution
Adrenal crisis100 mg IV then 50 mg IV qdsGive fluids and treat the precipitant too.

Source: Makindo topics, Emergency Drugs Collection (topic 1479). Editorial draft, not clinically signed off; doses are as written there. Check BNF and local policy before prescribing.

4 more dose entries from the chapters

Side effects

Hyperglycaemia, fluid retention, mood changes, adrenal suppression, infection.

Interactions

CYP3A4 inducers lower effect; diuretics and hypokalaemia.

Special advice

Sick-day rules and emergency card in adrenal insufficiency; double or triple dose in illness; never stop abruptly.

More from the textbook: uses, cautions and other points
  • ⚠️ Safety Pearl: IM adrenaline is the treatment for anaphylaxis - give it early and repeat it. Delaying adrenaline to give chlorphenamine and hydrocortisone is a common and dangerous mistake.
    Respiratory: Emergencies
  • Severe pneumonia: NICE NG250 suggests considering corticosteroids (IV hydrocortisone first). Note the MHRA warning about combining fluoroquinolones with steroids (tendon rupture).
    Respiratory: Emergencies
  • Pituitary apoplexy - bleeding into or infarction of a tumour: sudden headache, visual loss, eye movement problems and acute ACTH deficiency - give hydrocortisone.
    Endocrine: Anatomy Physiology and Pharmacology
  • Too little (adrenal insufficiency) - tiredness, weight loss, nausea, abdominal pain, low blood pressure, hyponatraemia , hypoglycaemia; adrenal crisis if stressed - an emergency needing IV or IM hydrocortisone.
    Endocrine: Anatomy Physiology and Pharmacology
  • … is in each system chapter. Your four questions for every patient: Is the patient shocked, hypoglycaemic or fitting? Could this be adrenal insufficiency (give hydrocortisone if in doubt)? What do glucose, ketones, sodium, potassium and calcium show? What triggered it?
    Endocrinology: Emergencies
  • Thyroid storm | Propranolol; propylthiouracil; iodine 1 hour later; hydrocortisone; cooling; ICU
    Endocrinology: Emergencies

Where it is discussed

Hydroxychloroquine

BNF entry for Hydroxychloroquine · Stand-alone drug page

Mechanism

Antimalarial that interferes with lysosomal activity and toll-like receptor signalling.

Uses

SLE, rheumatoid arthritis, Sjogren syndrome, malaria prophylaxis.

Dosing

  • Immunosuppressants compatible with pregnancy — prednisolone (mostly inactivated by the placenta), hydroxychloroquine , azathioprine , sulfasalazine (with folic acid 5 mg), ciclosporin, tacrolimus, most anti-TNF drugs (certolizumab minimal transfer).
    Obstetrics
  • Hydroxychloroquine | Raises lysosomal pH → impairs antigen presentation and Toll-like receptor signalling (reduces type I interferon) | Retinopathy (annual screening after 5 years; dose 5 mg/kg/day or less), QT prolongation, rare cardiomyopathy; safe in pregnancy — the backbone of SLE treatment
    Rheumatology Anatomy Physiology Pharmacology
  • Stop methotrexate (1–3 months before conception per BSR); continue sulfasalazine (with folic acid 5 mg daily) and consider adding hydroxychloroquine to keep disease controlled.
    Rheumatology: assessment, investigations and drugs
  • Hydroxychloroquine for all SLE patients unless contraindicated; aim for prednisolone 5 mg or less.
    Rheumatology: Connective tissue diseases
4 more dose entries from the chapters
  • 4. A 31-year-old woman with SLE (anti-Ro positive, antiphospholipid antibody negative) on hydroxychloroquine, mycophenolate and prednisolone 5 mg wants to become pregnant. Answer: Pre-pregnancy planning in SLE.
    Rheumatology: Emergencies, pregnancy and other systemic diseases
  • Hydroxychloroquine (and chloroquine) | Retinal toxicity ("bull's-eye" maculopathy) — irreversible; risk with dose over 5 mg/kg/day (actual body weight), long duration, renal impairment, tamoxifen — annual screening (OCT and fields) after 5 years of use (after 1 year if additional risk factors — RCOphth 2020)
    Ophthalmology: Anatomy Physiology and Pharmacology
  • 3. A 46-year-old woman with SLE has taken hydroxychloroquine 400 mg daily for 7 years. She weighs 58 kg and has eGFR 52. Answer: High risk of hydroxychloroquine retinopathy.
    Ophthalmology: Anatomy Physiology and Pharmacology
  • Hydroxychloroquine | Retinal toxicity (bull's-eye maculopathy, permanent). Keep dose at 5 mg/kg/day or less (actual body weight). RCOphth : yearly screening (OCT and fields) after 5 years , or after 1 year if extra risk (eGFR under 60, tamoxifen, higher doses).
    Ophthalmology: Neuro-ophthalmology

Side effects

Nausea, rash, headache; retinopathy with prolonged use; QT prolongation, cardiomyopathy rare.

Interactions

QT-prolonging drugs; antacids reduce absorption; digoxin levels may rise.

Special advice

Baseline and annual retinal screening after 5 years; weight-based daily dose limit.

More from the textbook: uses, cautions and other points

Where it is discussed

I

Ibuprofen

BNF entry for Ibuprofen · Stand-alone drug page

Mechanism

Non-selective NSAID inhibiting cyclo-oxygenase.

Uses

Pain, inflammation, fever, patent ductus arteriosus closure (neonates).

Dosing

4 more dose entries from the chapters
  • Ibuprofen / aspirin 400–600 mg / 900 mg | Mild migraine and tension-type headache; under 15 days a month.
    Neurology: Headache and Facial Pain
  • … or meningitis) 80 mg/kg (max 4 g) once daily Intranasal fentanyl 1.5 micrograms/kg Paracetamol oral 15 mg/kg (max 4 doses a day; age-banded doses on packets) Ibuprofen oral 5–10 mg/kg (up to 3 times a day)
    Emergency Medicine: Paediatric emergency medicine
  • Ibuprofen oral | 5–10 mg/kg (up to 3 times a day)
    Emergency Medicine: Paediatric emergency medicine
  • Step-wise approach (by pain severity — RCEM): Pain Options Mild (1–3) Oral paracetamol and/or ibuprofen Moderate (4–6) Paracetamol plus ibuprofen; oral codeine or oral morphine; Entonox for short periods Severe (7–10) IV morphine (titrated — e.g. 0.1 mg/kg in 1–2 mg increments in adults); IV paracetamol; intranasal fentanyl or …
    Emergency Medicine: ED procedures

Side effects

Dyspepsia, GI bleeding, renal impairment, hypertension, fluid retention, bronchospasm.

Interactions

Aspirin, anticoagulants, ACE inhibitors, diuretics, methotrexate, lithium; blocks aspirin antiplatelet effect.

Special advice

Take with food; avoid in kidney disease, peptic ulcer, heart failure and late pregnancy; lowest dose shortest time.

More from the textbook: uses, cautions and other points

Where it is discussed

Imipramine

BNF entry for Imipramine · Stand-alone drug page

Mechanism

Tricyclic antidepressant blocking serotonin and noradrenaline reuptake.

Uses

Depression, nocturnal enuresis, panic disorder.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Dry mouth, constipation, urinary retention, sedation, arrhythmias, postural hypotension; dangerous in overdose.

Interactions

MAOIs, serotonergic drugs, QT-prolonging drugs; CYP2D6 inhibitors raise levels.

Special advice

Limit supplies in at-risk patients; avoid after recent MI.

More from the textbook: uses, cautions and other points

Where it is discussed

Indapamide

BNF entry for Indapamide · Stand-alone drug page

Mechanism

Thiazide-like diuretic with vasodilator action.

Uses

Hypertension.

Dosing

  • 1. An 80-year-old woman on indapamide is confused. Sodium is 114 mmol/L; she has vomited and had a seizure. Answer: Severe symptomatic hyponatraemia.
    Endocrinology: Sodium and Water disorders
  • 1. An 86-year-old woman (CFS 6) is admitted after a fall. She takes: amlodipine 10 mg, ramipril 10 mg, indapamide, doxazosin, atorvastatin, aspirin 75 mg (no history of vascular disease), omeprazole 40 mg (started 6 years ago for dyspepsia), amitriptyline 25 mg (sleep), zopiclone, oxybutynin and gliclazide (HbA1c 49). Standing …
    Medicine of the older adult: .Prescribing and deprescribing in older people

Side effects

Hyponatraemia, hypokalaemia, hyperuricaemia, hypercalcaemia, rash.

Interactions

Lithium, digoxin, NSAIDs, QT-prolonging drugs (low potassium).

Special advice

Monitor sodium and potassium; avoid in severe renal or hepatic impairment.

More from the textbook: uses, cautions and other points

Where it is discussed

Infliximab

BNF entry for Infliximab · Stand-alone drug page

Mechanism

Chimeric monoclonal antibody neutralising TNF-alpha.

Uses

Crohn disease, ulcerative colitis, rheumatoid arthritis, ankylosing spondylitis, psoriasis, sarcoidosis (selected).

Dosing

4 more dose entries from the chapters

Side effects

Infusion reactions, infections, headache; reactivated TB, demyelination, hepatotoxicity, lupus-like syndrome.

Interactions

Methotrexate or azathioprine reduce antibody formation; live vaccines contraindicated.

Special advice

TB, hepatitis B and varicella screening; drug and antibody levels in loss of response.

More from the textbook: uses, cautions and other points

Where it is discussed

Insulin aspart

BNF entry for Insulin aspart · Stand-alone drug page

Mechanism

Rapid-acting insulin analogue activating insulin receptors.

Uses

Mealtime and correction insulin in type 1 and type 2 diabetes.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Hypoglycaemia, weight gain, lipohypertrophy, injection-site reactions.

Interactions

Beta-blockers mask hypoglycaemia symptoms; corticosteroids and thiazides raise glucose; alcohol.

Special advice

Inject just before or after eating; rotate sites; sick-day rules; dose by carbohydrate counting.

More from the textbook: uses, cautions and other points

Where it is discussed

Insulin glargine

BNF entry for Insulin glargine · Stand-alone drug page

Mechanism

Long-acting basal insulin analogue forming microprecipitates at injection site.

Uses

Basal insulin in type 1 and type 2 diabetes.

Dosing

  • 5. A 58-year-old man with type 2 diabetes is having a morning laparoscopic cholecystectomy as a day case. He takes metformin twice daily, gliclazide twice daily, dapagliflozin and insulin glargine at night. HbA1c is 62 mmol/mol. Answer: CPOC peri-operative diabetes plan.
    Surgery: Surgical principles and perioperative care

Side effects

Hypoglycaemia, weight gain, injection-site reactions.

Interactions

Beta-blockers mask hypoglycaemia; corticosteroids raise glucose.

Special advice

Never stop basal insulin in type 1 diabetes during illness; different strengths exist; rotate injection sites.

Where it is discussed

Ipratropium

BNF entry for Ipratropium · Stand-alone drug page

Mechanism

Antimuscarinic bronchodilator.

Uses

COPD, acute asthma (add-on), rhinitis.

Dosing

4 more dose entries from the chapters

Side effects

Dry mouth, cough, urinary retention, glaucoma risk with mask nebulisation.

Interactions

Additive antimuscarinic effects.

Special advice

Protect eyes from nebulised drug; use mouthpiece in glaucoma.

More from the textbook: uses, cautions and other points

Where it is discussed

Irbesartan

BNF entry for Irbesartan · Stand-alone drug page

Mechanism

Angiotensin II receptor blocker.

Uses

Hypertension, diabetic nephropathy.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Dizziness, hyperkalaemia, renal impairment; angioedema rare.

Interactions

NSAIDs, ACE inhibitors, potassium-sparing diuretics, lithium.

Special advice

U&E after initiation; avoid in pregnancy.

More from the textbook: uses, cautions and other points

Where it is discussed

Isosorbide mononitrate

BNF entry for Isosorbide mononitrate · Stand-alone drug page

Mechanism

Organic nitrate releasing nitric oxide to relax vascular smooth muscle.

Uses

Angina prophylaxis, heart failure (with hydralazine).

Dosing

Side effects

Headache, flushing, hypotension, tolerance.

Interactions

PDE5 inhibitors contraindicated; antihypertensives additive.

Special advice

Use a nitrate-free interval to avoid tolerance; avoid if hypertrophic obstructive cardiomyopathy or hypotension.

More from the textbook: uses, cautions and other points

Where it is discussed

Isotretinoin

BNF entry for Isotretinoin · Stand-alone drug page

Mechanism

Retinoid modulating sebum production, keratinisation and inflammation.

Uses

Severe acne unresponsive to other treatment (specialist).

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Dry skin and lips, photosensitivity, raised lipids and liver enzymes, mood changes; teratogenic.

Interactions

Tetracyclines (raised intracranial pressure); vitamin A supplements; methotrexate.

Special advice

Pregnancy prevention programme; monthly pregnancy tests; monitor lipids, LFT and mood.

More from the textbook: uses, cautions and other points
  • Raised intracranial pressure (IIH) | Tetracyclines (doxycycline, minocycline), isotretinoin and vitamin A, steroid withdrawal, lithium, growth hormone
    Neurology: Anatomy, Physiology and Pharmacology
  • Drugs - tetracyclines (doxycycline, minocycline), retinoids (isotretinoin), lithium, growth hormone, steroid withdrawal.
    Neurology: Headache and Facial Pain
  • Pregnancy prevention programmes — valproate , isotretinoin and oral retinoids, topiramate (MHRA 2024), thalidomide-type drugs — highly effective contraception and annual review.
    Obstetrics
  • Isotretinoin and oral retinoids (acitretin) | Severe craniofacial, cardiac and CNS defects — pregnancy prevention programme
    Obstetrics
  • Review medicines - stop or switch teratogenic drugs (e.g. valproate, isotretinoin, warfarin, ACE inhibitors, methotrexate, mycophenolate); don't stop essential drugs suddenly without advice.
    Obstetrics: Antenatal Care
  • Isotretinoin , acitretin | Severe malformations; pregnancy prevention programme.
    Obstetrics: Medical Problems

Where it is discussed

Itraconazole

BNF entry for Itraconazole · Stand-alone drug page

Mechanism

Triazole antifungal inhibiting ergosterol synthesis.

Uses

Aspergillosis, histoplasmosis, nail and skin fungal infection.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Nausea, rash, heart failure exacerbation, hepatotoxicity, QT prolongation.

Interactions

Potent CYP3A4 inhibitor; PPIs reduce absorption of capsules.

Special advice

Take capsules with food and acid; avoid in heart failure; monitor LFT.

More from the textbook: uses, cautions and other points
  • Interactions - CYP3A4 inhibitors ( clarithromycin , erythromycin, itraconazole, grapefruit juice with simvastatin), amiodarone and diltiazem (simvastatin dose limits), fibrates (gemfibrozil - avoid).
    Cardiology: Anatomy Physiology and Pharmacology
  • Antifungals - voriconazole (aspergillosis - visual disturbance, photosensitivity, skin cancer risk, many interactions); itraconazole (ABPA, chronic aspergillosis).
    Respiratory: Anatomy, Physiology and Pharmacology
  • Itraconazole (antifungal) to reduce the fungal load and steroid needs - check levels and watch for interactions (including steroid interactions causing Cushing's).
    Respiratory: Airways Disease
  • Itraconazole | ABPA; check levels and interactions (including with inhaled budesonide - risk of Cushing's).
    Respiratory: Airways Disease
  • Long courses of oral antifungals (itraconazole or voriconazole) for at least 6 months.
    Respiratory: Infections
  • Itraconazole / voriconazole | Chronic pulmonary aspergillosis (and ABPA); voriconazole for invasive aspergillosis. Level monitoring; many interactions; voriconazole causes visual disturbance and photosensitivity.
    Respiratory: Infections

Where it is discussed

K

Ketamine

BNF entry for Ketamine · Stand-alone drug page

Mechanism

NMDA receptor antagonist producing dissociative anaesthesia.

Uses

Procedural sedation and anaesthesia induction, analgesia, refractory depression (specialist).

Dosing

  • Ketamine at sub-dissociative doses (e.g. 0.1–0.3 mg/kg IV) — for severe pain, opioid-tolerant patients.
    Emergency Medicine: ED procedures
  • Ketamine sedation | 1–1.5 mg/kg IV; airway reflexes kept | Laryngospasm, emergence, vomiting
    Emergency Medicine: ED procedures
  • Induction — ketamine (1–2 mg/kg — haemodynamically safer in shock), propofol (1–2.5 mg/kg — reduced doses in unstable patients), thiopental (traditional for obstetric RSI), etomidate (adrenal suppression — not routinely in UK); often with fentanyl.
    Anaesthesia: Airway management and anaesthetic drugs
  • Ketamine | NMDA antagonist; 1–2 mg/kg IV, 5–10 mg/kg IM | Maintains BP (sympathomimetic), bronchodilator (asthma), analgesia, airway reflexes partly kept — shock, trauma, prehospital | Emergence phenomena, hypersalivation, raised BP and heart rate (IHD), possibly raised ICP (not clinically important — now used in head injury)
    Anaesthesia: Airway management and anaesthetic drugs

Side effects

Hallucinations, emergence reactions, hypertension, tachycardia, raised intracranial pressure, urological toxicity with chronic use.

Interactions

CNS depressants additive; theophylline lowers seizure threshold.

Special advice

Maintains airway reflexes better than other agents; caution in severe hypertension and psychosis.

More from the textbook: uses, cautions and other points
  • Glutamate | Main excitatory transmitter; learning and memory (NMDA and AMPA receptors) | Excitotoxic cell death in stroke and trauma; memantine and ketamine block NMDA; perampanel blocks AMPA; riluzole reduces release (MND)
    Neurology: Anatomy, Physiology and Pharmacology
  • Recreational drugs - boosters raise levels of MDMA, ketamine, GHB and some opioids (dangerous toxicity).
    ID: HIV, viral hepatitis and blood-borne viruses
  • Esketamine nasal spray - licensed for treatment-resistant depression but not recommended by NICE; ketamine used in some specialist services.
    Psychiatry: assessment, treatment and the law
  • Early sedation - IM or IV benzodiazepines; ketamine (IM) by experienced clinicians in some departments.
    Psychiatric emergencies
  • Ketamine (IM) | Severe acute behavioural disturbance by experienced emergency clinicians.
    Psychiatric emergencies
  • Substance use - alcohol, cannabis, vaping, nitrous oxide, ketamine (bladder damage); brief interventions, young people's substance misuse services; think about exploitation and safeguarding.
    Psychiatry: Safeguarding

Where it is discussed

Ketoconazole

BNF entry for Ketoconazole · Stand-alone drug page

Mechanism

Imidazole antifungal inhibiting ergosterol and steroid synthesis.

Uses

Cushing syndrome (off-label), topical seborrhoeic dermatitis and dandruff.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Hepatotoxicity, adrenal suppression, QT prolongation, nausea.

Interactions

Potent CYP3A4 inhibitor; QT-prolonging drugs; PPIs reduce absorption.

Special advice

Oral systemic use restricted for fungal infection because of liver toxicity; monitor LFT.

More from the textbook: uses, cautions and other points
  • Cushing's syndrome (before surgery or if surgery isn't possible) - metyrapone and osilodrostat (block cortisol synthesis - risk of adrenal insufficiency and low potassium/high blood pressure from precursor build-up), ketoconazole (liver toxicity - specialist), etomidate IV in severe cases.
    Endocrine: Anatomy Physiology and Pharmacology
  • Etomidate , ketoconazole, metyrapone | Adrenal suppression
    Endocrine: Anatomy Physiology and Pharmacology
  • … adrenal haemorrhage (anticoagulants, meningococcal sepsis, antiphospholipid syndrome); metastases (lung, breast, melanoma); bilateral adrenalectomy; drugs (ketoconazole, metyrapone, osilodrostat, etomidate, mitotane); adrenoleukodystrophy (young men); congenital adrenal hyperplasia; HIV-related infections; infiltration …
    Endocrinology: Adrenal Disease
  • Urgent medical control of cortisol: Metyrapone, osilodrostat or ketoconazole; IV etomidate in severe cases.
    Endocrinology: Adrenal Disease
  • Reduced absorption of drugs needing acid - itraconazole, ketoconazole, iron, levothyroxine, some HIV drugs (atazanavir, rilpivirine - avoid).
    Gastroenterology: Anatomy Physiology Pharmacology
  • Hepatocellular (ALT up) | Paracetamol (overdose), isoniazid , rifampicin, pyrazinamide, valproate , methotrexate, statins (usually mild), amiodarone, nitrofurantoin , ketoconazole, NSAIDs (diclofenac), herbal supplements (green tea extract, kava, turmeric), checkpoint inhibitors
    Gastroenterology: Anatomy Physiology Pharmacology

Where it is discussed

L

Labetalol

BNF entry for Labetalol · Stand-alone drug page

Mechanism

Combined alpha-1 and non-selective beta blocker.

Uses

Hypertension in pregnancy, hypertensive emergencies, acute aortic dissection (adjunct).

Dosing

Quick reference (Makindo topics site)

Main useAdult doseKey pearl / caution
Hypertensive emergency20–80 mg IV bolus every 10 min prnCaution in asthma, bradycardia, heart failure.

Source: Makindo topics, Emergency Drugs Collection (topic 1479). Editorial draft, not clinically signed off; doses are as written there. Check BNF and local policy before prescribing.

Side effects

Postural hypotension, bradycardia, bronchospasm, fatigue, tingling scalp, hepatotoxicity.

Interactions

Verapamil and diltiazem; halothane; additive hypotension.

Special advice

Avoid in asthma and heart block; rapid IV bolus can cause severe hypotension; first-line oral agent in pregnancy.

More from the textbook: uses, cautions and other points

Where it is discussed

Lacosamide

BNF entry for Lacosamide · Stand-alone drug page

Mechanism

Enhances slow inactivation of voltage-gated sodium channels.

Uses

Focal seizures (monotherapy or adjunct).

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Dizziness, diplopia, headache, nausea, PR prolongation.

Interactions

Other sodium-channel blockers; PR-prolonging drugs.

Special advice

ECG in cardiac conduction disease; avoid abrupt withdrawal.

More from the textbook: uses, cautions and other points
  • Drugs that block sodium channels - carbamazepine , phenytoin , lamotrigine , lacosamide (epilepsy), lidocaine and other local anaesthetics, class I antiarrhythmics, tricyclic antidepressants in overdose.
    Neurology: Anatomy, Physiology and Pharmacology
  • How they work - block sodium channels (carbamazepine, lamotrigine, phenytoin, lacosamide, oxcarbazepine), block calcium channels (ethosuximide - T-type, for absence; gabapentin, pregabalin), boost GABA (benzodiazepines, phenobarbital, valproate, vigabatrin), bind SV2A (levetiracetam, brivaracetam), or block glutamate …
    Neurology: Anatomy, Physiology and Pharmacology
  • Focal seizures | Lamotrigine or levetiracetam . Alternatives: carbamazepine, oxcarbazepine, zonisamide, lacosamide
    Neurology: Epilepsy
  • Lacosamide: Dizziness, PR prolongation (check ECG).
    Neurology: Epilepsy

Where it is discussed

Lamotrigine

BNF entry for Lamotrigine · Stand-alone drug page

Mechanism

Blocks voltage-gated sodium channels and glutamate release.

Uses

Epilepsy (focal and generalised), bipolar disorder maintenance.

Dosing

  • Folic acid 5 mg if she might become pregnant; discuss contraception (lamotrigine levels fall with the combined pill); DVLA advice.
    Neurology: Anatomy, Physiology and Pharmacology
  • If pregnancy is planned, consider switching to lamotrigine or levetiracetam and start folic acid 5 mg.
    Neurology: Epilepsy
  • Pregnancy: folic acid 5 mg; lamotrigine and levetiracetam are the safest; don't stop drugs suddenly.
    Neurology: Epilepsy
  • Carbamazepine, phenytoin, phenobarbital, topiramate | Malformations (NTDs, cleft lip and palate, heart defects); topiramate — cleft lip, low birth weight, possible neurodevelopmental effects; lamotrigine and levetiracetam are preferred (with folic acid 5 mg)
    Obstetrics
3 more dose entries from the chapters
  • Epilepsy — lamotrigine and levetiracetam preferred; folic acid 5 mg; never stop AEDs abruptly; vitamin K is no longer routinely given to mothers.
    Obstetrics
  • Epilepsy | Lamotrigine or levetiracetam ; folic acid 5 mg; avoid valproate
    Clinical pharmacology and prescribing: Prescribing in special groups
  • … risk of neurodevelopmental disorders. Under the Pregnancy Prevention Programme, she should have urgent specialist review to switch to a safer antiepileptic (e.g. lamotrigine or levetiracetam) before conception, and take folic acid 5 mg daily.
    Anatomy: Embryology and development

Side effects

Rash (including Stevens-Johnson), dizziness, headache, diplopia, tremor.

Interactions

Valproate more than doubles levels (halve dose); enzyme inducers halve levels; oestrogen contraceptives lower levels.

Special advice

Titrate slowly to reduce rash risk; stop at any rash with fever; restart titration if missed for more than 5 half-lives.

More from the textbook: uses, cautions and other points
  • Combined pill (oestrogen raises binding proteins) - falsely raises total T4 and cortisol; interacts with enzyme inducers (rifampicin, carbamazepine, St John's wort) and lamotrigine.
    Endocrine: Anatomy Physiology and Pharmacology
  • Drugs that block sodium channels - carbamazepine , phenytoin , lamotrigine , lacosamide (epilepsy), lidocaine and other local anaesthetics, class I antiarrhythmics, tricyclic antidepressants in overdose.
    Neurology: Anatomy, Physiology and Pharmacology
  • How they work - block sodium channels (carbamazepine, lamotrigine, phenytoin, lacosamide, oxcarbazepine), block calcium channels (ethosuximide - T-type, for absence; gabapentin, pregabalin), boost GABA (benzodiazepines, phenobarbital, valproate, vigabatrin), bind SV2A (levetiracetam, brivaracetam), or block glutamate …
    Neurology: Anatomy, Physiology and Pharmacology
  • Juvenile myoclonic epilepsy | Teenagers; morning myoclonic jerks , tonic-clonic seizures (often after sleep deprivation or alcohol), sometimes absences. Lifelong. Valproate (men), levetiracetam or lamotrigine. Carbamazepine, phenytoin and gabapentin worsen it
    Neurology: Epilepsy
  • Dravet syndrome | SCN1A gene; prolonged fever-related seizures in infancy. Avoid sodium-channel blockers (carbamazepine, lamotrigine). Cannabidiol and fenfluramine
    Neurology: Epilepsy
  • SUNCT / SUNA | Very brief stabbing attacks (seconds to minutes), up to hundreds a day, with eye watering and redness. Lamotrigine first line; MRI to look for nerve compression
    Neurology: Headache and Facial Pain

Where it is discussed

Lansoprazole

BNF entry for Lansoprazole · Stand-alone drug page

Mechanism

Proton pump inhibitor.

Uses

GORD, peptic ulcer, H. pylori regimens, NSAID gastroprotection.

Dosing

Side effects

Headache, diarrhoea, hypomagnesaemia, B12 deficiency, fracture risk, C. difficile.

Interactions

Reduces absorption of iron and levothyroxine; methotrexate levels rise.

Special advice

Review long-term need; take 30 minutes before food.

More from the textbook: uses, cautions and other points

Where it is discussed

Latanoprost

BNF entry for Latanoprost · Stand-alone drug page

Mechanism

Prostaglandin F2-alpha analogue increasing uveoscleral outflow.

Uses

Open-angle glaucoma and ocular hypertension.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Eye redness, iris and eyelash changes, periocular pigmentation, stinging.

Interactions

Few; other prostaglandin analogues avoided.

Special advice

Once daily in the evening; warn about permanent iris colour change; remove contact lenses before use.

More from the textbook: uses, cautions and other points
  • Prostaglandin analogues (latanoprost, bimatoprost, travoprost) — once daily at night; first-line drops | Increase uveoscleral outflow | Darkening of the iris (permanent, brown), eyelash growth , periocular skin darkening, periorbital fat loss, red eye; caution in uveitis and after complicated cataract surgery (macular oedema)
    Ophthalmology: Anatomy Physiology and Pharmacology
  • Prostaglandin analogues (latanoprost, bimatoprost, travoprost) - first-line drops , once at night. Increase outflow. Side effects: darker iris colour , longer eyelashes, red eyes, darkened eyelid skin.
    Ophthalmology Basics Cataract Glaucoma
  • Latanoprost (prostaglandin analogue) | First-line glaucoma drop, once at night. Darker iris, long lashes, red eye.
    Ophthalmology Basics Cataract Glaucoma

Where it is discussed

Levetiracetam

BNF entry for Levetiracetam · Stand-alone drug page

Mechanism

Binds synaptic vesicle protein SV2A.

Uses

Focal and generalised seizures, status epilepticus (second line), myoclonic seizures.

Dosing

Quick reference (Makindo topics site)

Main useAdult doseKey pearl / caution
Second-line status epilepticus / seizuresUsually 1–3 g IV loadDose-adjust in renal impairment.

Source: Makindo topics, Emergency Drugs Collection (topic 1479). Editorial draft, not clinically signed off; doses are as written there. Check BNF and local policy before prescribing.

  • IV levetiracetam (about 60 mg/kg, maximum 4.5 g) over about 10 minutes.
    Neurology: Anatomy, Physiology and Pharmacology
  • Status epilepticus | Benzodiazepine (IV lorazepam 4 mg or buccal midazolam 10 mg), repeat at 5–10 minutes; then levetiracetam, phenytoin or valproate; ICU
    Neurology: Emergencies
  • Levetiracetam IV (e.g. 60 mg/kg, maximum 4.5 g, over about 10–15 minutes) - quick to give, with fewer side effects.
    Neurology: Emergencies
  • If pregnancy is planned, consider switching to lamotrigine or levetiracetam and start folic acid 5 mg.
    Neurology: Epilepsy
4 more dose entries from the chapters
  • Pregnancy: folic acid 5 mg; lamotrigine and levetiracetam are the safest; don't stop drugs suddenly.
    Neurology: Epilepsy
  • Seizures (e.g. brain tumours): Continue antiepileptics by a non-oral route (SC levetiracetam via pump or midazolam in the pump). Buccal or SC midazolam 10 mg for a seizure.
    Palliative: End of Life Care
  • Carbamazepine, phenytoin, phenobarbital, topiramate | Malformations (NTDs, cleft lip and palate, heart defects); topiramate — cleft lip, low birth weight, possible neurodevelopmental effects; lamotrigine and levetiracetam are preferred (with folic acid 5 mg)
    Obstetrics
  • Epilepsy — lamotrigine and levetiracetam preferred; folic acid 5 mg; never stop AEDs abruptly; vitamin K is no longer routinely given to mothers.
    Obstetrics

Side effects

Drowsiness, irritability, depression and behavioural change, fatigue.

Interactions

Few pharmacokinetic interactions.

Special advice

Adjust dose in renal impairment; mood and behaviour changes may need dose change or switch.

More from the textbook: uses, cautions and other points
  • Vesicles release neurotransmitter (vesicle protein SV2A is the target of levetiracetam ; botulinum toxin blocks release; tetanus toxin blocks inhibitory release in the spinal cord).
    Neurology: Anatomy, Physiology and Pharmacology
  • … block calcium channels (ethosuximide - T-type, for absence; gabapentin, pregabalin), boost GABA (benzodiazepines, phenobarbital, valproate, vigabatrin), bind SV2A (levetiracetam, brivaracetam), or block glutamate (perampanel, topiramate). Several act in more than one way.
    Neurology: Anatomy, Physiology and Pharmacology
  • If still fitting: IV levetiracetam (or phenytoin or valproate).
    Neurology: Emergencies
  • Status epilepticus: benzodiazepine twice, then levetiracetam, phenytoin or valproate, then ICU.
    Neurology: Emergencies
  • Juvenile myoclonic epilepsy | Teenagers; morning myoclonic jerks , tonic-clonic seizures (often after sleep deprivation or alcohol), sometimes absences. Lifelong. Valproate (men), levetiracetam or lamotrigine. Carbamazepine, phenytoin and gabapentin worsen it
    Neurology: Epilepsy
  • Focal seizures | Lamotrigine or levetiracetam . Alternatives: carbamazepine, oxcarbazepine, zonisamide, lacosamide
    Neurology: Epilepsy

Where it is discussed

Levothyroxine

BNF entry for Levothyroxine · Stand-alone drug page

Mechanism

Synthetic T4, converted to active T3.

Uses

Hypothyroidism, TSH suppression in thyroid cancer.

Dosing

Side effects

With over-replacement: palpitations, AF, weight loss, tremor, osteoporosis, anxiety.

Interactions

Iron, calcium, PPIs and cholestyramine reduce absorption; enzyme inducers increase requirement; warfarin effect rises as thyroid function normalises.

Special advice

Take on an empty stomach 30–60 minutes before food, separate from iron and calcium by 4 hours; check TSH 6–8 weeks after dose change; start low in older people and cardiac disease.

More from the textbook: uses, cautions and other points

Where it is discussed

Lidocaine

BNF entry for Lidocaine · Stand-alone drug page

Mechanism

Class Ib sodium-channel blocker; local anaesthetic.

Uses

Local and regional anaesthesia, ventricular arrhythmia (when amiodarone unavailable), topical analgesia.

Dosing

4 more dose entries from the chapters

Side effects

Perioral numbness, dizziness, confusion, seizures, bradycardia, hypotension; toxicity if intravascular or excess.

Interactions

Beta-blockers and cimetidine reduce clearance; additive with other antiarrhythmics.

Special advice

Check maximum dose by weight with and without adrenaline; have lipid emulsion available for local anaesthetic toxicity; reduce in liver failure and heart failure.

More from the textbook: uses, cautions and other points

Where it is discussed

Linagliptin

BNF entry for Linagliptin · Stand-alone drug page

Mechanism

DPP-4 inhibitor raising incretin levels.

Uses

Type 2 diabetes.

Dosing

  • Linagliptin 5 mg daily (no renal dose adjustment - useful in CKD).
    Endocrinology: Diabetes
  • Sitagliptin / linagliptin Type 2 | Sitagliptin 100 mg daily (reduce in CKD). Linagliptin 5 mg daily (no renal adjustment). Not with GLP-1 agonists.
    Endocrinology: Diabetes

Side effects

Nasopharyngitis, pancreatitis (rare), arthralgia, bullous pemphigoid.

Interactions

Rifampicin reduces effect; sulfonylureas increase hypoglycaemia.

Special advice

No renal dose adjustment; stop if pancreatitis suspected.

More from the textbook: uses, cautions and other points

Where it is discussed

Lithium

BNF entry for Lithium · Stand-alone drug page

Mechanism

Mood stabiliser; inhibits inositol monophosphatase and GSK-3.

Uses

Bipolar disorder prophylaxis, resistant depression, cluster headache (specialist).

Dosing

3 more dose entries from the chapters

Side effects

Tremor, polyuria, hypothyroidism, hypercalcaemia, weight gain, renal impairment; toxicity causes ataxia, confusion, seizures.

Interactions

NSAIDs, ACE inhibitors, ARBs, thiazides and loop diuretics raise levels; dehydration.

Special advice

Narrow therapeutic index; level 12 hours post-dose; monitor U&E, TFT and calcium; stop in vomiting or diarrhoea; carry lithium card.

More from the textbook: uses, cautions and other points

Where it is discussed

Loperamide

BNF entry for Loperamide · Stand-alone drug page

Mechanism

Opioid agonist at gut mu receptors reducing motility.

Uses

Acute non-infective diarrhoea, chronic diarrhoea, ileostomy output.

Dosing

  • Loperamide 2 mg after each loose stool (max 16 mg/day) | IBS-D, bile acid diarrhoea, incontinence; avoid in colitis and C. difficile.
    Gastroenterology: Bowel Disorders
  • High-dose loperamide (4 mg, then 2 mg every 2 hours).
    Oncology: Emergencies
  • Restrict hypotonic oral fluids (about 500–1,000 mL a day) and give an oral rehydration solution (St Mark's); loperamide 30–60 minutes before meals (high doses may be needed), ± codeine and a PPI.
    Surgery: Colorectal and anal surgery

Side effects

Constipation, abdominal cramps, ileus, toxic megacolon; cardiac toxicity in overdose.

Interactions

CYP3A4 and P-gp inhibitors raise systemic exposure.

Special advice

Avoid in bloody diarrhoea, fever, C. difficile and acute colitis.

More from the textbook: uses, cautions and other points

Where it is discussed

Loratadine

BNF entry for Loratadine · Stand-alone drug page

Mechanism

Non-sedating H1 antihistamine.

Uses

Allergic rhinitis, urticaria.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Headache, dry mouth, drowsiness uncommon.

Interactions

Few; CYP3A4 and 2D6 inhibitors modest effect.

Special advice

Once daily; reduced dose in severe liver impairment.

More from the textbook: uses, cautions and other points

Where it is discussed

Lorazepam

BNF entry for Lorazepam · Stand-alone drug page

Mechanism

Benzodiazepine enhancing GABA-A activity.

Uses

Status epilepticus, acute agitation, anxiety, sedation, alcohol withdrawal.

Dosing

Quick reference (Makindo topics site)

Main useAdult doseKey pearl / caution
Status epilepticus2–4 mg IV, may repeat onceBe airway-ready; check glucose early.

Source: Makindo topics, Emergency Drugs Collection (topic 1479). Editorial draft, not clinically signed off; doses are as written there. Check BNF and local policy before prescribing.

4 more dose entries from the chapters

Side effects

Drowsiness, respiratory depression, ataxia, dependence, confusion in older adults.

Interactions

Opioids, alcohol, CNS depressants; valproate raises levels.

Special advice

Short-acting; avoid long-term use; refrigerate injection; monitor airway and breathing with IV doses.

More from the textbook: uses, cautions and other points

Where it is discussed

Losartan

BNF entry for Losartan · Stand-alone drug page

Mechanism

Angiotensin II receptor blocker.

Uses

Hypertension, heart failure, diabetic nephropathy, stroke prevention in LVH.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Dizziness, hyperkalaemia, renal impairment, angioedema rare.

Interactions

NSAIDs, potassium-sparing diuretics, ACE inhibitors, lithium.

Special advice

Check U&E after starting; avoid in pregnancy and bilateral renal artery stenosis.

More from the textbook: uses, cautions and other points

Where it is discussed

M

Magnesium sulfate

BNF entry for Magnesium sulfate · Stand-alone drug page

Mechanism

Calcium antagonist and NMDA blocker; cofactor for ATP-dependent enzymes.

Uses

Pre-eclampsia seizure prophylaxis and treatment, torsades de pointes, severe asthma (selected), hypomagnesaemia.

Dosing

Quick reference (Makindo topics site)

Main useAdult doseKey pearl / caution
Torsades / eclampsia / severe asthma2 g IV over 10–15 minCaution in renal failure; watch reflexes and respiratory rate.

Source: Makindo topics, Emergency Drugs Collection (topic 1479). Editorial draft, not clinically signed off; doses are as written there. Check BNF and local policy before prescribing.

Check: the Resuscitation Council UK tachycardia algorithm gives 2 g over 10 minutes for torsades.

4 more dose entries from the chapters

Side effects

Flushing, hypotension, loss of tendon reflexes, respiratory depression, muscle weakness.

Interactions

Calcium channel blockers, neuromuscular blockers potentiated; aminoglycosides.

Special advice

Monitor reflexes, respiratory rate and urine output; calcium gluconate as antidote; reduce dose in renal impairment.

More from the textbook: uses, cautions and other points

Where it is discussed

Melatonin

BNF entry for Melatonin · Stand-alone drug page

Mechanism

Hormone acting at MT1 and MT2 receptors regulating circadian rhythm.

Uses

Insomnia in people aged 55 and over (short term), sleep disorders in neurodevelopmental conditions.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Headache, drowsiness, nausea, nightmares.

Interactions

Fluvoxamine raises levels; smoking and carbamazepine reduce levels.

Special advice

Take 1–2 hours before bedtime; prescribed modified-release licensed for short courses.

More from the textbook: uses, cautions and other points

Where it is discussed

Memantine

BNF entry for Memantine · Stand-alone drug page

Mechanism

NMDA receptor antagonist.

Uses

Moderate to severe Alzheimer disease.

Dosing

Side effects

Dizziness, headache, constipation, hypertension, confusion.

Interactions

Other NMDA antagonists (amantadine, ketamine, dextromethorphan).

Special advice

Titrate slowly; reduce dose in renal impairment; caution in epilepsy.

More from the textbook: uses, cautions and other points

Where it is discussed

Meropenem

BNF entry for Meropenem · Stand-alone drug page

Mechanism

Carbapenem inhibiting cell-wall synthesis; broad spectrum.

Uses

Severe sepsis, nosocomial infection, meningitis, febrile neutropenia, ESBL infection.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Diarrhoea, nausea, rash, seizures, C. difficile.

Interactions

Valproate levels fall markedly (avoid combination); probenecid raises levels.

Special advice

Reduce dose in renal impairment; cross-reactivity with penicillin allergy is low but check history.

More from the textbook: uses, cautions and other points
  • Severe or higher risk of resistance (e.g. recent antibiotics, ICU, known resistant organisms): IV piperacillin-tazobactam , a cephalosporin or meropenem, guided by local microbiology.
    Respiratory: Emergencies
  • Interactions - enzyme inhibitor : doubles lamotrigine levels (rash risk - use a lower, slower lamotrigine titration); carbapenems (meropenem) cause a rapid, large fall in valproate levels (avoid - seizures).
    Neurology: Anatomy, Physiology and Pharmacology
  • Seizures return when a patient on valproate gets meropenem | Carbapenem interaction - valproate levels crash
    Neurology: Anatomy, Physiology and Pharmacology
  • Penicillin allergy: Follow local policy (e.g. meropenem for non-severe allergy; other combinations for severe allergy).
    Oncology: Emergencies
  • Pseudomonas - naturally resistant to many drugs; options include piperacillin–tazobactam, ceftazidime, meropenem, ciprofloxacin, aminoglycosides.
    ID: How Infection Happens
  • Meropenem / ertapenem | ESBL and severe sepsis; reserve; seizures; lowers valproate.
    ID: How Infection Happens

Where it is discussed

Mesalazine

BNF entry for Mesalazine · Stand-alone drug page

Mechanism

5-aminosalicylate with local anti-inflammatory action in gut mucosa.

Uses

Ulcerative colitis induction and maintenance, mild Crohn colitis.

Dosing

Side effects

Headache, nausea, abdominal pain; rarely interstitial nephritis, pancreatitis, blood dyscrasias.

Interactions

Azathioprine may increase myelosuppression; nephrotoxic drugs.

Special advice

Monitor renal function at baseline and periodically; choose formulation by site of disease.

More from the textbook: uses, cautions and other points

Where it is discussed

Metformin

BNF entry for Metformin · Stand-alone drug page

Mechanism

Biguanide reducing hepatic gluconeogenesis and improving insulin sensitivity.

Uses

Type 2 diabetes, polycystic ovary syndrome (off-label).

Dosing

  • Established atherosclerotic cardiovascular disease: Triple therapy - metformin MR, an SGLT2 inhibitor and subcutaneous semaglutide - added in sequence, titrating semaglutide to 1 mg weekly.
    Endocrinology: Diabetes
  • Metformin MR Type 2 first-line | 500 mg daily with the evening meal, titrated to max 2 g daily. Max 1 g/day if eGFR below 45; stop if below 30. GI upset; B12 deficiency.
    Endocrinology: Diabetes
  • 1. A 62-year-old with type 2 diabetes has eGFR 41 and ACR 58 mg/mmol (confirmed). She takes metformin 1 g twice daily and amlodipine. BP 148/88. Answer: Diabetic kidney disease, CKD G3b A3.
    Renal: Chronic Kidney Disease
  • Reduce metformin (eGFR under 45); atorvastatin 20 mg; BP target under 140/90 (under 130/80 if ACR 70 or more).
    Renal: Chronic Kidney Disease
4 more dose entries from the chapters

Side effects

Gastrointestinal upset, metallic taste, B12 deficiency, rarely lactic acidosis.

Interactions

Iodinated contrast, alcohol excess, cimetidine; hold with acute kidney injury.

Special advice

Titrate slowly with meals; review if eGFR below 45 and stop if below 30; sick-day rules; check B12 periodically.

More from the textbook: uses, cautions and other points
  • Sick-day rules — temporarily stop ACE inhibitors, ARBs, diuretics, SGLT2 inhibitors and metformin during dehydrating illness — give individualised advice, not blanket instructions.
    Cardiology: Presentations
  • Hold metformin around the procedure if kidney function is impaired.
    Cardiology Investigations
  • Metformin - usually continued if eGFR is 30 or more; withhold for 48 hours after contrast if eGFR is below 30 or there is AKI (follow local radiology guidance).
    Cardiology Investigations
  • Iodinated contrast (CT with contrast, CTPA) - check kidney function, allergy history and metformin (follow local radiology guidance).
    Respiratory: Investigations
  • NICE NG28 - offer an SGLT2 inhibitor with metformin in type 2 diabetes if there is heart failure, established cardiovascular disease or high cardiovascular risk (check the current version - recent updates widen early use).
    Endocrine: Anatomy Physiology and Pharmacology
  • Metformin | First-line type 2; GI upset, B12 deficiency; stop if eGFR under 30 and during dehydrating illness.
    Endocrine: Anatomy Physiology and Pharmacology

Where it is discussed

Methadone

BNF entry for Methadone · Stand-alone drug page

Mechanism

Long-acting mu-opioid agonist and NMDA antagonist.

Uses

Opioid dependence substitution, chronic and neuropathic pain (specialist).

Dosing

Side effects

Respiratory depression, constipation, QT prolongation, sedation, sweating.

Interactions

CYP3A4 inhibitors and inducers, QT-prolonging drugs, benzodiazepines.

Special advice

Long variable half-life; accumulation causes late overdose; supervised dosing; ECG if cardiac risk; do not restart at previous dose after a break.

More from the textbook: uses, cautions and other points

Where it is discussed

Methotrexate

BNF entry for Methotrexate · Stand-alone drug page

Mechanism

Folate antagonist inhibiting dihydrofolate reductase.

Uses

Rheumatoid arthritis, psoriasis, Crohn disease, malignancy, ectopic pregnancy.

Dosing

  • Treatment: Corticosteroids (e.g. prednisolone 30–40 mg daily, tapered) for active disease, with methotrexate as a steroid-sparing agent and anti-TNF therapy for refractory cases.
    Cardiology: Cardiomyopathies › 3.30 Cardiac Sarcoidosis
  • Methotrexate 25 mg weekly, then 15 mg weekly | Crohn's; folic acid 5 mg weekly; teratogenic; once WEEKLY.
    Gastroenterology: Inflammatory Bowel Disease
  • Treatment toxicity checks: baseline echo and cumulative anthracycline dose (usually kept below 450 mg/m²); rituximab infusion reactions (slow first infusion, premedicate); vincristine neuropathy and constipation; methotrexate clearance (avoid NSAIDs, PPIs and co-trimoxazole during high-dose methotrexate).
    Haematology: Myeloma and Lymphoma
  • Methotrexate 50 mg/m² IM | Stable ectopic meeting criteria; hCG days 4 and 7; avoid pregnancy for 3 months.
    Obstetrics: Antenatal Care
4 more dose entries from the chapters
  • 2. A 24-year-old at 6 weeks has left iliac fossa pain and light bleeding. She is stable. Scan shows a 25 mm left adnexal mass, no heartbeat, empty womb. hCG is 1,200 IU/L. Answer: Unruptured tubal ectopic pregnancy suitable for methotrexate (or expectant management if hCG falling and pain-free).
    Obstetrics: Antenatal Care
  • 3. A 52-year-old woman with RA on methotrexate 15 mg weekly is prescribed trimethoprim for a UTI. She develops mouth ulcers and a sore throat. Answer: Methotrexate toxicity (myelosuppression) from an antifolate interaction.
    Rheumatology Anatomy Physiology Pharmacology
  • 2. A 58-year-old woman on methotrexate 15 mg weekly for RA is prescribed trimethoprim for a UTI. A week later she has mouth ulcers, fever and bruising. Neutrophils 0.3, platelets 35. Answer: Methotrexate toxicity (marrow suppression) from a trimethoprim interaction.
    Rheumatology: assessment, investigations and drugs
  • Stop methotrexate (1–3 months before conception per BSR); continue sulfasalazine (with folic acid 5 mg daily) and consider adding hydroxychloroquine to keep disease controlled.
    Rheumatology: assessment, investigations and drugs

Side effects

Nausea, mucositis, marrow suppression, hepatotoxicity, pneumonitis, teratogenic.

Interactions

Trimethoprim and co-trimoxazole (severe marrow suppression), NSAIDs, PPIs, penicillins reduce clearance.

Special advice

Once-weekly dosing for autoimmune disease; error causes fatalities; folic acid weekly; FBC, LFT and U&E monitoring; avoid in pregnancy.

More from the textbook: uses, cautions and other points

Where it is discussed

Methylphenidate

BNF entry for Methylphenidate · Stand-alone drug page

Mechanism

Dopamine and noradrenaline reuptake inhibitor.

Uses

ADHD, narcolepsy.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Reduced appetite, insomnia, tachycardia, hypertension, anxiety, tics, growth effects in children.

Interactions

MAOIs contraindicated; antihypertensives antagonised.

Special advice

Monitor BP, pulse, weight and height; controlled drug; misuse potential; take earlier in the day.

More from the textbook: uses, cautions and other points

Where it is discussed

Metoclopramide

BNF entry for Metoclopramide · Stand-alone drug page

Mechanism

Dopamine D2 antagonist and 5-HT4 agonist.

Uses

Nausea and vomiting, gastroparesis, migraine adjunct.

Dosing

4 more dose entries from the chapters
  • Metoclopramide 10 mg up to three times daily | Gastroparesis and nausea; MHRA limit 5 days; extrapyramidal effects and tardive dyskinesia; avoid in Parkinson's.
    Gastroenterology: Oesophagus and Stomach
  • Antiemetics: Metoclopramide 10 mg or prochlorperazine - they help nausea and also absorption of other drugs.
    Neurology: Headache and Facial Pain
  • Gastric stasis - "squashed stomach" (liver enlargement, ascites), autonomic failure, opioids | Early fullness, large-volume vomits soon after eating, relief after vomiting. Metoclopramide 10 mg three times daily (or domperidone). Avoid in complete bowel obstruction
    Palliative: Symptoms Management
  • Metoclopramide 10 mg three times daily | Gastric stasis; hiccups; avoid in complete obstruction with colic and in Parkinson's.
    Palliative: Symptoms Management

Side effects

Extrapyramidal effects (especially in young women), drowsiness, tardive dyskinesia, hyperprolactinaemia.

Interactions

Antipsychotics increase extrapyramidal risk; opioids and antimuscarinics antagonise effect.

Special advice

Maximum 5 days; avoid in Parkinson disease, bowel obstruction and age under 20 for acute dystonia risk.

More from the textbook: uses, cautions and other points
  • Causes of high prolactin - pregnancy and breastfeeding, drugs (antipsychotics, metoclopramide, domperidone, some antidepressants), prolactinoma, stalk compression, primary hypothyroidism (high TRH stimulates prolactin), kidney failure, stress (including a difficult blood test), seizures, chest wall injury, macroprolactin …
    Endocrine: Anatomy Physiology and Pharmacology
  • Antipsychotics , metoclopramide, domperidone | Hyperprolactinaemia ; olanzapine and clozapine - weight gain and diabetes
    Endocrine: Anatomy Physiology and Pharmacology
  • Gastroparesis - early fullness, vomiting, bloating and erratic glucose (food absorbed unpredictably, causing post-meal hypoglycaemia). Manage with small, low-fat, low-fibre meals; prokinetics (metoclopramide or domperidone short-term, erythromycin); adjust insulin timing; gastric electrical stimulation in severe cases.
    Endocrinology: Diabetes
  • Triggers: Surgery, anaesthesia, tumour manipulation, contrast, beta-blockers given alone , glucocorticoids, metoclopramide, tricyclics, pregnancy and labour.
    Endocrinology: Emergencies
  • BP 260/140 after metoclopramide, known adrenal mass | Phaeochromocytoma crisis
    Endocrinology: Emergencies
  • Metoclopramide and domperidone .
    Endocrinology: Pituitary Disease

Where it is discussed

Metoprolol

BNF entry for Metoprolol · Stand-alone drug page

Mechanism

Cardioselective beta-1 blocker.

Uses

Angina, hypertension, heart failure, post-MI, arrhythmia, migraine prophylaxis.

Dosing

Side effects

Bradycardia, fatigue, cold extremities, bronchospasm, sleep disturbance.

Interactions

Verapamil and diltiazem (heart block); clonidine rebound; insulin masks hypoglycaemia.

Special advice

Do not stop abruptly; avoid in severe asthma and heart block.

More from the textbook: uses, cautions and other points

Where it is discussed

Metronidazole

BNF entry for Metronidazole · Stand-alone drug page

Mechanism

Nitroimidazole forming DNA-damaging radicals in anaerobes and protozoa.

Uses

Anaerobic infection, C. difficile (alternative), amoebiasis, giardiasis, bacterial vaginosis, trichomoniasis.

Dosing

4 more dose entries from the chapters
  • Metronidazole (e.g. 400 mg three times daily for 5 days) or tinidazole.
    Gastroenterology: Bowel Disorders
  • Systemically unwell, immunosuppressed or significant comorbidity: Co-amoxiclav (500/125 mg three times daily for 5 days) - or cefalexin plus metronidazole, or trimethoprim plus metronidazole, if allergic to penicillin.
    Gastroenterology: Bowel Disorders
  • Metronidazole 400 mg twice daily for 7 days (or 2 g single dose); avoid alcohol during and 48 hours after.
    Gynaecology: Sexual health
  • Treatment - metronidazole 400 mg twice daily for 7 days (preferred over a single 2 g dose); treat partners ; avoid sex until both treated; test for other STIs.
    Gynaecology: Sexual health

Side effects

Metallic taste, nausea, peripheral neuropathy with prolonged use, disulfiram-like reaction.

Interactions

Alcohol; warfarin effect rises; lithium levels rise.

Special advice

Avoid alcohol during and 48 hours after; limit prolonged courses because of neuropathy.

More from the textbook: uses, cautions and other points

Where it is discussed

Miconazole

BNF entry for Miconazole · Stand-alone drug page

Mechanism

Imidazole antifungal inhibiting ergosterol synthesis.

Uses

Oral and skin candidiasis, tinea.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Local irritation; oral gel absorbed systemically with interactions.

Interactions

Oral gel inhibits warfarin metabolism (raised INR); CYP3A4 substrates.

Special advice

Check INR if on warfarin; apply after food.

More from the textbook: uses, cautions and other points
  • Enzyme inhibitors - amiodarone , fluconazole and miconazole (including oral gel ), metronidazole , clarithromycin and erythromycin, ciprofloxacin , co-trimoxazole , allopurinol, cimetidine, SSRIs (fluoxetine, fluvoxamine).
    Haematology: Anatomy Physiology and Pharmacology
  • Warfarin interactions: amiodarone, azoles (including miconazole gel), macrolides, metronidazole raise INR; rifampicin, carbamazepine, St John's wort lower it.
    Haematology: Anatomy Physiology and Pharmacology
  • Nipple thrush - burning, shooting pain after feeds, shiny skin; baby has oral thrush: treat both (miconazole for mother's nipples, miconazole or nystatin for the baby).
    Obstetrics: Post Natal Care
  • Topical - terbinafine cream (1–2 weeks) or an imidazole (clotrimazole, miconazole -2–4 weeks, continue 1–2 weeks after clearing).
    Dermatology: Skin infections and infestations
  • Treatment - keep skin folds dry; topical imidazole (clotrimazole, miconazole) for 2 weeks (with mild steroid if inflamed); oral fluconazole for extensive or resistant infection; check glucose or HbA1c if recurrent.
    Dermatology: Skin infections and infestations
  • Treatment - miconazole oral gel (avoid with warfarin - raises INR), nystatin, or oral fluconazole; denture hygiene; rinse after inhalers.
    ENT: Common Nose and Throat disorders

Where it is discussed

Midazolam

BNF entry for Midazolam · Stand-alone drug page

Mechanism

Short-acting benzodiazepine.

Uses

Procedural sedation, status epilepticus (buccal), palliative care seizures and agitation, anaesthesia premedication.

Dosing

4 more dose entries from the chapters

Side effects

Respiratory depression, hypotension, paradoxical agitation, amnesia.

Interactions

CYP3A4 inhibitors raise levels; opioids synergistic.

Special advice

Monitor oxygen saturation and airway; reduce dose in older people; flumazenil reverses sedation.

More from the textbook: uses, cautions and other points
  • Bronchoscopy and EBUS - sedation (midazolam, opioids - respiratory depression in type 2 respiratory failure); risks of bleeding (stop anticoagulants and clopidogrel per protocol before biopsy), pneumothorax after transbronchial biopsy, hypoxia, infection; fast beforehand; check platelets and clotting.
    Respiratory: Investigations
  • Sedation: Throat spray alone, or IV sedation (midazolam with or without an opioid).
    Gastroenterology: Investigations
  • Midazolam | Conscious sedation; lower doses in older people; reverse with flumazenil.
    Gastroenterology: Investigations
  • Bleeding near the end of life: Agree a plan in advance (dark towels, midazolam).
    Gastroenterology: Cirrhosis and Transplantation
  • Third-line (refractory status) - about 30–45 minutes after onset: anaesthetist and ITU - rapid sequence induction with propofol, thiopental or midazolam, with EEG monitoring.
    Neurology: Anatomy, Physiology and Pharmacology
  • ⚠️ Safety Pearl: Count every benzodiazepine dose given before arrival (buccal midazolam by family or paramedics counts). Two doses total, then move to a second-line drug - more benzodiazepines mostly add respiratory depression.
    Neurology: Anatomy, Physiology and Pharmacology

Where it is discussed

Minoxidil

BNF entry for Minoxidil · Stand-alone drug page

Mechanism

Direct arterial vasodilator opening potassium channels.

Uses

Resistant hypertension (oral), alopecia (topical).

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Fluid retention, tachycardia, hypertrichosis, pericardial effusion.

Interactions

Combine with beta-blocker and loop diuretic to limit side effects.

Special advice

Specialist use for hypertension; pericardial effusion risk.

More from the textbook: uses, cautions and other points

Where it is discussed

Mirtazapine

BNF entry for Mirtazapine · Stand-alone drug page

Mechanism

Alpha-2 antagonist increasing noradrenaline and serotonin release; H1 antagonist.

Uses

Depression, particularly with insomnia and poor appetite.

Dosing

Side effects

Sedation, weight gain, increased appetite, dizziness; neutropenia rare.

Interactions

MAOIs; alcohol and sedatives additive; carbamazepine reduces levels.

Special advice

Take at night; useful in older people with weight loss; report fever or sore throat.

More from the textbook: uses, cautions and other points

Where it is discussed

Morphine

BNF entry for Morphine · Stand-alone drug page

Mechanism

Mu-opioid receptor agonist.

Uses

Severe pain, acute pulmonary oedema (selected), palliative breathlessness, MI analgesia.

Dosing

4 more dose entries from the chapters
  • Immediate-release morphine (e.g. oral solution) 2.5–5 mg every 4 hours as needed , then convert to regular dosing; or
    Palliative: Symptoms Management
  • Modified-release morphine 10–15 mg twice daily , plus immediate-release morphine for breakthrough pain.
    Palliative: Symptoms Management
  • Pain or breathlessness | Morphine 2–5 mg SC hourly as needed (opioid-naive), or 1/6 of the 24-hour SC dose if already on opioids. eGFR under 30 - oxycodone 1–2 mg SC or alfentanil (specialist advice)
    Palliative: End of Life Care
  • From oral morphine: Divide the 24-hour total by 2 for SC morphine (e.g. MR morphine 30 mg twice daily = 60 mg a day oral = 30 mg SC over 24 hours ).
    Palliative: End of Life Care

Side effects

Constipation, nausea, drowsiness, respiratory depression, itching, hypotension; metabolites accumulate in renal failure.

Interactions

Benzodiazepines, alcohol and CNS depressants; MAOIs.

Special advice

Co-prescribe laxatives; prefer alternatives (oxycodone) in renal impairment; titrate cautiously; naloxone for toxicity.

More from the textbook: uses, cautions and other points

Where it is discussed

Moxifloxacin

BNF entry for Moxifloxacin · Stand-alone drug page

Mechanism

Fluoroquinolone inhibiting DNA gyrase and topoisomerase IV.

Uses

Community-acquired pneumonia (second line), TB (second line), pelvic infection (specialist).

Dosing

  • Doxycycline 100 mg twice daily for 7 days , then moxifloxacin 400 mg daily for 10 days (if macrolide resistance or status unknown).
    Gynaecology: Sexual health
  • Moxifloxacin 400 mg for 10 days | Mycoplasma genitalium (after doxycycline); QT and tendon risks.
    Gynaecology: Sexual health

Side effects

Tendinopathy, QT prolongation, C. difficile, aortic aneurysm, neuropsychiatric effects, hypoglycaemia.

Interactions

QT-prolonging drugs; corticosteroids increase tendon rupture risk; antacids reduce absorption.

Special advice

Restricted to specialist guidance under MHRA warnings; stop at first tendon pain.

More from the textbook: uses, cautions and other points
  • All-oral regimens built around newer drugs - bedaquiline , pretomanid and linezolid (with or without moxifloxacin) for 6 months (the "BPaL(M)" regimen) in many cases, or longer individualised regimens.
    Respiratory: Infections
  • Side effects: QT prolongation (bedaquiline, moxifloxacin), and myelosuppression and neuropathy (linezolid).
    Respiratory: Infections
  • Kidney impairment | No dose change usually - ceftriaxone, doxycycline, clindamycin, linezolid, moxifloxacin, metronidazole | Reduce - most penicillins and cephalosporins at low eGFR (seizures), aminoglycosides , vancomycin , aciclovir , co-trimoxazole, fluconazole; avoid nitrofurantoin if eGFR under 45
    ID: How Infection Happens
  • All-oral regimens built around newer drugs — bedaquiline , pretomanid and linezolid (with or without moxifloxacin) for 6 months (the "BPaL(M)" regimen) in many cases, or longer individualised regimens.
    Integrated respiratory chapter › 4.13 Drug-resistant TB
  • Multidrug-resistant TB (resistant to rifampicin and isoniazid) - specialist regimens (e.g. BPaLM: bedaquiline, pretomanid, linezolid ± moxifloxacin).
    Microbiology: Bacteriology - structure, classification and important pathogens
  • DNA gyrase | Fluoroquinolones | Ciprofloxacin, levofloxacin, moxifloxacin | Ciprofloxacin - Gram-negatives including Pseudomonas; levofloxacin and moxifloxacin - respiratory
    Microbiology: Diagnostic microbiology, antimicrobials and resistance

Where it is discussed

Mycophenolate mofetil

BNF entry for Mycophenolate mofetil · Stand-alone drug page

Mechanism

Inhibits inosine monophosphate dehydrogenase, reducing lymphocyte proliferation.

Uses

Transplant rejection prophylaxis, lupus nephritis, vasculitis.

Dosing

Side effects

Diarrhoea, nausea, leucopenia, infection, teratogenicity.

Interactions

Antacids and PPIs reduce absorption; azathioprine increases marrow suppression.

Special advice

Pregnancy prevention programme; monitor FBC; avoid live vaccines.

More from the textbook: uses, cautions and other points

Where it is discussed

N

Naloxone

BNF entry for Naloxone · Stand-alone drug page

Mechanism

Competitive opioid receptor antagonist.

Uses

Opioid overdose reversal, postoperative respiratory depression.

Dosing

Quick reference (Makindo topics site)

Main useAdult doseKey pearl / caution
Opioid toxicity0.04–0.4 mg IV titratedReverse breathing, not full consciousness.

Source: Makindo topics, Emergency Drugs Collection (topic 1479). Editorial draft, not clinically signed off; doses are as written there. Check BNF and local policy before prescribing.

  • Opioid toxicity | Support breathing; naloxone 400 micrograms IV/IM (titrate smaller doses in opioid-dependent or palliative patients)
    Respiratory: Emergencies
  • Naloxone 400 micrograms IV or IM , repeated as needed.
    Respiratory: Emergencies
  • Action: Reduce or stop the dose, hydrate, and switch opioid if needed. Naloxone only for serious respiratory depression (small titrated doses - e.g. 20–40 micrograms IV at a time) to avoid sudden severe pain.
    Palliative: Symptoms Management
  • IV morphine | Titrate 1–2 mg increments | Respiratory depression — naloxone
    Emergency Medicine: ED procedures
4 more dose entries from the chapters

Side effects

Withdrawal in dependent patients (agitation, vomiting, pulmonary oedema), short duration.

Interactions

Reverses opioid analgesia.

Special advice

Short half-life, so re-sedation may occur; observe and repeat or infuse; titrate in postoperative use.

More from the textbook: uses, cautions and other points

Where it is discussed

Naproxen

BNF entry for Naproxen · Stand-alone drug page

Mechanism

Non-selective NSAID.

Uses

Pain and inflammation, gout, inflammatory arthritis, dysmenorrhoea.

Dosing

Side effects

Dyspepsia, GI bleeding, renal impairment, hypertension; lower cardiovascular risk than diclofenac.

Interactions

Anticoagulants, ACE inhibitors, diuretics, methotrexate, lithium.

Special advice

Take with food and consider PPI; avoid in renal impairment and heart failure.

More from the textbook: uses, cautions and other points

Where it is discussed

Nebivolol

BNF entry for Nebivolol · Stand-alone drug page

Mechanism

Cardioselective beta blocker with nitric oxide-mediated vasodilation.

Uses

Hypertension, heart failure in older people.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Bradycardia, headache, fatigue, dizziness.

Interactions

Verapamil and diltiazem; clonidine; amiodarone.

Special advice

Do not stop abruptly; caution in asthma.

More from the textbook: uses, cautions and other points

Where it is discussed

Neostigmine

BNF entry for Neostigmine · Stand-alone drug page

Mechanism

Reversible acetylcholinesterase inhibitor.

Uses

Reversal of non-depolarising muscle relaxants, myasthenia gravis, acute colonic pseudo-obstruction (specialist).

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Bradycardia, salivation, bronchospasm, abdominal cramps.

Interactions

Given with glycopyrronium or atropine to counter muscarinic effects.

Special advice

Cholinergic crisis if excess; monitor ECG when used for pseudo-obstruction.

More from the textbook: uses, cautions and other points

Where it is discussed

Nifedipine

BNF entry for Nifedipine · Stand-alone drug page

Mechanism

Dihydropyridine calcium channel blocker.

Uses

Hypertension, angina, Raynaud phenomenon, preterm labour tocolysis, hypertension in pregnancy.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Ankle oedema, flushing, headache, palpitations, gingival hyperplasia.

Interactions

CYP3A4 inhibitors (clarithromycin) and grapefruit raise levels; beta-blockers hypotension.

Special advice

Avoid short-acting capsules for hypertension; avoid in unstable angina and severe aortic stenosis.

More from the textbook: uses, cautions and other points

Where it is discussed

Nitrofurantoin

BNF entry for Nitrofurantoin · Stand-alone drug page

Mechanism

Damages bacterial DNA and ribosomes; concentrates in urine.

Uses

Uncomplicated lower urinary tract infection, prophylaxis.

Dosing

Side effects

Nausea, rash, pulmonary reactions, hepatitis, peripheral neuropathy.

Interactions

Antacids (magnesium trisilicate) reduce absorption; quinolones antagonistic.

Special advice

Avoid if eGFR below 45 (short-course use allowed with caution), at term and in G6PD deficiency; take with food.

More from the textbook: uses, cautions and other points

Where it is discussed

Noradrenaline

BNF entry for Noradrenaline · Stand-alone drug page

Mechanism

Alpha-1 agonist with beta-1 effect; vasopressor.

Uses

Septic and vasodilatory shock, hypotension unresponsive to fluids.

Dosing

  • 3. A 60-year-old man with septic shock from cholangitis has a MAP of 55 mmHg despite 30 mL/kg of fluid and noradrenaline at 0.4 micrograms/kg/min. Lactate is 6. Answer: Refractory septic shock.
    Critical care: Admission and organ support

Side effects

Hypertension, bradycardia, arrhythmia, peripheral and mesenteric ischaemia, extravasation necrosis.

Interactions

MAOIs, tricyclics and linezolid potentiate; beta-blockers.

Special advice

Central line infusion with invasive BP monitoring; titrate to MAP target; correct hypovolaemia first.

More from the textbook: uses, cautions and other points

Where it is discussed

Nortriptyline

BNF entry for Nortriptyline · Stand-alone drug page

Mechanism

Tricyclic antidepressant, mainly noradrenaline reuptake inhibitor.

Uses

Depression, neuropathic pain, smoking cessation (off-label).

Dosing

  • Amitriptyline (and nortriptyline) - TCA; start low at night (10 mg); side effects - drowsiness, dry mouth, constipation, urinary retention, weight gain, postural hypotension, QT prolongation ; dangerous in overdose (arrhythmias, seizures); caution in older people and heart disease.
    Neurology: Anatomy, Physiology and Pharmacology

Side effects

Dry mouth, constipation, sedation, urinary retention, arrhythmia, postural hypotension; toxic in overdose.

Interactions

MAOIs, other serotonergic drugs, QT-prolonging drugs.

Special advice

Lower anticholinergic burden than amitriptyline; limit supplies if overdose risk.

More from the textbook: uses, cautions and other points

Where it is discussed

Nystatin

BNF entry for Nystatin · Stand-alone drug page

Mechanism

Polyene antifungal binding fungal membrane ergosterol.

Uses

Oral and intestinal candidiasis.

Dosing

  • Oral candida - white plaques, sore red mouth. Nystatin suspension or fluconazole 50 mg daily for 7 days (watch interactions). Clean dentures.
    Palliative: Symptoms Management

Side effects

Nausea, diarrhoea at high doses; not absorbed.

Interactions

None significant.

Special advice

Hold in mouth after food; treat dentures; continue 48 hours after clearance.

More from the textbook: uses, cautions and other points
  • Nipple thrush - burning, shooting pain after feeds, shiny skin; baby has oral thrush: treat both (miconazole for mother's nipples, miconazole or nystatin for the baby).
    Obstetrics: Post Natal Care
  • Oral thrush - miconazole oral gel (warfarin interaction) or nystatin; fluconazole if severe; rinse mouth after inhaled steroids.
    Dermatology: Skin infections and infestations
  • Treatment - miconazole oral gel (avoid with warfarin - raises INR), nystatin, or oral fluconazole; denture hygiene; rinse after inhalers.
    ENT: Common Nose and Throat disorders
  • Miconazole oral gel / nystatin / fluconazole | Oral candida; miconazole raises INR with warfarin.
    ENT: Common Nose and Throat disorders
  • Nystatin , miconazole, clotrimazole | Topical and oral thrush, vaginal candidiasis | Nystatin not absorbed; miconazole oral gel raises INR with warfarin
    ID: How Infection Happens
  • Oral thrush - white plaques that can be scraped off; dentures, inhaled steroids, antibiotics, diabetes, immunosuppression, frailty - nystatin or miconazole gel ( raises INR with warfarin ), or fluconazole.
    ID: Viral, fungal and parasitic infections

Where it is discussed

O

Olanzapine

BNF entry for Olanzapine · Stand-alone drug page

Mechanism

Atypical antipsychotic blocking dopamine and serotonin receptors.

Uses

Schizophrenia, bipolar mania, agitation, nausea (palliative).

Dosing

  • 5. A 30-year-old man with schizophrenia has gained 15 kg on olanzapine. HbA1c is 50 mmol/mol. Answer: Antipsychotic-induced weight gain and type 2 diabetes.
    Psychiatry: Psychosis and schizophrenia

Side effects

Weight gain, metabolic syndrome, sedation, sialorrhoea; neuroleptic malignant syndrome.

Interactions

CNS depressants; smoking reduces levels; fluvoxamine raises levels; parenteral IM olanzapine with benzodiazepine caution.

Special advice

Monitor weight, glucose and lipids; avoid in dementia with Lewy bodies.

More from the textbook: uses, cautions and other points

Where it is discussed

Omeprazole

BNF entry for Omeprazole · Stand-alone drug page

Mechanism

Proton pump inhibitor.

Uses

GORD, peptic ulcer, H. pylori regimens, gastroprotection with NSAIDs.

Dosing

2 more dose entries from the chapters
  • 3. A 72-year-old man has tiredness. Hb 92 g/L, MCV 71 fL, ferritin 6 micrograms/L. He takes omeprazole. He has no GI symptoms. Answer: Iron deficiency anaemia - must be investigated for GI cancer.
    Haematology: Anatomy Physiology and Pharmacology
  • … (CFS 6) is admitted after a fall. She takes: amlodipine 10 mg, ramipril 10 mg, indapamide, doxazosin, atorvastatin, aspirin 75 mg (no history of vascular disease), omeprazole 40 mg (started 6 years ago for dyspepsia), amitriptyline 25 mg (sleep), zopiclone, oxybutynin and gliclazide (HbA1c 49). Standing BP 106/60. Answer: …
    Medicine of the older adult: .Prescribing and deprescribing in older people

Side effects

Headache, diarrhoea, hypomagnesaemia, B12 deficiency, fracture risk, C. difficile.

Interactions

Clopidogrel activation reduced; methotrexate levels rise; reduces absorption of iron and levothyroxine.

Special advice

Review long-term need; use the lowest effective dose.

More from the textbook: uses, cautions and other points

Where it is discussed

Ondansetron

BNF entry for Ondansetron · Stand-alone drug page

Mechanism

5-HT3 receptor antagonist.

Uses

Chemotherapy and postoperative nausea and vomiting, hyperemesis (selected).

Dosing

Side effects

Constipation, headache, QT prolongation, flushing.

Interactions

QT-prolonging drugs; apomorphine contraindicated.

Special advice

Check electrolytes and ECG in cardiac risk; avoid in congenital long QT.

More from the textbook: uses, cautions and other points

Where it is discussed

Oseltamivir

BNF entry for Oseltamivir · Stand-alone drug page

Mechanism

Neuraminidase inhibitor preventing viral release.

Uses

Influenza treatment and prophylaxis.

Dosing

  • Oseltamivir Influenza | 75 mg twice daily for 5 days (adjust for renal function); for at-risk patients and all hospital admissions with suspected influenza in season.
    Respiratory: Infections

Side effects

Nausea, vomiting, headache, neuropsychiatric events rare.

Interactions

Few; probenecid raises levels.

Special advice

Start within 48 hours of symptoms in at-risk patients; adjust for renal function.

More from the textbook: uses, cautions and other points
  • Antivirals - oseltamivir for influenza in at-risk people (within 48 hours); COVID-19 antivirals in eligible high-risk patients.
    Respiratory: Anatomy, Physiology and Pharmacology
  • Influenza in season: Antivirals (e.g. oseltamivir) for hospitalised patients.
    Respiratory: Emergencies
  • Influenza - oseltamivir (oral) within 48 hours of symptoms for people at risk of complications, all hospitalised patients with suspected influenza, and as post-exposure prophylaxis in at-risk groups when flu is circulating (NICE); zanamivir (inhaled - bronchospasm; IV for resistant or severe cases).
    ID: How Infection Happens
  • Oseltamivir | Influenza within 48 hours in at-risk and hospitalised patients.
    ID: How Infection Happens
  • Treatment - oseltamivir (5 days) for at-risk people with influenza-like illness when flu is circulating, ideally within 48 hours of symptoms, and for all hospitalised patients with suspected influenza (even later); zanamivir for resistance or severe illness; treat bacterial complications.
    ID: Viral, fungal and parasitic infections
  • Oseltamivir | Influenza - at-risk within 48 hours, all hospitalised; prophylaxis in outbreaks.
    ID: Viral, fungal and parasitic infections

Where it is discussed

Oxybutynin

BNF entry for Oxybutynin · Stand-alone drug page

Mechanism

Antimuscarinic reducing detrusor contractions.

Uses

Overactive bladder, nocturnal enuresis, hyperhidrosis.

Dosing

  • … dysfunction, gynaecomastia; halves PSA (double the value when interpreting) Combination Bothersome symptoms with a large prostate Both sets Antimuscarinic (oxybutynin, solifenacin) or mirabegron Storage symptoms (overactive bladder) if persisting Antimuscarinics - dry mouth, constipation, confusion in older people …
    Surgey: Urology
  • 2. A 78-year-old man had a hip replacement 2 days ago. He hasn't passed urine for 10 hours and has lower abdominal pain. A bladder scan shows 950 mL. He takes oxybutynin and morphine. Answer: Acute urinary retention (post-operative, drug-related, likely BPH).
    Surgey: Urology
  • … atorvastatin, aspirin 75 mg (no history of vascular disease), omeprazole 40 mg (started 6 years ago for dyspepsia), amitriptyline 25 mg (sleep), zopiclone, oxybutynin and gliclazide (HbA1c 49). Standing BP 106/60. Answer: Problematic polypharmacy contributing to falls.
    Medicine of the older adult: .Prescribing and deprescribing in older people

Side effects

Dry mouth, constipation, blurred vision, confusion, urinary retention.

Interactions

Other anticholinergics additive; acetylcholinesterase inhibitors antagonistic.

Special advice

Avoid in older people with cognitive impairment; consider mirabegron as alternative.

More from the textbook: uses, cautions and other points

Where it is discussed

Oxycodone

BNF entry for Oxycodone · Stand-alone drug page

Mechanism

Mu-opioid receptor agonist.

Uses

Moderate to severe pain, breakthrough pain, palliative care.

Dosing

1 more dose entries from the chapters

Side effects

Constipation, nausea, sedation, respiratory depression, dependence.

Interactions

Benzodiazepines, alcohol, CYP3A4 inhibitors (clarithromycin, ritonavir).

Special advice

Co-prescribe laxatives; safer than morphine in renal impairment; avoid abrupt withdrawal.

More from the textbook: uses, cautions and other points
  • Opioids: Use cautiously at low doses; they can trigger encephalopathy (through constipation and sedation). Give laxatives. Avoid codeine, and avoid morphine in severe disease (oxycodone in low doses, or fentanyl, is used with specialist advice).
    Gastroenterology: Cirrhosis and Transplantation
  • Morphine and codeine (active metabolites - drowsiness, myoclonus, respiratory depression) - prefer low-dose oxycodone, or fentanyl or alfentanil in advanced CKD and palliative care; tramadol with caution.
    Renal: Anatomy, Physiology and Pharmacology
  • Switch to a safer opioid at a low dose (e.g. oxycodone with caution, or fentanyl or alfentanil with specialist advice); regular paracetamol; consider a nerve block for the hip.
    Renal: Anatomy, Physiology and Pharmacology
  • Opioids - avoid morphine and codeine in advanced CKD (metabolites accumulate); oxycodone with caution; fentanyl, alfentanil and buprenorphine are safer.
    Renal: Chronic Kidney Disease
  • Strong opioid for severe pain - e.g. morphine or diamorphine (IV, SC or intranasal), or oral oxycodone. Avoid pethidine .
    Haematology: Haemoglobinopathies and Transfusion
  • Strong opioid (morphine, diamorphine, oxycodone) | Sickle pain crisis within 30 minutes; reassess every 30 minutes; avoid pethidine; laxative and antiemetic.
    Haematology: Haemoglobinopathies and Transfusion

Where it is discussed

P

Pantoprazole

BNF entry for Pantoprazole · Stand-alone drug page

Mechanism

Proton pump inhibitor.

Uses

GORD, peptic ulcer, gastroprotection with NSAIDs.

Dosing

Side effects

Headache, diarrhoea, hypomagnesaemia, B12 deficiency, fracture risk, C. difficile.

Interactions

Lower CYP2C19 inhibition so less effect on clopidogrel; reduces iron and levothyroxine absorption.

Special advice

Review long-term need; IV form available.

More from the textbook: uses, cautions and other points

Where it is discussed

Paracetamol

BNF entry for Paracetamol · Stand-alone drug page

Mechanism

Analgesic and antipyretic acting centrally (COX inhibition and other pathways).

Uses

Pain, fever.

Dosing

4 more dose entries from the chapters

Side effects

Rare at therapeutic dose; hepatotoxicity in overdose.

Interactions

Warfarin effect may rise with regular use; flucloxacillin with paracetamol and acidosis risk.

Special advice

Dose by weight if under 50 kg or at risk of hepatotoxicity; overdose treated with acetylcysteine by protocol.

More from the textbook: uses, cautions and other points

Where it is discussed

Phenobarbital

BNF entry for Phenobarbital · Stand-alone drug page

Mechanism

Barbiturate enhancing GABA-A activity.

Uses

Seizures (including neonatal), status epilepticus (later line), alcohol withdrawal (selected).

Dosing

  • Carbamazepine, phenytoin, phenobarbital, topiramate | Malformations (NTDs, cleft lip and palate, heart defects); topiramate — cleft lip, low birth weight, possible neurodevelopmental effects; lamotrigine and levetiracetam are preferred (with folic acid 5 mg)
    Obstetrics

Side effects

Sedation, cognitive slowing, respiratory depression, rash, osteomalacia, dependence.

Interactions

Strong CYP inducer reducing levels of warfarin, contraceptives, DOACs, many drugs.

Special advice

Long half-life; levels useful; avoid abrupt withdrawal.

More from the textbook: uses, cautions and other points
  • Crigler–Najjar syndrome: Severe lack of the same enzyme - high unconjugated bilirubin in infants. Type 1 risks kernicterus (phototherapy, transplant). Type 2 responds to phenobarbital.
    Gastroenterology: Liver disease
  • … phenytoin, lacosamide, oxcarbazepine), block calcium channels (ethosuximide - T-type, for absence; gabapentin, pregabalin), boost GABA (benzodiazepines, phenobarbital, valproate, vigabatrin), bind SV2A (levetiracetam, brivaracetam), or block glutamate (perampanel, topiramate). Several act in more than one way.
    Neurology: Anatomy, Physiology and Pharmacology
  • Brand consistency (MHRA categories) - keep patients on the same manufacturer for category 1 drugs ( phenytoin, carbamazepine, phenobarbital, primidone ); use clinical judgement for category 2 (valproate, lamotrigine, topiramate, oxcarbazepine, clobazam, others).
    Neurology: Anatomy, Physiology and Pharmacology
  • Third line (refractory status, usually at about 30–60 minutes): General anaesthesia in ICU (e.g. propofol or midazolam infusion) with EEG monitoring, or phenobarbital.
    Neurology: Emergencies
  • Prescribe by brand for some drugs (category 1 - carbamazepine, phenytoin, phenobarbital, primidone ) to avoid switching between products.
    Neurology: Epilepsy
  • Enzyme-inducing drugs (carbamazepine, oxcarbazepine, phenytoin, phenobarbital, topiramate, eslicarbazepine) make the combined pill, progestogen-only pill and implant unreliable.
    Neurology: Epilepsy

Where it is discussed

Phenytoin

BNF entry for Phenytoin · Stand-alone drug page

Mechanism

Blocks voltage-gated sodium channels.

Uses

Focal and generalised tonic-clonic seizures, status epilepticus (second line).

Dosing

Quick reference (Makindo topics site)

Main useAdult doseKey pearl / caution
Second-line status epilepticus15–20 mg/kg IV at ≤50 mg/minECG and BP monitoring needed.

Source: Makindo topics, Emergency Drugs Collection (topic 1479). Editorial draft, not clinically signed off; doses are as written there. Check BNF and local policy before prescribing.

4 more dose entries from the chapters
  • Phenytoin IV (20 mg/kg, no faster than 50 mg/minute, with ECG and BP monitoring).
    Neurology: Emergencies
  • Carbamazepine, phenytoin, phenobarbital, topiramate | Malformations (NTDs, cleft lip and palate, heart defects); topiramate — cleft lip, low birth weight, possible neurodevelopmental effects; lamotrigine and levetiracetam are preferred (with folic acid 5 mg)
    Obstetrics
  • Second line — levetiracetam (40–60 mg/kg), phenytoin (20 mg/kg) or sodium valproate (40 mg/kg) over 5–20 minutes.
    Emergency Medicine: Paediatric emergency medicine
  • Loading dose - a larger first dose to reach the target level quickly, when waiting 4–5 half-lives would be too slow: digoxin , amiodarone , phenytoin (and levetiracetam in status), vancomycin , teicoplanin, aminophylline , warfarin (in some regimens), clopidogrel (300–600 mg in ACS), ticagrelor.
    Clinical pharmacology and prescribing: Principles of clinical pharmacology

Side effects

Nystagmus, ataxia, gingival hyperplasia, hirsutism, rash, osteomalacia; IV causes hypotension and arrhythmia.

Interactions

Strong enzyme inducer; many interactions including warfarin and contraceptives; amiodarone and fluconazole raise levels.

Special advice

Non-linear kinetics; monitor levels; IV must be slow with ECG and BP monitoring; avoid extravasation.

More from the textbook: uses, cautions and other points
  • Many interactions - enzyme inhibitors raise INR (amiodarone, clarithromycin, erythromycin, fluconazole, metronidazole, ciprofloxacin, alcohol binges); inducers lower it (rifampicin, carbamazepine, phenytoin, St John's wort); diet (vitamin K-rich foods).
    Cardiology: Anatomy Physiology and Pharmacology
  • Metabolised by CYP1A2 - levels raised by ciprofloxacin , clarithromycin , erythromycin, fluvoxamine, cimetidine, heart failure, liver disease, viral infection, stopping smoking; lowered by smoking , rifampicin, carbamazepine, phenytoin, alcohol.
    Respiratory: Anatomy, Physiology and Pharmacology
  • Interactions - CYP3A4 inhibitors (ritonavir and cobicistat, itraconazole, clarithromycin) block breakdown of inhaled or nasal fluticasone and budesonide → Cushing's syndrome and adrenal suppression; enzyme inducers (rifampicin, carbamazepine, phenytoin) reduce steroid effect - double replacement doses may be needed.
    Endocrine: Anatomy Physiology and Pharmacology
  • Enzyme inducers (rifampicin, carbamazepine, phenytoin) increase steroid requirements.
    Endocrinology: Adrenal Disease
  • Enzyme inducers (rifampicin, phenytoin, carbamazepine): Speed up steroid breakdown, which can precipitate crisis in treated patients. They may need higher doses.
    Endocrinology: Adrenal Disease
  • Enzyme inducers (carbamazepine, phenytoin, rifampicin) speed up breakdown.
    Endocrinology: Thyroid disease

Where it is discussed

Pioglitazone

BNF entry for Pioglitazone · Stand-alone drug page

Mechanism

Thiazolidinedione PPAR-gamma agonist improving insulin sensitivity.

Uses

Type 2 diabetes.

Dosing

  • Pioglitazone Type 2 | 15–30 mg daily (max 45 mg). Contraindicated in heart failure; fluid retention, fractures, bladder cancer caution.
    Endocrinology: Diabetes

Side effects

Fluid retention, weight gain, fractures, heart failure, bladder cancer risk.

Interactions

Gemfibrozil raises levels; insulin increases oedema.

Special advice

Contraindicated in heart failure; stop if macular oedema or haematuria without cause.

More from the textbook: uses, cautions and other points

Where it is discussed

Piperacillin and tazobactam

BNF entry for Piperacillin and tazobactam · Stand-alone drug page

Mechanism

Broad-spectrum penicillin with beta-lactamase inhibitor.

Uses

Severe sepsis, hospital-acquired pneumonia, intra-abdominal infection, febrile neutropenia.

Dosing

  • Piperacillin–tazobactam 4.5 g IV (NICE) - don't routinely add an aminoglycoside unless there is shock or local policy says so.
    Oncology: Emergencies
  • Piperacillin–tazobactam 4.5 g IV | Neutropenic sepsis within 1 hour; add glycopeptide for line infection.
    Oncology: Emergencies

Side effects

Diarrhoea, rash, nausea, C. difficile, neutropenia with prolonged use.

Interactions

Methotrexate levels rise; aminoglycosides inactivated if mixed; warfarin.

Special advice

Penicillin allergy contraindication; adjust in renal impairment; extended infusion in some protocols.

More from the textbook: uses, cautions and other points
  • Severe or higher risk of resistance (e.g. recent antibiotics, ICU, known resistant organisms): IV piperacillin-tazobactam , a cephalosporin or meropenem, guided by local microbiology.
    Respiratory: Emergencies
  • IV antibiotics per local policy - e.g. a third-generation cephalosporin or piperacillin-tazobactam (wider cover if hospital-acquired).
    Gastroenterology: Gastroenterology Emergencies (Complete)
  • IV antibiotics per local policy (e.g. piperacillin-tazobactam).
    Gastroenterology: Gastroenterology Emergencies (Complete)
  • Acute tubular necrosis | Aminoglycosides (gentamicin), vancomycin (especially with piperacillin–tazobactam), amphotericin , cisplatin , iodinated contrast , IV bisphosphonates (zoledronic acid), colistin, high-dose methotrexate, rhabdomyolysis (statins with fibrates or macrolides, cocaine, prolonged lie)
    Renal: Anatomy, Physiology and Pharmacology
  • Neutropenic sepsis - temperature over 38°C or signs of sepsis with neutrophils 0.5 × 10⁹/L or less (usually after chemotherapy) - IV broad-spectrum antibiotics within 1 hour (e.g. piperacillin–tazobactam) without waiting for the count if chemotherapy is recent (NICE).
    Haematology: Anatomy Physiology and Pharmacology
  • IV piperacillin–tazobactam within 1 hour; consider G-CSF.
    Haematology: Emergencies

Where it is discussed

Prednisolone

BNF entry for Prednisolone · Stand-alone drug page

Mechanism

Glucocorticoid with anti-inflammatory and immunosuppressive effects.

Uses

Asthma and COPD exacerbation, giant cell arteritis, polymyalgia, inflammatory bowel disease, vasculitis, nephrotic syndrome.

Dosing

4 more dose entries from the chapters
  • Prednisolone | Asthma attack: 40–50 mg for at least 5 days. COPD exacerbation: 30 mg for 5 days. ABPA: tapering course.
    Respiratory: Airways Disease
  • Acute severe asthma | Oxygen to 94–98%; salbutamol 5 mg and ipratropium 0.5 mg nebulised (oxygen-driven); prednisolone 40–50 mg
    Respiratory: Emergencies
  • COPD with hypercapnic acidosis | Controlled oxygen to 88–92%; nebulisers; prednisolone 30 mg; NIV if pH below 7.35 and PaCO2 above 6.5 kPa persist
    Respiratory: Emergencies
  • First line: Oral prednisolone (e.g. 20–40 mg daily for pulmonary disease), tapered to the lowest effective dose over 6–12 months or more. Give bone protection.
    Respiratory: Interstitial Lung Disease

Side effects

Hyperglycaemia, insomnia, mood change, weight gain, osteoporosis, adrenal suppression, infection, gastric irritation.

Interactions

NSAIDs raise GI bleed risk; enzyme inducers reduce effect; warfarin and antidiabetic drug effects change.

Special advice

Steroid card and sick-day rules when long term; bone protection with prolonged courses; taper if more than 3 weeks.

More from the textbook: uses, cautions and other points

Where it is discussed

Pregabalin

BNF entry for Pregabalin · Stand-alone drug page

Mechanism

Binds alpha-2-delta subunit of calcium channels.

Uses

Neuropathic pain, focal seizures adjunct, generalised anxiety.

Dosing

  • Amitriptyline / duloxetine / pregabalin / gabapentin Painful neuropathy | E.g. amitriptyline 10 mg at night, titrated; duloxetine 60 mg daily; pregabalin 75 mg twice daily, titrated. Adjust for renal function and frailty.
    Endocrinology: Diabetes

Side effects

Drowsiness, dizziness, weight gain, oedema, blurred vision; misuse potential; respiratory depression with opioids.

Interactions

Opioids and CNS depressants; ACE inhibitors may increase angioedema.

Special advice

Controlled drug in the UK; reduce in renal impairment; taper on stopping.

More from the textbook: uses, cautions and other points
  • Ankle swelling - both legs (heart failure, nephrotic syndrome, liver disease, drugs - amlodipine and other calcium channel blockers, NSAIDs, steroids, pregabalin) versus one leg (DVT, cellulitis, Baker's cyst, venous obstruction). Ask about weight gain (fluid), abdominal swelling (ascites), and swelling of the sacrum in …
    Cardiology: History and Examination
  • Respiratory depressants - opioids , benzodiazepines , Z-drugs, gabapentin and pregabalin , alcohol, barbiturates, anaesthetic agents. Combinations are especially dangerous (MHRA warnings on opioids with benzodiazepines or gabapentinoids). Highest risk - COPD, sleep apnoea, obesity hypoventilation, neuromuscular disease, older …
    Respiratory: Anatomy, Physiology and Pharmacology
  • Offer amitriptyline, duloxetine, gabapentin or pregabalin ; switch to another if one is ineffective or not tolerated.
    Endocrinology: Diabetes
  • The action potential reaches the nerve ending → voltage-gated calcium channels open (target of gabapentin and pregabalin , and of antibodies in Lambert–Eaton syndrome) → calcium enters.
    Neurology: Anatomy, Physiology and Pharmacology
  • Neuropathic - nerve damage: burning, shooting, electric shock-like , pins and needles, allodynia (pain from light touch) - responds poorly to standard painkillers; use amitriptyline, duloxetine, gabapentin or pregabalin.
    Neurology: Anatomy, Physiology and Pharmacology
  • Myoclonic | Levetiracetam or valproate (males). Avoid carbamazepine, oxcarbazepine, phenytoin, gabapentin, pregabalin, vigabatrin (they can worsen it)
    Neurology: Epilepsy

Where it is discussed

Primidone

BNF entry for Primidone · Stand-alone drug page

Mechanism

Metabolised to phenobarbital and PEMA; anticonvulsant.

Uses

Seizures, essential tremor.

Dosing

Side effects

Sedation, ataxia, nausea, rash, megaloblastic anaemia.

Interactions

Strong enzyme inducer through phenobarbital.

Special advice

Start at low dose to avoid initial sedation; folate supplementation.

More from the textbook: uses, cautions and other points

Where it is discussed

Propranolol

BNF entry for Propranolol · Stand-alone drug page

Mechanism

Non-selective beta blocker.

Uses

Hypertension, angina, migraine prophylaxis, essential tremor, anxiety (somatic), thyrotoxicosis, variceal prophylaxis.

Dosing

3 more dose entries from the chapters

Side effects

Bradycardia, fatigue, bronchospasm, cold extremities, sleep disturbance.

Interactions

Verapamil and diltiazem; insulin masks hypoglycaemia; clonidine rebound.

Special advice

Avoid in asthma and heart block; do not stop abruptly.

More from the textbook: uses, cautions and other points

Where it is discussed

Propylthiouracil

BNF entry for Propylthiouracil · Stand-alone drug page

Mechanism

Inhibits thyroid peroxidase and peripheral T4 to T3 conversion.

Uses

Hyperthyroidism, thyroid storm, first trimester of pregnancy.

Dosing

  • Propylthiouracil First trimester / thyroid storm | 200–400 mg daily in divided doses, then a lower maintenance dose. Storm: e.g. 500–1000 mg loading, then 250 mg 4-hourly. Risk of severe hepatotoxicity.
    Endocrinology: Thyroid disease

Side effects

Rash, agranulocytosis, severe hepatotoxicity.

Interactions

Warfarin effect reduces as thyroid function normalises.

Special advice

Report sore throat or fever; monitor LFT; carbimazole preferred except in specific settings.

More from the textbook: uses, cautions and other points
  • Thyroid peroxidase (TPO) attaches iodine to tyrosines on thyroglobulin and couples them into T4 and T3 (the step blocked by carbimazole and propylthiouracil ; TPO antibodies mark autoimmune thyroid disease).
    Endocrine: Anatomy Physiology and Pharmacology
  • 3. A 32-year-old woman with Graves' disease on carbimazole finds out she is 6 weeks pregnant. Answer: Switch from carbimazole to propylthiouracil for the first trimester.
    Endocrine: Anatomy Physiology and Pharmacology
  • Thyroid storm | Propranolol; propylthiouracil; iodine 1 hour later; hydrocortisone; cooling; ICU
    Endocrinology: Emergencies
  • Thionamide: Propylthiouracil preferred, or high-dose carbimazole, to block new hormone synthesis.
    Endocrinology: Emergencies
  • How they work: Thionamides - carbimazole and propylthiouracil (PTU) - block TPO and so stop new hormone synthesis. Stored hormone is still released, so it takes 4–6 weeks to see an effect. PTU also reduces conversion of T4 to T3.
    Endocrinology: Thyroid disease
  • Glomerular disease | NSAIDs (minimal change, membranous), penicillamine and gold (membranous), hydralazine and propylthiouracil (ANCA vasculitis), pamidronate (FSGS), VEGF inhibitors such as bevacizumab (proteinuria, hypertension)
    Renal: Anatomy, Physiology and Pharmacology

Where it is discussed

Q

Quetiapine

BNF entry for Quetiapine · Stand-alone drug page

Mechanism

Atypical antipsychotic with antihistamine and alpha-1 blocking effects.

Uses

Schizophrenia, bipolar depression and mania, adjunct for depression.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Sedation, postural hypotension, weight gain, dry mouth, metabolic effects, QT prolongation.

Interactions

CYP3A4 inhibitors raise levels; QT-prolonging drugs; antihypertensives.

Special advice

Monitor weight, glucose and lipids; avoid in dementia unless risk assessed.

More from the textbook: uses, cautions and other points

Where it is discussed

R

Ramipril

BNF entry for Ramipril · Stand-alone drug page

Mechanism

ACE inhibitor prodrug (ramiprilat).

Uses

Hypertension, heart failure, post-MI, cardiovascular prevention, diabetic nephropathy.

Dosing

4 more dose entries from the chapters

Side effects

Dry cough, hypotension, hyperkalaemia, renal impairment, angioedema.

Interactions

NSAIDs, potassium-sparing diuretics, ARBs, lithium.

Special advice

Check U&E 1–2 weeks after starting; stop in pregnancy or angioedema.

More from the textbook: uses, cautions and other points

Where it is discussed

Rifampicin

BNF entry for Rifampicin · Stand-alone drug page

Mechanism

Inhibits bacterial DNA-dependent RNA polymerase.

Uses

Tuberculosis, meningococcal prophylaxis, staphylococcal infection (combination), brucellosis.

Dosing

  • Increased dose needs - pregnancy (increase as soon as pregnancy is confirmed - often by 25–50 micrograms - and check TFTs each trimester), oral oestrogen, enzyme inducers (rifampicin, carbamazepine, phenytoin), weight gain.
    Endocrine: Anatomy Physiology and Pharmacology
  • Hospital - ABC, blood cultures, then IV ceftriaxone 2 g every 12 hours within 1 hour; add IV amoxicillin 2 g every 4 hours if Listeria is possible (over 60, immunosuppressed, pregnant, alcohol excess); add vancomycin (± rifampicin) if penicillin-resistant pneumococcus is possible (recent travel to areas of high resistance).
    ID: Sepsis, fever and serious bacterial infections

Side effects

Orange body fluids, hepatotoxicity, rash, flu-like syndrome, thrombocytopenia.

Interactions

Potent CYP inducer: reduces warfarin, DOACs, contraceptives, steroids, methadone, many others.

Special advice

Monitor LFT; warn about contact-lens staining; review all interacting drugs.

More from the textbook: uses, cautions and other points
  • Many interactions - enzyme inhibitors raise INR (amiodarone, clarithromycin, erythromycin, fluconazole, metronidazole, ciprofloxacin, alcohol binges); inducers lower it (rifampicin, carbamazepine, phenytoin, St John's wort); diet (vitamin K-rich foods).
    Cardiology: Anatomy Physiology and Pharmacology
  • Metabolised by CYP1A2 - levels raised by ciprofloxacin , clarithromycin , erythromycin, fluvoxamine, cimetidine, heart failure, liver disease, viral infection, stopping smoking; lowered by smoking , rifampicin, carbamazepine, phenytoin, alcohol.
    Respiratory: Anatomy, Physiology and Pharmacology
  • Monitoring - LFTs (raised transaminases), eye checks in children (cataracts), mood; many CYP3A4 interactions (e.g. rifampicin, clarithromycin, azole antifungals).
    Respiratory: Anatomy, Physiology and Pharmacology
  • Rapid molecular test (NAAT) - e.g. GeneXpert - detects TB DNA and rifampicin resistance within hours.
    Respiratory: Infections
  • Continuation phase - 4 months of rifampicin and isoniazid.
    Respiratory: Infections
  • Interactions - CYP3A4 inhibitors (ritonavir and cobicistat, itraconazole, clarithromycin) block breakdown of inhaled or nasal fluticasone and budesonide → Cushing's syndrome and adrenal suppression; enzyme inducers (rifampicin, carbamazepine, phenytoin) reduce steroid effect - double replacement doses may be needed.
    Endocrine: Anatomy Physiology and Pharmacology

Where it is discussed

Risperidone

BNF entry for Risperidone · Stand-alone drug page

Mechanism

Atypical antipsychotic with D2 and 5-HT2A antagonism.

Uses

Schizophrenia, bipolar mania, behavioural symptoms in dementia (short term).

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Extrapyramidal symptoms, hyperprolactinaemia, weight gain, postural hypotension, QT prolongation.

Interactions

CYP2D6 inhibitors (fluoxetine, paroxetine) raise levels; QT-prolonging drugs.

Special advice

Increased stroke risk in dementia; monitor prolactin and metabolic parameters.

More from the textbook: uses, cautions and other points

Where it is discussed

Rivaroxaban

BNF entry for Rivaroxaban · Stand-alone drug page

Mechanism

Direct factor Xa inhibitor.

Uses

Stroke prevention in non-valvular AF, VTE treatment and prophylaxis, secondary prevention in coronary and peripheral artery disease.

Dosing

4 more dose entries from the chapters

Side effects

Bleeding, anaemia, nausea, abnormal LFT.

Interactions

Strong CYP3A4 and P-gp inhibitors or inducers; avoid other anticoagulants.

Special advice

Take with food for 15 and 20 mg doses; reduce or avoid in renal impairment; andexanet alfa reversal.

More from the textbook: uses, cautions and other points

Where it is discussed

Rivastigmine

BNF entry for Rivastigmine · Stand-alone drug page

Mechanism

Acetylcholinesterase and butyrylcholinesterase inhibitor.

Uses

Alzheimer and Parkinson disease dementia.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Nausea, vomiting, weight loss, bradycardia, skin reaction with patch.

Interactions

Anticholinergics antagonistic; beta-blockers bradycardia.

Special advice

Rotate patch site and remove old patch; do not use if previous severe skin reaction; monitor weight.

More from the textbook: uses, cautions and other points

Where it is discussed

Rosuvastatin

BNF entry for Rosuvastatin · Stand-alone drug page

Mechanism

HMG-CoA reductase inhibitor.

Uses

Hypercholesterolaemia, cardiovascular prevention.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Myalgia, raised ALT, proteinuria at high dose, new-onset diabetes.

Interactions

Ciclosporin, gemfibrozil raise levels; warfarin effect increased.

Special advice

Lower dose in Asian patients and renal impairment; check CK if muscle symptoms.

More from the textbook: uses, cautions and other points

Where it is discussed

S

Salbutamol

BNF entry for Salbutamol · Stand-alone drug page

Mechanism

Short-acting beta-2 agonist.

Uses

Asthma and COPD relief, acute severe asthma, hyperkalaemia.

Dosing

4 more dose entries from the chapters

Side effects

Tremor, tachycardia, palpitations, hypokalaemia, headache.

Interactions

Beta-blockers antagonise; corticosteroids and diuretics worsen hypokalaemia.

Special advice

Monitor potassium with high or repeated doses; check inhaler technique and use of spacer.

More from the textbook: uses, cautions and other points
  • Beta-2 | Bronchi and blood vessels (muscle) - dilatation; some heart effect | Agonist: salbutamol. Non-selective blockers (propranolol) cause bronchospasm
    Cardiology: Anatomy Physiology and Pharmacology
  • Ask about - thyroid symptoms, anaemia, caffeine, energy drinks, alcohol, recreational drugs (cocaine, amphetamines), medicines (salbutamol, levothyroxine, QT-prolonging drugs), family history of sudden death.
    Cardiology: History and Examination
  • Duration, frequency, triggers (exercise, caffeine, alcohol, drugs — salbutamol, thyroxine, stimulants).
    Cardiology: Presentations
  • SABA (short-acting) - salbutamol , terbutaline: work in minutes, last 4–6 hours; reliever.
    Respiratory: Anatomy, Physiology and Pharmacology
  • Side effects - tremor , tachycardia and palpitations, hypokalaemia (high doses), lactic acidosis (high-dose nebulised or IV salbutamol), headache, muscle cramps.
    Respiratory: Anatomy, Physiology and Pharmacology
  • The big change (BTS/NICE/SIGN 2024): People aged 12 and over should not use a salbutamol (SABA) inhaler alone. Relying on SABA without inhaled steroid is linked to severe attacks and asthma deaths. Treatment is now built around a combined inhaled steroid plus formoterol inhaler (e.g. budesonide/formoterol). Formoterol works …
    Respiratory: Airways Disease

Where it is discussed

Salmeterol

BNF entry for Salmeterol · Stand-alone drug page

Mechanism

Long-acting beta-2 agonist.

Uses

Asthma (with inhaled corticosteroid), COPD.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Tremor, palpitations, headache, cramps.

Interactions

Beta-blockers, ketoconazole increases levels.

Special advice

Never use alone in asthma; not for acute relief.

More from the textbook: uses, cautions and other points

Where it is discussed

Semaglutide

BNF entry for Semaglutide · Stand-alone drug page

Mechanism

GLP-1 receptor agonist slowing gastric emptying and reducing appetite.

Uses

Type 2 diabetes, obesity, cardiovascular risk reduction.

Dosing

  • Established atherosclerotic cardiovascular disease: Triple therapy - metformin MR, an SGLT2 inhibitor and subcutaneous semaglutide - added in sequence, titrating semaglutide to 1 mg weekly.
    Endocrinology: Diabetes
  • Semaglutide SC weekly: 0.25 mg, then 0.5 mg, up to 1 mg for type 2 diabetes.
    Endocrinology: Diabetes
  • Semaglutide 2.4 mg Obesity | Weekly SC, titrated over 16 weeks. NICE TA875; specialist service; maximum 2 years.
    Endocrinology: Lipids and obesity

Side effects

Nausea, vomiting, diarrhoea, pancreatitis, gallstones, retinopathy complications.

Interactions

Slows absorption of oral drugs; insulin and sulfonylureas increase hypoglycaemia.

Special advice

Titrate slowly; stop in suspected pancreatitis; avoid in pregnancy; monitor retinopathy.

More from the textbook: uses, cautions and other points

Where it is discussed

Sertraline

BNF entry for Sertraline · Stand-alone drug page

Mechanism

SSRI inhibiting serotonin reuptake.

Uses

Depression, anxiety disorders, OCD, PTSD, panic.

Dosing

Side effects

Nausea, diarrhoea, insomnia, sexual dysfunction, hyponatraemia, bleeding risk.

Interactions

MAOIs, other serotonergic drugs, NSAIDs and anticoagulants bleeding.

Special advice

Safer in cardiac disease; taper on stopping; check sodium in older adults.

More from the textbook: uses, cautions and other points

Where it is discussed

Sildenafil

BNF entry for Sildenafil · Stand-alone drug page

Mechanism

PDE5 inhibitor enhancing cGMP.

Uses

Erectile dysfunction, pulmonary arterial hypertension.

Dosing

Side effects

Headache, flushing, dyspepsia, visual disturbance, hypotension.

Interactions

Nitrates and nicorandil contraindicated; CYP3A4 inhibitors raise levels.

Special advice

Avoid in recent MI or stroke, severe hypotension; seek help for priapism.

More from the textbook: uses, cautions and other points

Where it is discussed

Simvastatin

BNF entry for Simvastatin · Stand-alone drug page

Mechanism

HMG-CoA reductase inhibitor.

Uses

Hypercholesterolaemia, cardiovascular prevention.

Dosing

1 more dose entries from the chapters

Side effects

Myalgia, myopathy, raised ALT, rarely rhabdomyolysis.

Interactions

Amlodipine, diltiazem, verapamil limit dose; clarithromycin, azole antifungals contraindicated; ciclosporin.

Special advice

Take at night; avoid large amounts of grapefruit; check CK if muscle symptoms.

More from the textbook: uses, cautions and other points

Where it is discussed

Sodium valproate

BNF entry for Sodium valproate · Stand-alone drug page

Mechanism

Increases GABA, blocks sodium channels and T-type calcium channels.

Uses

Generalised and focal epilepsy, bipolar disorder (valproate semisodium), migraine prophylaxis.

Dosing

  • IV sodium valproate (about 40 mg/kg) - avoid in women who could become pregnant where possible, and in liver disease.
    Neurology: Anatomy, Physiology and Pharmacology
  • Status epilepticus | Benzodiazepine (IV lorazepam 4 mg or buccal midazolam 10 mg), repeat at 5–10 minutes; then levetiracetam, phenytoin or valproate; ICU
    Neurology: Emergencies
  • Sodium valproate IV (40 mg/kg, maximum 3 g). Avoid in women and girls of childbearing potential unless there is no alternative (MHRA).
    Neurology: Emergencies
  • Prevention - folic acid 400 micrograms daily from before conception to 12 weeks; 5 mg for higher risk (previous NTD, family history, antiepileptic drugs, diabetes, BMI 30 or more, sickle cell disease). Avoid valproate in pregnancy. Folic acid fortification of non-wholemeal flour in the UK is being introduced.
    Paediatrics: Neurology, bones and joints in children
4 more dose entries from the chapters

Side effects

Weight gain, tremor, hair loss, thrombocytopenia, hepatotoxicity, pancreatitis, hyperammonaemia, teratogenic.

Interactions

Lamotrigine levels double; carbapenems reduce levels; enzyme inducers.

Special advice

Not for women of childbearing potential without Pregnancy Prevention Programme; check LFT and FBC.

More from the textbook: uses, cautions and other points

Where it is discussed

Solifenacin

BNF entry for Solifenacin · Stand-alone drug page

Mechanism

Antimuscarinic selective for M3 receptors.

Uses

Overactive bladder.

Dosing

  • … gynaecomastia; halves PSA (double the value when interpreting) Combination Bothersome symptoms with a large prostate Both sets Antimuscarinic (oxybutynin, solifenacin) or mirabegron Storage symptoms (overactive bladder) if persisting Antimuscarinics - dry mouth, constipation, confusion in older people (anticholinergic …
    Surgey: Urology

Side effects

Dry mouth, constipation, blurred vision, urinary retention, QT prolongation.

Interactions

CYP3A4 inhibitors raise levels; other anticholinergics additive.

Special advice

Avoid in older people with cognitive impairment; consider mirabegron.

More from the textbook: uses, cautions and other points

Where it is discussed

Spironolactone

BNF entry for Spironolactone · Stand-alone drug page

Mechanism

Aldosterone receptor antagonist.

Uses

Heart failure, ascites, resistant hypertension, primary hyperaldosteronism, hirsutism and acne.

Dosing

4 more dose entries from the chapters

Side effects

Hyperkalaemia, gynaecomastia, menstrual irregularity, renal impairment.

Interactions

ACE inhibitors, ARBs, potassium supplements, NSAIDs, digoxin levels rise.

Special advice

Check potassium and creatinine at baseline, 1 week and regularly; use eplerenone if breast symptoms.

More from the textbook: uses, cautions and other points

Where it is discussed

Sulfasalazine

BNF entry for Sulfasalazine · Stand-alone drug page

Mechanism

Prodrug cleaved to 5-ASA and sulfapyridine; anti-inflammatory.

Uses

Ulcerative colitis, rheumatoid arthritis.

Dosing

  • Sulfasalazine (with folic acid 5 mg ).
    Gastroenterology: Inflammatory Bowel Disease
  • Folic acid 400 mcg (5 mg if on sulfasalazine).
    Gastroenterology: Inflammatory Bowel Disease
  • Immunosuppressants compatible with pregnancy — prednisolone (mostly inactivated by the placenta), hydroxychloroquine , azathioprine , sulfasalazine (with folic acid 5 mg), ciclosporin, tacrolimus, most anti-TNF drugs (certolizumab minimal transfer).
    Obstetrics
  • Sulfasalazine | Sulfapyridine plus 5-aminosalicylic acid — reduces cytokines and leucocyte function | GI upset, rash, marrow suppression , hepatitis, orange urine and tears , reversible oligospermia; safe in pregnancy (with folic acid 5 mg)
    Rheumatology Anatomy Physiology Pharmacology
3 more dose entries from the chapters

Side effects

Nausea, rash, headache, oligospermia, agranulocytosis, orange urine.

Interactions

Digoxin and folate absorption reduced.

Special advice

FBC and LFT monitoring; avoid in sulfonamide allergy; male fertility reversible.

More from the textbook: uses, cautions and other points

Where it is discussed

Sumatriptan

BNF entry for Sumatriptan · Stand-alone drug page

Mechanism

5-HT1B/1D agonist causing cranial vasoconstriction.

Uses

Acute migraine, cluster headache.

Dosing

Side effects

Chest tightness, flushing, dizziness, tingling, rarely coronary vasospasm.

Interactions

MAOIs, SSRIs (serotonin syndrome risk), ergot drugs.

Special advice

Avoid in ischaemic heart disease, uncontrolled hypertension and stroke; limit medication-overuse headache.

More from the textbook: uses, cautions and other points

Where it is discussed

T

Tacrolimus

BNF entry for Tacrolimus · Stand-alone drug page

Mechanism

Calcineurin inhibitor suppressing T-cell activation.

Uses

Transplant rejection prophylaxis, atopic dermatitis (topical).

Dosing

  • Immunosuppressants compatible with pregnancy — prednisolone (mostly inactivated by the placenta), hydroxychloroquine , azathioprine , sulfasalazine (with folic acid 5 mg), ciclosporin, tacrolimus, most anti-TNF drugs (certolizumab minimal transfer).
    Obstetrics

Side effects

Nephrotoxicity, tremor, hyperglycaemia, hypertension, hyperkalaemia, infection.

Interactions

CYP3A4 inhibitors and inducers markedly alter levels; nephrotoxic drugs; grapefruit.

Special advice

Trough level monitoring; avoid live vaccines; skin cancer surveillance.

More from the textbook: uses, cautions and other points

Where it is discussed

Tadalafil

BNF entry for Tadalafil · Stand-alone drug page

Mechanism

PDE5 inhibitor with long half-life.

Uses

Erectile dysfunction, benign prostatic hyperplasia, pulmonary arterial hypertension.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Headache, flushing, back pain, myalgia, dyspepsia.

Interactions

Nitrates and nicorandil contraindicated; alpha-blockers hypotension.

Special advice

Effect lasts up to 36 hours; avoid within recent MI or stroke periods.

More from the textbook: uses, cautions and other points
  • Contraindicated with PDE5 inhibitors (sildenafil, tadalafil - severe hypotension), severe aortic stenosis, HCM with obstruction, hypotension, RV infarction (preload-dependent).
    Cardiology: Anatomy Physiology and Pharmacology
  • Nitric oxide pathway - PDE5 inhibitors (sildenafil, tadalafil - never with nitrates ; headache, flushing); riociguat (soluble guanylate cyclase stimulator - also for CTEPH; don't combine with PDE5 inhibitors).
    Respiratory: Anatomy, Physiology and Pharmacology
  • PDE5 inhibitors - sildenafil, tadalafil. Do not combine with nitrates (severe hypotension).
    Respiratory: Pulmonary Vascular Disease
  • PDE5 inhibitors (sildenafil, tadalafil) | PAH (specialist); never with nitrates.
    Respiratory: Pulmonary Vascular Disease
  • Pulmonary arterial hypertension - endothelin receptor antagonists (bosentan, ambrisentan, macitentan), PDE5 inhibitors (sildenafil, tadalafil), riociguat, prostacyclin analogues (iloprost, epoprostenol, selexipag); oxygen, diuretics, anticoagulation in some (see the Respiratory chapters).
    Rheumatology: Connective tissue diseases
  • Erectile dysfunction - often an early sign of cardiovascular disease (check BP, lipids, HbA1c); also neurological, hormonal (testosterone), drugs (beta-blockers, thiazides, SSRIs, finasteride), psychological; PDE5 inhibitors (sildenafil, tadalafil) - never with nitrates (severe hypotension).
    Surgey: Urology

Where it is discussed

Tamoxifen

BNF entry for Tamoxifen · Stand-alone drug page

Mechanism

Selective oestrogen receptor modulator.

Uses

ER-positive breast cancer treatment and prevention.

Dosing

  • Retinal toxicity - dose no more than 5 mg/kg/day; baseline eye check within 1 year and annual retinal screening after 5 years of use (earlier - after 1 year - with risk factors such as kidney impairment, tamoxifen or higher doses) (RCOphth).
    Rheumatology: assessment, investigations and drugs
  • Hydroxychloroquine (and chloroquine) | Retinal toxicity ("bull's-eye" maculopathy) — irreversible; risk with dose over 5 mg/kg/day (actual body weight), long duration, renal impairment, tamoxifen — annual screening (OCT and fields) after 5 years of use (after 1 year if additional risk factors — RCOphth 2020)
    Ophthalmology: Anatomy Physiology and Pharmacology
  • Hydroxychloroquine | Retinal toxicity (bull's-eye maculopathy, permanent). Keep dose at 5 mg/kg/day or less (actual body weight). RCOphth : yearly screening (OCT and fields) after 5 years , or after 1 year if extra risk (eGFR under 60, tamoxifen, higher doses).
    Ophthalmology: Neuro-ophthalmology

Side effects

Hot flushes, VTE, endometrial hyperplasia and cancer, visual disturbance.

Interactions

CYP2D6 inhibitors (paroxetine, fluoxetine) reduce activation; warfarin effect rises.

Special advice

Report abnormal vaginal bleeding; avoid in VTE history; review duration with oncology.

More from the textbook: uses, cautions and other points

Where it is discussed

Tamsulosin

BNF entry for Tamsulosin · Stand-alone drug page

Mechanism

Alpha-1A adrenoceptor antagonist.

Uses

Lower urinary tract symptoms in benign prostatic hyperplasia.

Dosing

  • Medicines : Drug Use Side effects Alpha-blocker (tamsulosin, alfuzosin) First-line for moderate to severe voiding symptoms; works in days Postural hypotension , dizziness, retrograde ejaculation, floppy iris syndrome (tell the eye surgeon before cataract surgery) 5-alpha reductase inhibitor (finasteride, dutasteride) Enlarged …
    Surgey: Urology
  • … hesitancy, poor stream; examine abdomen and prostate, urinalysis, U&E, PSA after counselling; frequency–volume chart. Treatment: lifestyle, alpha-blocker (tamsulosin) for moderate–severe voiding symptoms, 5-alpha reductase inhibitor (finasteride) if prostate is estimated >30 g or PSA >1.4; antimuscarinic or mirabegron …
    General Practice: Child health, women's health and men's health in primary care

Side effects

Postural hypotension, dizziness, retrograde ejaculation, floppy iris syndrome.

Interactions

Other antihypertensives and PDE5 inhibitors additive; CYP3A4 and 2D6 inhibitors.

Special advice

Take after food; tell ophthalmologist before cataract surgery.

More from the textbook: uses, cautions and other points

Where it is discussed

Teicoplanin

BNF entry for Teicoplanin · Stand-alone drug page

Mechanism

Glycopeptide inhibiting cell-wall synthesis.

Uses

MRSA and resistant Gram-positive infection, endocarditis, bone and joint infection.

Dosing

  • Loading dose - a larger first dose to reach the target level quickly, when waiting 4–5 half-lives would be too slow: digoxin , amiodarone , phenytoin (and levetiracetam in status), vancomycin , teicoplanin, aminophylline , warfarin (in some regimens), clopidogrel (300–600 mg in ACS), ticagrelor.
    Clinical pharmacology and prescribing: Principles of clinical pharmacology

Side effects

Rash, fever, thrombocytopenia, injection-site reactions; less nephrotoxic than vancomycin.

Interactions

Aminoglycosides increase nephrotoxicity and ototoxicity.

Special advice

Loading doses needed; trough level monitoring in serious infection.

More from the textbook: uses, cautions and other points
  • MRSA suspected: Add vancomycin or teicoplanin.
    Respiratory: Emergencies
  • Add vancomycin or teicoplanin for suspected line infection, MRSA or skin infection; antifungals for persistent fever (after 4–7 days).
    Oncology: Emergencies
  • Severe or systemically unwell - IV flucloxacillin (or co-amoxiclav, cefuroxime, ceftriaxone, clindamycin per local policy); MRSA - vancomycin, teicoplanin or linezolid.
    Dermatology: Skin infections and infestations
  • Cell wall | Beta-lactams (penicillins, cephalosporins, carbapenems, aztreonam) - bind penicillin-binding proteins; glycopeptides (vancomycin, teicoplanin)
    ID: How Infection Happens
  • MRSA (meticillin-resistant S. aureus) - resistant to flucloxacillin and most beta-lactams; treat with vancomycin, teicoplanin, linezolid, daptomycin, or doxycycline or co-trimoxazole for milder infections (depending on sensitivities); decolonise (nasal mupirocin and chlorhexidine body wash) before some surgery.
    ID: How Infection Happens
  • Line infection | Staphylococci (including CoNS, MRSA), Gram-negatives, Candida | Vancomycin or teicoplanin ± Gram-negative cover; remove the line in many cases
    ID: Sepsis, fever and serious bacterial infections

Where it is discussed

Temazepam

BNF entry for Temazepam · Stand-alone drug page

Mechanism

Short-acting benzodiazepine.

Uses

Short-term insomnia.

Dosing

Side effects

Drowsiness, hangover effect, falls, confusion, dependence.

Interactions

Opioids, alcohol, CNS depressants.

Special advice

Controlled drug; maximum 2–4 weeks; avoid in older adults; withdraw gradually.

More from the textbook: uses, cautions and other points

Where it is discussed

Terbinafine

BNF entry for Terbinafine · Stand-alone drug page

Mechanism

Allylamine inhibiting squalene epoxidase.

Uses

Onychomycosis, tinea infections.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Nausea, taste disturbance, rash, hepatotoxicity.

Interactions

CYP2D6 inhibitor raising tricyclics, beta-blockers, SSRIs; rifampicin reduces levels.

Special advice

Baseline LFT before oral use; stop if jaundice or liver symptoms.

More from the textbook: uses, cautions and other points

Where it is discussed

Testosterone

BNF entry for Testosterone · Stand-alone drug page

Mechanism

Androgen receptor agonist.

Uses

Male hypogonadism, gender-affirming therapy.

Dosing

  • Testosterone Male hypogonadism | E.g. daily transdermal gel, or testosterone undecanoate 1 g IM every 10–14 weeks. Monitor haematocrit and PSA.
    Endocrinology: Pituitary Disease
  • Testosterone undecanoate 1 g IM , every 10–14 weeks after a loading dose at 6 weeks. Long-acting.
    Endocrinology: Reproductive
  • Testosterone esters (e.g. Sustanon 250 mg IM), every 2–4 weeks. Peaks and troughs cause mood swings.
    Endocrinology: Reproductive

Side effects

Acne, polycythaemia, fluid retention, mood change, hepatic effects, prostate stimulation.

Interactions

Warfarin effect rises; insulin requirements change.

Special advice

Monitor haematocrit, PSA and lipids; avoid in prostate or breast cancer.

More from the textbook: uses, cautions and other points
  • Binding proteins - most cortisol, thyroid hormone and testosterone is bound (to CBG, TBG and SHBG); only the free fraction is active. Oestrogen (pregnancy, the pill) raises binding proteins, so total levels rise but free levels may be normal - measure free hormone where possible.
    Endocrine: Anatomy Physiology and Pharmacology
  • GnRH (pulsatile) | LH and FSH | Gonads → testosterone, oestrogen, progesterone, inhibin | Sex steroids and inhibin suppress (oestrogen can also trigger the mid-cycle LH surge)
    Endocrine: Anatomy Physiology and Pharmacology
  • Gonadal axis: LH, FSH and oestradiol (women) or 9 am testosterone (men). Low sex hormones with low or normal gonadotrophins means pituitary failure. In post-menopausal women, "normal" gonadotrophins are abnormally low.
    Endocrinology: Pituitary Disease
  • 💡 Clinical Pearl: An older patient with hyponatraemia, fatigue and low libido may have a non-functioning macroadenoma with hypopituitarism, not SIADH. Check 9 am cortisol, FT4, gonadotrophins and testosterone.
    Endocrinology: Pituitary Disease
  • Men: Testosterone, SHBG, LH and FSH.
    Endocrinology: Bone Medicine
  • Testosterone in hypogonadal men improves bone density, but is not a substitute for bone treatment when the fracture risk is high.
    Endocrinology: Bone Medicine

Where it is discussed

Thiamine

BNF entry for Thiamine · Stand-alone drug page

Mechanism

Vitamin B1, cofactor in carbohydrate metabolism.

Uses

Prevention and treatment of Wernicke encephalopathy, alcohol dependence, malnutrition.

Dosing

1 more dose entries from the chapters
  • … breathless, weak, phosphate 0.3 mmol/L. Answer: Refeeding syndrome - IV phosphate replacement, check potassium and magnesium, reduce feeding rate temporarily, thiamine and vitamin B, cardiac monitoring, fluid balance; involve dietitians and follow MEED guidance (Medical Emergencies in Eating Disorders, RCPsych 2022).
    Pathology: Immunopathology, amyloidosis, genetic and environmental disease

Side effects

Rare anaphylaxis with IV preparations; local reactions.

Interactions

Few; glucose before thiamine may precipitate Wernicke encephalopathy.

Special advice

Give before or with glucose in at-risk patients; use IV high-dose preparation when Wernicke suspected.

More from the textbook: uses, cautions and other points

Where it is discussed

Ticagrelor

BNF entry for Ticagrelor · Stand-alone drug page

Mechanism

Reversible P2Y12 receptor antagonist.

Uses

Acute coronary syndrome, post-MI secondary prevention.

Dosing

2 more dose entries from the chapters

Side effects

Bleeding, dyspnoea, bradycardia, raised uric acid and creatinine.

Interactions

Strong CYP3A4 inhibitors and inducers; simvastatin dose limit.

Special advice

Dyspnoea is usually benign; avoid in prior intracranial haemorrhage; hold before surgery per guidance.

More from the textbook: uses, cautions and other points

Where it is discussed

Timolol

BNF entry for Timolol · Stand-alone drug page

Mechanism

Non-selective beta blocker.

Uses

Glaucoma (eye drops), hypertension, angina, migraine.

Dosing

Side effects

Eye drops: ocular irritation; systemic absorption can cause bradycardia and bronchospasm.

Interactions

Verapamil and other beta-blockers; CYP2D6 inhibitors.

Special advice

Avoid eye drops in asthma and heart block; press the tear duct after instillation.

More from the textbook: uses, cautions and other points

Where it is discussed

Tiotropium

BNF entry for Tiotropium · Stand-alone drug page

Mechanism

Long-acting muscarinic antagonist.

Uses

COPD, asthma add-on.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Dry mouth, urinary retention, constipation, blurred vision.

Interactions

Other anticholinergics additive.

Special advice

Check inhaler technique; caution in glaucoma and prostatic hypertrophy.

More from the textbook: uses, cautions and other points

Where it is discussed

Tirzepatide

BNF entry for Tirzepatide · Stand-alone drug page

Mechanism

Dual GIP and GLP-1 receptor agonist.

Uses

Type 2 diabetes, obesity.

Dosing

  • Tirzepatide weekly: A dual GIP/GLP-1 agonist, starting at 2.5 mg and increased in 2.5 mg steps every 4 weeks, to 5–15 mg.
    Endocrinology: Diabetes
  • Tirzepatide Type 2; obesity | 2.5 mg weekly for 4 weeks, increasing by 2.5 mg every 4 weeks to 5–15 mg. Reduces oral contraceptive effectiveness during titration.
    Endocrinology: Diabetes
  • Tirzepatide Obesity | 2.5 mg weekly, increased by 2.5 mg every 4 weeks to 15 mg maximum. NICE TA1026; phased primary care rollout. Reduces oral contraceptive reliability.
    Endocrinology: Lipids and obesity

Side effects

Nausea, vomiting, diarrhoea, constipation, pancreatitis, gallstones.

Interactions

Oral contraceptive absorption affected at initiation and dose escalation; insulin and sulfonylureas increase hypoglycaemia.

Special advice

Titrate slowly; use additional contraception at starts and escalations.

More from the textbook: uses, cautions and other points
  • Weight loss - this can cure mild OSA. GLP-1 based drugs (e.g. tirzepatide) reduce OSA severity.
    Respiratory: Sleep and Breathing (Complete)
  • GLP-1 - from the small bowel after eating; boosts insulin, reduces glucagon, slows stomach emptying and reduces appetite - the basis of semaglutide and tirzepatide for weight loss.
    Endocrine: Anatomy Physiology and Pharmacology
  • Tirzepatide - dual GIP and GLP-1 agonist , weekly injection; greater weight and glucose reduction; similar side effects.
    Endocrine: Anatomy Physiology and Pharmacology
  • Weight-loss medicines: GLP-1 agonists and tirzepatide (see below).
    Endocrinology: Diabetes
  • Early-onset type 2 diabetes (under 40): Consider triple therapy with metformin MR, an SGLT2 inhibitor and a GLP-1 agonist or tirzepatide.
    Endocrinology: Diabetes
  • How incretin drugs work: GLP-1 is a gut hormone released after eating. GLP-1 receptor agonists act on the brain to reduce appetite and increase fullness , slow gastric emptying, and boost insulin when glucose is high. Tirzepatide also activates the GIP receptor (a "twincretin"), which gives greater weight loss.
    Endocrinology: Lipids and obesity

Where it is discussed

Tobramycin

BNF entry for Tobramycin · Stand-alone drug page

Mechanism

Aminoglycoside inhibiting 30S ribosome.

Uses

Pseudomonas infection, cystic fibrosis exacerbations (IV or inhaled).

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Nephrotoxicity, ototoxicity, neuromuscular blockade.

Interactions

Loop diuretics, ciclosporin and vancomycin increase toxicity.

Special advice

Level monitoring and renal function checks; avoid in myasthenia gravis.

More from the textbook: uses, cautions and other points
  • Antibiotics - prophylactic flucloxacillin (young children, in many centres); treat infections promptly; Pseudomonas eradication and nebulised antibiotics (tobramycin, colistin).
    Paediatrics: Respiratory and heart problems in children
  • Aminoglycosides (gentamicin, amikacin, tobramycin) | Permanent cochlear (high-frequency hearing loss) and vestibular toxicity (gentamicin — oscillopsia, imbalance); risk with high or prolonged levels, renal impairment, loop diuretics; MT-RNR1 m.1555A>G carriers can go deaf after a single dose — monitor levels, shortest course, …
    ENT Anatomy Physiology
  • Aminoglycosides (gentamicin, amikacin, tobramycin) | Permanent hearing loss and balance loss (vestibular toxicity -"oscillopsia" and unsteadiness). Monitor levels; higher risk with the m.1555A>G mitochondrial variant (rapid genetic testing in neonatal units).
    ENT: Common Ear disorders
  • Uses - serious Gram-negative sepsis (often a single empirical dose while cultures are awaited), pyelonephritis, Pseudomonas, synergy in endocarditis; tobramycin nebulised in CF.
    ID: How Infection Happens
  • Treatment - specialist CF centres; airway clearance physiotherapy; nebulised dornase alfa and hypertonic saline; antibiotics (inhaled tobramycin or colistin for Pseudomonas ); pancreatic enzyme replacement and high-calorie diet with vitamins A, D, E, K; CFTR modulators - elexacaftor/tezacaftor/ivacaftor (Kaftrio) for people …
    Clinical Genetics: Single-gene, repeat-expansion and mitochondrial disorders
  • Antibiotics — prophylactic flucloxacillin (young children, in many centres); treat infections promptly; Pseudomonas eradication and nebulised antibiotics (tobramycin, colistin).
    Integrated paediatrics chapter › Cystic Fibrosis

Where it is discussed

Tocilizumab

BNF entry for Tocilizumab · Stand-alone drug page

Mechanism

Interleukin-6 receptor antagonist.

Uses

Rheumatoid arthritis, giant cell arteritis, COVID-19 (selected), cytokine release syndrome.

Dosing

Side effects

Infections, raised LFT and lipids, neutropenia, gastrointestinal perforation.

Interactions

Live vaccines contraindicated; CYP-substrate drug levels may fall.

Special advice

Screen for TB; monitor FBC and LFT; may blunt CRP and fever in infection.

More from the textbook: uses, cautions and other points

Where it is discussed

Topiramate

BNF entry for Topiramate · Stand-alone drug page

Mechanism

Blocks sodium channels, enhances GABA and inhibits carbonic anhydrase.

Uses

Epilepsy, migraine prophylaxis, idiopathic intracranial hypertension.

Dosing

  • Topiramate Up to 50 mg twice daily | Migraine prevention, IIH; teratogenic - pregnancy prevention programme; reduces contraceptive effect.
    Neurology: Headache and Facial Pain
  • Carbamazepine, phenytoin, phenobarbital, topiramate | Malformations (NTDs, cleft lip and palate, heart defects); topiramate — cleft lip, low birth weight, possible neurodevelopmental effects; lamotrigine and levetiracetam are preferred (with folic acid 5 mg)
    Obstetrics

Side effects

Cognitive slowing, paraesthesia, weight loss, kidney stones, metabolic acidosis, glaucoma, teratogenic.

Interactions

Enzyme inducers reduce levels; high dose reduces oestrogen contraceptive efficacy.

Special advice

Titrate slowly; pregnancy prevention counselling; report eye pain or visual change.

More from the textbook: uses, cautions and other points
  • … pregabalin), boost GABA (benzodiazepines, phenobarbital, valproate, vigabatrin), bind SV2A (levetiracetam, brivaracetam), or block glutamate (perampanel, topiramate). Several act in more than one way.
    Neurology: Anatomy, Physiology and Pharmacology
  • Brand consistency (MHRA categories) - keep patients on the same manufacturer for category 1 drugs ( phenytoin, carbamazepine, phenobarbital, primidone ); use clinical judgement for category 2 (valproate, lamotrigine, topiramate, oxcarbazepine, clobazam, others).
    Neurology: Anatomy, Physiology and Pharmacology
  • Topiramate: Word-finding difficulty, weight loss, kidney stones, tingling, angle-closure glaucoma. Teratogenic (pregnancy prevention programme).
    Neurology: Epilepsy
  • Enzyme-inducing drugs (carbamazepine, oxcarbazepine, phenytoin, phenobarbital, topiramate, eslicarbazepine) make the combined pill, progestogen-only pill and implant unreliable.
    Neurology: Epilepsy
  • Prevention: Propranolol or amitriptyline. Avoid topiramate, valproate and candesartan .
    Neurology: Headache and Facial Pain
  • Lithium, topiramate (specialist).
    Neurology: Headache and Facial Pain

Where it is discussed

Tramadol

BNF entry for Tramadol · Stand-alone drug page

Mechanism

Weak opioid agonist with serotonin and noradrenaline reuptake inhibition.

Uses

Moderate pain.

Dosing

Side effects

Nausea, dizziness, constipation, seizures, serotonin syndrome, hyponatraemia, hypoglycaemia.

Interactions

SSRIs and other serotonergic drugs; carbamazepine reduces effect; warfarin.

Special advice

Reduce dose in renal impairment; avoid in epilepsy; controlled drug in the UK.

More from the textbook: uses, cautions and other points
  • Serotonin syndrome - too much serotonin (SSRIs with tramadol, MAOIs, linezolid, St John's wort, MDMA): agitation, sweating, fever, tremor, clonus and brisk reflexes (legs more than arms), diarrhoea; rapid onset; stop the drugs, cooling, benzodiazepines, cyproheptadine.
    Neurology: Anatomy, Physiology and Pharmacology
  • MAO-B inhibitors - rasagiline, selegiline, safinamide - reduce dopamine breakdown; mild effect; caution with pethidine, tramadol, SSRIs and other serotonergic drugs (serotonin syndrome).
    Neurology: Anatomy, Physiology and Pharmacology
  • Look for provoking causes: Hypoglycaemia, hyponatraemia, hypocalcaemia, alcohol or benzodiazepine withdrawal, drugs (tramadol, bupropion, recreational drugs), head injury, infection.
    Neurology: Emergencies
  • Cause | NMS: Dopamine antagonists (antipsychotics, metoclopramide), or stopping levodopa. Serotonin syndrome: Serotonergic drugs - SSRIs, SNRIs, MAOIs, tramadol, linezolid, triptans, ondansetron, MDMA - especially in combination
    Neurology: Emergencies
  • Drugs (tramadol, bupropion, ciprofloxacin, cocaine).
    Neurology: Epilepsy
  • Tramadol only as short-term rescue.
    Neurology: Neuromuscular disease

Where it is discussed

Tranexamic acid

BNF entry for Tranexamic acid · Stand-alone drug page

Mechanism

Antifibrinolytic blocking lysine binding sites on plasminogen.

Uses

Haemorrhage in trauma, menorrhagia, post-partum haemorrhage, surgical bleeding.

Dosing

  • Tranexamic acid - IV (e.g. 1 g) or nebulised.
    Respiratory: Emergencies
  • Tranexamic acid Haemoptysis | e.g. 1 g IV, or nebulised.
    Respiratory: Emergencies
  • Tranexamic acid 1 g IV over 10 minutes (then 1 g over 8 hours) - in trauma within 3 hours and obstetric haemorrhage. Not in GI bleeding (no benefit, more clots).
    Haematology: Emergencies
  • Tranexamic acid 1 g IV over 10 min, then 1 g over 8 h | Trauma (within 3 hours), obstetric haemorrhage, surgery; not GI bleeding.
    Haematology: Emergencies
4 more dose entries from the chapters

Side effects

Nausea, diarrhoea, seizures at high doses, thrombotic events.

Interactions

Combined oral contraceptives increase thrombosis risk.

Special advice

Early administration is critical in trauma; reduce in renal impairment; avoid in active thromboembolic disease.

More from the textbook: uses, cautions and other points

Where it is discussed

Trazodone

BNF entry for Trazodone · Stand-alone drug page

Mechanism

Serotonin antagonist and reuptake inhibitor.

Uses

Depression, anxiety, insomnia and agitation in dementia (off-label).

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Sedation, postural hypotension, priapism, QT prolongation.

Interactions

MAOIs, serotonergic drugs, CYP3A4 inhibitors.

Special advice

Warn about priapism; caution in cardiac disease.

More from the textbook: uses, cautions and other points

Where it is discussed

Trimethoprim

BNF entry for Trimethoprim · Stand-alone drug page

Mechanism

Folate antagonist inhibiting dihydrofolate reductase.

Uses

Urinary tract infection, prophylaxis.

Dosing

2 more dose entries from the chapters
  • 3. A 52-year-old woman with RA on methotrexate 15 mg weekly is prescribed trimethoprim for a UTI. She develops mouth ulcers and a sore throat. Answer: Methotrexate toxicity (myelosuppression) from an antifolate interaction.
    Rheumatology Anatomy Physiology Pharmacology
  • 2. A 58-year-old woman on methotrexate 15 mg weekly for RA is prescribed trimethoprim for a UTI. A week later she has mouth ulcers, fever and bruising. Neutrophils 0.3, platelets 35. Answer: Methotrexate toxicity (marrow suppression) from a trimethoprim interaction.
    Rheumatology: assessment, investigations and drugs

Side effects

Nausea, rash, hyperkalaemia, raised creatinine, folate deficiency.

Interactions

Methotrexate (severe marrow toxicity), ACE inhibitors and spironolactone (hyperkalaemia), warfarin, phenytoin.

Special advice

Avoid in first trimester; check urine culture; adjust in renal impairment.

More from the textbook: uses, cautions and other points
  • Find and stop the cause: AKI, CKD, ACE inhibitors, ARBs, spironolactone, trimethoprim, potassium supplements, rhabdomyolysis, DKA, adrenal insufficiency.
    Cardiology: Cardiology Emergencies
  • Heparin , ACE inhibitors, ARBs, spironolactone, trimethoprim | Hyperkalaemia
    Endocrine: Anatomy Physiology and Pharmacology
  • Drugs: ACE inhibitors, ARBs, spironolactone and eplerenone, heparin (which inhibits aldosterone production), NSAIDs, ciclosporin and tacrolimus. Trimethoprim and amiloride cause a similar picture by blocking the sodium channel.
    Endocrinology: Adrenal Disease
  • Folate | Jejunum | Stores last only about 4 months. Deficiency - poor diet, alcohol, coeliac disease, pregnancy, haemolysis, drugs ( methotrexate , trimethoprim, phenytoin, sulfasalazine).
    Gastroenterology: Anatomy Physiology Pharmacology
  • Methotrexate (weekly, oral or subcutaneous) - mainly Crohn's; folic acid on another day; FBC, LFTs and U&E monitoring; teratogenic (effective contraception, for men and women); pneumonitis; avoid trimethoprim and co-trimoxazole (marrow suppression); "once weekly" prescribing errors are a known cause of death.
    Gastroenterology: Anatomy Physiology Pharmacology
  • Some drugs block creatinine secretion by the tubules ( trimethoprim , cimetidine, some HIV drugs such as dolutegravir) → creatinine rises without a true fall in GFR.
    Renal: Anatomy, Physiology and Pharmacology

Where it is discussed

V

Valaciclovir

BNF entry for Valaciclovir · Stand-alone drug page

Mechanism

Prodrug of aciclovir; inhibits viral DNA polymerase.

Uses

Herpes zoster, genital herpes, cold sores, CMV prophylaxis.

Dosing

  • First episode - aciclovir 400 mg three times daily for 5 days (or valaciclovir 500 mg twice daily), started within 5 days or while new lesions are forming; saline bathing, analgesia, topical lidocaine; catheter (suprapubic) for retention.
    Gynaecology: Sexual health
  • Oral antiviral within 72 hours of rash onset - aciclovir 800 mg five times a day , valaciclovir or famciclovir for 7 days - for people over 50 , immunocompromised, non-truncal involvement (face, neck, limbs, genitals), moderate or severe pain or rash, or eczema. Ophthalmic and immunocompromised patients - treat even after 72 …
    Dermatology: Skin infections and infestations
  • Aciclovir / valaciclovir / famciclovir | Shingles within 72 hours (aciclovir 800 mg five times daily, 7 days); severe HSV; eczema herpeticum.
    Dermatology: Skin infections and infestations
  • Oral antiviral within 72 hours of rash onset (or later if new lesions are still appearing) - aciclovir 800 mg five times daily or valaciclovir 1 g three times daily for 7 days.
    Ophthalmology: Red emergencies
3 more dose entries from the chapters
  • Aciclovir 800 mg five times daily or valaciclovir 1 g three times daily | Herpes zoster ophthalmicus for 7 days, within 72 hours.
    Ophthalmology: Red emergencies
  • Treatment - oral aciclovir 800 mg five times daily or valaciclovir 1 g three times daily for 7 days, ideally within 72 hours of the rash (NICE CKS) - for people over 50, immunosuppressed people, non-truncal shingles (face, eyes, limbs, perineum), moderate or severe pain or rash; any time for ophthalmic zoster or …
    ID: Viral, fungal and parasitic infections
  • Valaciclovir | Shingles (1 g three times daily for 7 days within 72 hours), genital herpes; post-exposure prophylaxis for VZV in pregnancy (days 7–14).
    ID: Viral, fungal and parasitic infections

Side effects

Nausea, headache, confusion in older adults, renal impairment, thrombotic microangiopathy at high dose.

Interactions

Nephrotoxic drugs; probenecid raises levels.

Special advice

Hydrate well; adjust in renal impairment; start within 72 hours of zoster rash.

More from the textbook: uses, cautions and other points
  • Aciclovir or valaciclovir plus prednisolone .
    Neurology: Neuromuscular disease
  • Aciclovir / valaciclovir | Ramsay Hunt syndrome (with prednisolone).
    Neurology: Neuromuscular disease
  • Not immune - oral antiviral prophylaxis (aciclovir or valaciclovir) from day 7 to day 14 after exposure (UKHSA); VZIG is reserved for some cases.
    Obstetrics: Medical Problems
  • Cytomegalovirus (CMV) | The commonest congenital infection ; a leading cause of sensorineural hearing loss in children, also microcephaly, learning disability. Often from young children's saliva and urine - hand hygiene, don't share cutlery. Specialist treatment (valaciclovir) in some first-trimester infections.
    Obstetrics: Medical Problems
  • Ramsay Hunt syndrome (VZV of the geniculate ganglion) — painful ear, vesicles in the ear canal or palate, LMN facial palsy, often hearing loss and vertigo — aciclovir or valaciclovir plus prednisolone ; worse prognosis than Bell's.
    ENT Anatomy Physiology
  • Ramsay Hunt syndrome (herpes zoster oticus) - vesicles in the ear canal or on the palate , severe ear pain, facial palsy, often hearing loss and vertigo. Worse prognosis than Bell's. Treat with prednisolone plus valaciclovir or aciclovir within 72 hours.
    ENT: Emergencies

Where it is discussed

Valsartan

BNF entry for Valsartan · Stand-alone drug page

Mechanism

Angiotensin II receptor blocker.

Uses

Hypertension, heart failure, post-MI.

Dosing

Side effects

Dizziness, hyperkalaemia, renal impairment, angioedema rare.

Interactions

NSAIDs, potassium-sparing diuretics, ACE inhibitors, lithium.

Special advice

U&E after starting; avoid in pregnancy; used with sacubitril in heart failure (never with ACE inhibitor).

More from the textbook: uses, cautions and other points

Where it is discussed

Vancomycin

BNF entry for Vancomycin · Stand-alone drug page

Mechanism

Glycopeptide inhibiting cell-wall synthesis.

Uses

MRSA infection, endocarditis, C. difficile (oral), severe Gram-positive infection with penicillin allergy.

Dosing

4 more dose entries from the chapters

Side effects

Nephrotoxicity, ototoxicity, red man syndrome, neutropenia.

Interactions

Aminoglycosides, loop diuretics increase toxicity.

Special advice

IV: slow infusion and trough monitoring; oral not absorbed and used only for C. difficile.

More from the textbook: uses, cautions and other points

Where it is discussed

Varenicline

BNF entry for Varenicline · Stand-alone drug page

Mechanism

Partial agonist at nicotinic alpha-4 beta-2 receptors.

Uses

Smoking cessation.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Nausea, abnormal dreams, insomnia, headache; neuropsychiatric events reported.

Interactions

Few; alcohol tolerance may reduce.

Special advice

Start 1–2 weeks before quit date; take after food; report mood changes.

More from the textbook: uses, cautions and other points
  • Stop smoking - the only measure (with oxygen in selected people) proven to slow decline and improve survival. Offer behavioural support plus drugs (NRT, varenicline where available, bupropion). E-cigarettes are a less harmful alternative to smoking.
    Respiratory: Airways Disease
  • Smoking cessation | NRT (combination patch plus short-acting form), varenicline where available, bupropion; with behavioural support.
    Respiratory: Airways Disease
  • Action - stop-smoking support (varenicline, cytisine, NRT, e-cigarettes), statins, diabetes management, healthy lifestyle programmes; consider switching antipsychotics with fewer metabolic effects; metformin can limit antipsychotic weight gain.
    Psychiatry: assessment, treatment and the law
  • Varenicline / cytisine / NRT | Stop-smoking treatment - vital in severe mental illness; check clozapine and olanzapine levels when smoking changes.
    Psychiatry: assessment, treatment and the law
  • Varenicline (partial nicotine receptor agonist) -12 weeks; available again in the UK (reformulated); nausea, vivid dreams.
    Psychiatry: Alcohol, drugs and addiction
  • Varenicline / cytisine | Smoking cessation - most effective single drugs.
    Psychiatry: Alcohol, drugs and addiction

Where it is discussed

Venlafaxine

BNF entry for Venlafaxine · Stand-alone drug page

Mechanism

Serotonin and noradrenaline reuptake inhibitor.

Uses

Depression, generalised anxiety, panic, social anxiety.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Nausea, sweating, hypertension, insomnia, sexual dysfunction, discontinuation symptoms.

Interactions

MAOIs, serotonergic drugs, QT-prolonging drugs; cimetidine raises levels.

Special advice

Monitor BP; taper slowly; dangerous in overdose; avoid in uncontrolled hypertension.

More from the textbook: uses, cautions and other points

Where it is discussed

Verapamil

BNF entry for Verapamil · Stand-alone drug page

Mechanism

Non-dihydropyridine calcium channel blocker.

Uses

Angina, SVT, AF rate control, hypertension, cluster headache prophylaxis.

Dosing

4 more dose entries from the chapters

Side effects

Constipation, bradycardia, heart block, ankle oedema, hypotension.

Interactions

Beta-blockers (heart block), digoxin levels rise, statins, ciclosporin.

Special advice

Avoid in heart failure with reduced EF, WPW with AF and with IV beta-blockers.

More from the textbook: uses, cautions and other points

Where it is discussed

Vigabatrin

BNF entry for Vigabatrin · Stand-alone drug page

Mechanism

Irreversibly inhibits GABA transaminase.

Uses

Refractory focal epilepsy, infantile spasms.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Visual field defects (often permanent), drowsiness, depression, weight gain.

Interactions

Phenytoin levels fall.

Special advice

Visual field monitoring; use specialist guidance; avoid if prior visual field defect.

More from the textbook: uses, cautions and other points
  • GABA | Main inhibitory transmitter in the brain | Benzodiazepines , barbiturates, Z-drugs, propofol, alcohol enhance GABA-A; baclofen acts on GABA-B; valproate and vigabatrin raise GABA; withdrawal of these → seizures
    Neurology: Anatomy, Physiology and Pharmacology
  • … oxcarbazepine), block calcium channels (ethosuximide - T-type, for absence; gabapentin, pregabalin), boost GABA (benzodiazepines, phenobarbital, valproate, vigabatrin), bind SV2A (levetiracetam, brivaracetam), or block glutamate (perampanel, topiramate). Several act in more than one way.
    Neurology: Anatomy, Physiology and Pharmacology
  • Infantile spasms (West syndrome) | Babies; clusters of flexion spasms; hypsarrhythmia on EEG; developmental regression. Steroids or vigabatrin (tuberous sclerosis). Urgent
    Neurology: Epilepsy
  • Myoclonic | Levetiracetam or valproate (males). Avoid carbamazepine, oxcarbazepine, phenytoin, gabapentin, pregabalin, vigabatrin (they can worsen it)
    Neurology: Epilepsy
  • Tuberous sclerosis complex (TSC1 or TSC2) | Ash-leaf macules , facial angiofibromas , shagreen patch, nail fibromas; epilepsy (infantile spasms - vigabatrin), learning disability, autism; cortical tubers; renal angiomyolipomas ; cardiac rhabdomyomas (infancy); lung LAM in women. Everolimus (mTOR inhibitor)
    Neurology: Spine and Sleep Disorders
  • … developmental regression ; EEG - hypsarrhythmia . Causes include tuberous sclerosis , HIE, genetic. Urgent (same-week) treatment - prednisolone (or ACTH) with vigabatrin ; vigabatrin first in tuberous sclerosis. Vigabatrin can cause visual field loss.
    Paediatrics: Neurology, bones and joints in children

Where it is discussed

W

Warfarin

BNF entry for Warfarin · Stand-alone drug page

Mechanism

Vitamin K antagonist inhibiting synthesis of clotting factors II, VII, IX and X.

Uses

Mechanical heart valves, AF with moderate or severe mitral stenosis, VTE (selected), antiphospholipid syndrome.

Dosing

  • Vitamin K + PCC Warfarin with major bleed | Vitamin K 5 mg IV plus prothrombin complex concentrate (dose by weight and INR).
    Gastroenterology: Gastroenterology Emergencies (Complete)
  • 5. An 80-year-old woman started on carbamazepine for trigeminal neuralgia is brought in confused. Sodium 119 mmol/L. She also takes bendroflumethiazide and warfarin; her INR has fallen to 1.4. Answer: Carbamazepine-induced hyponatraemia (worsened by the thiazide) and enzyme induction lowering warfarin effect.
    Neurology: Anatomy, Physiology and Pharmacology
  • Consider prophylactic anticoagulation when albumin is very low (e.g. under 20–25 g/L , or higher in membranous nephropathy) and bleeding risk is low - LMWH or warfarin; DOACs used in some units.
    Renal: Glomerular Disease
  • Major bleeding - stop warfarin; IV vitamin K 5–10 mg ; prothrombin complex concentrate (FFP only if PCC is unavailable).
    Haematology: Anatomy Physiology and Pharmacology
4 more dose entries from the chapters
  • INR 5–8 with minor bleeding - stop warfarin; IV vitamin K 1–3 mg; restart when INR under 5.
    Haematology: Anatomy Physiology and Pharmacology
  • Warfarin: Prothrombin complex concentrate (PCC, e.g. 25–50 units/kg) plus IV vitamin K 5–10 mg . Recheck the INR after PCC.
    Haematology: Emergencies
  • Prothrombin complex concentrate 25–50 units/kg | Warfarin reversal (with vitamin K 5–10 mg IV); Xa inhibitor bleeding.
    Haematology: Emergencies
  • Fresh frozen plasma (FFP) | Bleeding with abnormal clotting (major haemorrhage, DIC); plasma exchange in TTP. Dose 15 mL/kg. Not for warfarin reversal (use prothrombin complex concentrate) and not routinely before procedures for mildly abnormal clotting
    Haematology: Haemoglobinopathies and Transfusion

Side effects

Bleeding, skin necrosis, teratogenicity, purple toe syndrome.

Interactions

Many: antibiotics, azoles, amiodarone, NSAIDs, alcohol raise INR; rifampicin, carbamazepine, St John's wort lower INR.

Special advice

INR monitoring; vitamin K and prothrombin complex concentrate for reversal; consistent vitamin K diet; alert card.

More from the textbook: uses, cautions and other points
  • Where drugs act - aspirin (COX-1), clopidogrel/prasugrel/ticagrelor (P2Y12), warfarin (vitamin K-dependent factors II, VII, IX, X), heparins (antithrombin), apixaban/rivaroxaban/edoxaban (Xa), dabigatran (thrombin), alteplase/tenecteplase (plasminogen).
    Cardiology: Anatomy Physiology and Pharmacology
  • Not for mechanical heart valves or moderate–severe mitral stenosis (use warfarin); caution with very low or very high body weight; avoid with antiphospholipid syndrome (triple positive).
    Cardiology: Anatomy Physiology and Pharmacology
  • Complications - AF, stroke (anticoagulation with warfarin in moderate–severe mitral stenosis), pulmonary hypertension.
    Cardiology: History and Examination
  • Anticoagulant prescriptions must state — indication , agent , dose , renal adjustment , interactions , duration and bleeding plan ; take particular care with mechanical valves (warfarin only — DOACs contraindicated), pregnancy (LMWH) and triple-positive antiphospholipid syndrome (warfarin).
    Cardiology: Presentations
  • Warfarin — INR; many interactions (antibiotics, azoles, amiodarone).
    Cardiology: Presentations
  • Invasive procedures and anticoagulation - follow local protocols; radial access often allows warfarin or DOACs to be continued or interrupted for less time.
    Cardiology Investigations

Where it is discussed

Z

Zopiclone

BNF entry for Zopiclone · Stand-alone drug page

Mechanism

Non-benzodiazepine hypnotic acting at GABA-A receptors.

Uses

Short-term insomnia.

Dosing

Side effects

Bitter taste, drowsiness, next-day impairment, confusion, dependence.

Interactions

Opioids, alcohol, CNS depressants; CYP3A4 inhibitors raise levels.

Special advice

Maximum 2–4 weeks; lower dose in older adults and hepatic impairment; warn about driving.

More from the textbook: uses, cautions and other points

Where it is discussed

End of chapter